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Abstract 
 
Autonomic function may help to localize and manage the epilepsies. It is likely that the 
mechanisms of Sudden Unexpected death in Epilepsy (SUDEP) involve autonomic 
disturbance and a better understanding of these might lead to measures that would 
help reduce the mortality in patients afflicted with epilepsy. In this thesis, I first provide 
a comprehensive literature review of the association between epilepsy and the 
autonomic nervous system. I then evaluate heart rate variability and other cardiac and 
endocrine parameters as indices of cardiac autonomic function to test three hypothesis; 
1) Changes in heart rate variability (HRV), can occur in the peri-ictal period during both 
(a) subclinical electrographic seizures and (b) clinically overt partial seizures, and can 
help to localise and lateralise the ictal discharge. 2) Intractable epilepsy can disrupt the 
heart rate variability and its circadian rhythm. 3) Epileptic seizures affect the serum 
concentration of the catecholamines and the electrolytes and that these changes could 
impact on the corrected QT interval. Subjects (n=207) with intractable epilepsy who 
were being evaluated with video-EEG telemetry for epilepsy surgery were recruited for 
this study.  
 
I found that subclinical seizures have no effect on the HRV. However, in overt partial 
seizures, HRV decreases, corrected QT is prolonged and plasma catecholamines 
increases. The reduction in HRV during seizures is not affected by the hemispheric or 
lobar location of the epileptic focus. However, in the interictal period, reduced HRV 
differs in left vs. right hemisphere, and in temporal vs. extratemporal areas. The diurnal 
pattern of HRV is not altered in epilepsy and the mean day HRV were significantly 
different from mean night HRV. The reduction in HRV is also associated with the 
following clinical factors: prolonged medical history of epilepsy, the cortical pathology 
itself, the nature of the seizures, higher seizure frequency and the antiepileptic drug 
treatment. The plasma electrolytes: Na, K
+
, Ca
2+
 and cardiac troponin are not affected 
after a seizure. However, plasma Mg
2+
 was seen to increase after a seizure. These 
abnormalities in autonomic control, particularly the reduction in HRV might be one 
contributory mechanism of Sudden Unexpected Death in Epilepsy (SUDEP). 
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Chapter 1  
 
Aims  
 
The general basis for this study is that in epilepsy significant changes occur in body 
physiology particularly the cardiovascular system, as a result of the activation of the 
autonomic nervous system. In this thesis, I studied a number of aspects of autonomic 
function ictally and interictally, to elucidate the nature and extent of the perturbation 
caused by epilepsy. The aims of the work were as follows:  
 
1. To provide a comprehensive literature review of the links between epilepsy and 
the autonomic nervous system (both the effects of epilepsy on the autonomic 
nervous system and the effects of the autonomic nervous system on epilepsy). 
 
2. To test three hypotheses:  
• Changes in heart rate variability (HRV), as an index of autonomic function 
can occur in the peri-ictal period during: (a) Subclinical electrographic 
seizures, (b) Clinically overt complex partial seizures, and can help to 
localise and lateralise the ictal discharge.  
 
• Intractable epilepsy can disrupt the heart rate variability and its circadian 
rhythm.  
 
• Epileptic seizures affect the serum concentration of adrenalin and 
noradrenalin, and the electrolytes (sodium, calcium, magnesium and 
potassium) and that these changes could impact on the corrected QT 
interval. 
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Chapter 2 
 
Literature Review: the links between epilepsy and the autonomic 
nervous system 
 
The first aim of this thesis was to provide a comprehensive review of the autonomic 
aspects of epileptic seizures and of epilepsy. Epileptic seizures are recurrent paroxysmal 
and unprovoked episodes of abnormal brain cortex electrical activity and result in a 
range of clinical symptoms that includes abnormal autonomic phenomena, sensory 
phenomena, involuntary movements, altered levels of consciousness, abnormalities of 
behaviour and cognitive function.  A wide range of autonomic features (some of which 
may be life threatening) occur during seizures and indeed some partial seizures are 
manifest only by autonomic symptoms or signs (Baumgartner et al. 2001; 
Panayiotopoulos 2007). These autonomic features are thought to be mediated by 
cortical discharges recruiting the  central autonomic network, pathways (Devinsky et al. 
1994).  The clinical range and significance of autonomic dysfunction during seizures are 
not fully understood and in some cases have been misdiagnosed as a primary disorder of 
the target organ such as seizure associated arrhythmias (Freeman et al. 1995).  
 
Autonomic changes during convulsive seizures have been studied, mainly in the artificial 
setting of electroconvulsive therapy and these studies have concentrated on the 
neurocardiac and neurorespiratory axis.  In these studies, an initial fall in the blood 
pressure (BP) without compensatory rise in heart rate (HR) was observed; this was 
followed by a subsequent rise and fall of the (BP) and (HR), the latter persisting well into 
the post ictal period. At the same time there was respiratory arrest (Brown et al. 1973; 
Mosier et al. 1957). After these pioneering studies, several investigators in recent times, 
have linked varied autonomic responses to epilepsy (Druschky et al. 2001; Faustmann et 
al. 1994; Frysinger et al. 1993; Massetani et al. 1997; Tomson et al. 1998); one intriguing 
possibility is that the autonomic dysfunction in partial epilepsy may be lateralised and 
that its occurrence will therefore assist in cerebral lateralisation or localisation of 
seizures. Autonomic changes during seizures may have other implications. Sudden 
Unexplained Death in Epilepsy (SUDEP) is an important cause of death in epilepsy 
occurring in as many as one in a hundred patients per year in severe epilepsy (Sander et 
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al. 1996). The mechanisms underpinning SUDEP are unknown, but it is possible that 
autonomic dysfunction plays an important role. Patients with seizure related autonomic 
changes may be particularly at risk of SUDEP but this question has yet to be extensively 
investigated (Surges et al. 2009c).  Heart rate variability (HRV) is a direct measure of 
autonomic influences on the heart. In non-epileptic patients, decreased HRV has been 
shown to be an independent predictor of cardiac arrhythmia and mortality, regardless of 
other risk factors (Ponikowski et al. 1996). While a large degree of variability is 
detrimental to efficient physiologic function too little variability is also pathological. HRV 
is a non invasive measure, that estimates the naturally occurring beat to beat variations 
in the heart rate; this is usually overlooked when the average heart rate is calculated 
(Kleiger et al. 2005). It is a useful method to evaluate the responsiveness and resilience 
of the heart. In most clinical applications, HRV is analysed by time and or frequency 
domain methods, the former is derived from measuring and calculating the differences 
in the normal to normal (NN) RR intervals  and the latter involves spectral analysis of 
normal to normal RR interval series (Malik 1996). Autonomic cardiovascular function and 
cardiac excitability are substantially modulated by electrolytes such as potassium, 
calcium and magnesium as well as by direct modulation of stress hormones. These 
parameters can be modified during and after seizures.  
 
An increase of potassium depresses the activity of the sinus node and leads to an 
increased excitability of ventricular myocytes due to a shift in the resting membrane 
potential. This increases the risk of ectopic cardiac excitation and arrhythmias. 
Moreover, a serum acidosis causes an increase in free calcium, leading to increased 
influx of calcium during cardiac action potentials, which could potentially lead to an 
increase in oxygen consumption. This seizure related changes in serum composition may 
favour the occurrence of threatening cardiac arrhythmias which possibly are linked to 
SUDEP. Also, cardiac injury related to seizures has been shown in some previous studies 
such as the occurrence of ST segment depression (Tigaran et al. 2003) and the presence 
of cardiac fibrosis in SUDEP patients (Natelson et al. 1998). In contrast to this, cardiac 
Troponin levels, a highly sensitive and specific biochemical marker of myocardial injury, 
remained unchanged following complex partial seizures in a small series of 
patients(Woodruff et al. 2003); cardiac muscle damage may however be more evident 
following tonic-clonic seizures. In addition to cardiac parameters, there are other 
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methods of measuring autonomic function. The autonomic skin response is a purely 
sympathetic phenomenon that remains lateralised to one side (Bannister et al. 1999)and 
it may be valuable in localising the seizure discharge focus in partial epilepsy. A variety of 
stimuli including electrical, can activate sweat glands cause production of sweat and a 
change in skin resistance in response to sympathetic cholinergic activation. There are 
limited studies on observations of the sympathetic skin response (SSR) in autonomic 
nervous system disorders (Bannister et al. 1988). Quantitative studies of skin resistance 
have methodological problems and poor sensitivity and specificity.  
 
There is no doubt that any part of autonomic nervous system function, affecting many  
physiological systems can be affected during epilepsy and because of the presumed 
hemispheric specialization, certain autonomic symptoms could provide both 
lateralization and localization data in the seizure onset zone. A thorough search for 
paroxysmal autonomic abnormalities could contribute to the diagnosis and management 
for epilepsy, in fact the commonly occurring peri-ictal tachycardia led to the 
development of seizure detection algorithms that are used during epilepsy 
monitoring(O'Donovan et al. 1995), though these are not without errors.  
 
So, why study autonomic functions in epilepsy? The rationale is two-fold. First, 
Autonomic function may help to localize, classify and manage the epilepsies accordingly; 
this research area has not been systematically explored. Second, it is likely that the 
mechanisms of SUDEP involve autonomic disturbance and a better understanding of 
these might lead to measures that would help reduce the mortality in patients afflicted 
with epilepsy.  
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2.1 Epilepsy 
 
Epilepsy remains one of the oldest documented neurological conditions. It affects 
approximately 0.5-1% of the population. In the developed world, there are 
approximately 40-70/100000 people per year who develop epilepsy. There is a higher 
incidence in the developing world (100-190/100000 people per year). The incidence of 
epilepsy is higher in the low socioeconomic group, and this and the higher incidence of 
parasitic infections probably account for the higher incidence in the developing world 
(Sander 2007). A definition of epilepsy should be simple and precise (Panayiotopoulos 
2007). Epilepsy is characterised by recurrent paroxysmal episodes of cerebral cortical 
dysfunction manifested by stereotyped alterations in behaviour. However, the response 
to a simple question, such as  “what is epilepsy?” may differ from physician to physician, 
between patient and physician and even from patient to patient (Engel et al. 2008). In 
trying to come out with a unified concept for the definition of epilepsy, epileptic seizures 
and epilepsy have been defined separately. This separation is recognised by the 
international league against epilepsy (ILAE) which has definitions for both: 
 
• Epileptic seizures are occurrence of transient signs and symptoms as a result of 
abnormal excessive and synchronous discharge of cortical neuronal activity. 
 
• Epilepsy on the other is defined according to the ILAE commission as   “A chronic 
condition of the brain characterised by an enduring propensity to generate and have 
epileptic seizures and by the neurobiological, cognitive, psychological and social 
consequences of this chronic condition.  
 
These ILAE definitions are not without controversy as is seen in the comments (Ahmed 
2005; Gomez-Alonso et al. 2005) related to the publication of the definitions (Fisher et 
al. 2005), but this is beyond the scope of this thesis. What is an essential feature of the 
definition is the emphasis on the presence of an intrinsic brain pathology (condition of 
the brain), which is still present (enduring propensity) even when seizures are not 
occurring (Engel et al. 2008). The neurobiological basis for epilepsy has been proposed 
to be: 1) alterations in cellular excitability, arising from abnormalities of mechanisms 
that affect membrane depolarisation and repolarisation, 2) a network defect, resulting 
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from abnormalities of neuronal integration and communication; such abnormal 
neuronal networks facilitates the aberrant generation and propagation of neuronal 
discharges. The clinical phenomenology of seizures in epilepsy results from the 
recruitment or dysfunction of distinct brain areas. These areas may be neighboring, but 
seizures can also propagate to distant brain areas including parts of the central 
autonomic network (CAN). The definitions for these brain regions in epilepsy are; 
 
• Irritative zone; the cortical area that generates the interictal spike. 
• Ictal onset zone; cortical area that generates ictal activity. 
• Epileptogenic lesion is the structural abnormality of the brain responsible for the 
seizures 
• Symptomatogenic zone is the region of the brain directly responsible for the first 
clinical symptoms. 
• Functional deficit zone is the area of the cortex that exhibits deficits that are non 
epileptic in origin. 
• And finally the epileptogenic zone which is the total region of the brain that must be 
removed to prevent seizure occurrence and symptomatology, and may include or 
overlap with all the above (Engel et al. 2008). 
 
2.2 Epilepsy and the Autonomic Nervous System 
 
The recruitment of the central autonomic network during seizure propagation is 
mediated by the extensive connections it has throughout the brain and brainstem and 
the presumed abnormality of neuronal networks in patients with epilepsy. Considering 
the extensive interconnection of the central autonomic network, it would be extremely 
surprising if widespread and localised abnormal and synchronised electrical discharge 
such as is seen in epilepsy occurred without some form of associated autonomic 
dysfunction. The dysfunction of autonomic nervous system associated with seizures, 
varies from subtle to gross alterations. In epilepsy, the signs of autonomic nervous 
system dysfunction are often overshadowed by the more apparent motor and higher 
cerebral effects of seizures, but autonomic disturbance is a common feature of many 
seizure types (Ansakorpi et al. 2000; Ansakorpi et al. 2002a). Altered autonomic activity 
in epilepsy has long been recognised and is mentioned in early texts. In an eighteenth 
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century (1769) text, there is a  description of a priest whose epileptic seizures were 
always preceded by the onset of  chest pain followed by nausea and vomiting (Uluc et al. 
2004), and chest pain mimicking acute coronary syndromes have been observed in 
patients with epilepsy by Devinsky (Devinsky et al. 1986) and it was thought to be due to 
abnormal cardiac autonomic responses during seizures. Autonomic activity in epilepsy 
was recognised by Gower’s but it was Wilder Penfield and colleagues who most 
thoroughly studied autonomic function by precipitating and observing autonomic 
symptoms through cortical electrical stimulation experiments (Penfield et al. 1957). 
Signs and symptoms attributable to the autonomic nervous system are present in the 
symptom complex of all generalized tonic- clonic seizures and most complex partial 
seizures and may occur as the only manifestation of a simple partial seizure, the majority 
of these being referred to the epigastrium (Wannamaker 1985).  
 
When paroxysmal events predominantly cause recurrent stereotypical autonomic 
symptoms affecting the cardiovascular, respiratory, genitourinary, and digestive systems 
or pilomotor function of skin and integument and the pupillary sphincters, they are 
often referred to as autonomic seizures. These seizures have an ictal focus in the cortex 
that involves the central autonomic network. In other seizures the autonomic symptoms  
tend to occur in the post event or later in the ictal period (Goodman et al. 2008). 
Occasionally the symptom complex of a patient with epilepsy may include palpitations 
during the seizures (particularly during the aura) or peri-ictally and yet without evidence 
of ictal tachycardia. Whether these patients are describing a change in cardiac 
contractility or just an abnormal perception of stimuli remains unknown. The peripheral 
autonomic nervous system is under the influence of the cerebral neocortex through the 
integrated activity of the central autonomic network (Barron et al. 1993) and epilepsy 
has a variety of effects on the autonomic nervous system (Figure 1), during “Partial” and 
“Generalized” epilepsy and these responses which remain largely stereotypical in both 
epilepsy types, have a final common pathway for autonomic symptoms from the 
cerebral neocortex (Figure 2). 
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Figure 1   Illustration of how cortical activity may cause ictal autonomic changes. 
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Figure 2 Illustration of autonomic propagation from the cortex to the brainstem cardiorespiratory 
centres’. There exist reciprocal connections between the limbic system and cortical epileptic foci. The 
central autonomic network which exerts modulating influence on the peripheral autonomic system is 
directly influenced by the limbic system and the epileptic foci. This scheme of hierarchal control is much 
more complex than presented here.  
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To understand the relation between epilepsy and the autonomic nervous system, I will 
discuss three themes: 
• The effects of epilepsy on the autonomic nervous system (Section 2.2.1)  
• The effects of the autonomic nervous system on epilepsy (Section 2.2.2)  
• The clinical consequences of this interaction (Section 2.2.3)  
2.2.1 The effects Epilepsy has on the Autonomic Nervous System  
Autonomic changes in Generalized Tonic Clonic Seizures 
During generalized tonic clonic seizure, massive autonomic changes occur 
predominantly during the ictal period. Autonomic changes in generalized seizures have 
been documented through monitoring of general body physiology following 
experimental electroconvulsive therapy. In electroconvulsive therapy, earlier 
researchers  were able to describe a specific pattern of increase in the heart rate, blood 
pressure and intravesical pressure at the onset of a generalized tonic-clonic seizure, 
peaking  at the end of the tonic phase and returning progressively to pre seizure levels at 
the end of the clonic phase (Mosier et al. 1957; Panayiotopoulos 2007). Whilst cardiac 
autonomic indices increase, respiratory rate falls suddenly, patients experience apnoea 
and respiratory arrest, which recovers during the clonic phase of a generalized tonic 
clonic seizure.  In some cases, however, these changes continue into and throughout the 
post ictal phase. These changes are usually not associated with other forms of 
generalized seizures such as myoclonic, atonic and absence seizures. The acute 
autonomic response reflects acute vagal activation followed by excessive 
sympathoadrenal activation; these are independent of the associated excessive 
muscular activity.  
 
These autonomic responses can be complicated by arrhythmias and neurogenic 
pulmonary edema, the mechanism of which is said to be a consequence of excessive 
sympathoexcitation of the pulmonary vascular bed. This causes an increase in 
pulmonary vascular pressure which in contrast to the associated transient increase in 
systemic vascular pressure, is independent of the number of seizures and persists for a 
much longer time. Fatal arrhythmias complicating electroconvulsive induced seizures 
have been prevented by the use of assisted ventilation with 100% oxygen (Bennaroch 
1997). It is not surprising that sympathetic-mediated neurogenic pulmonary edema 
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occurring during generalized tonic clonic seizures has been suggested to be a cause of 
SUDEP, although direct evidence is lacking (Langan et al. 2005; Tomson et al. 2008). 
Nevertheless, there is a strong association of SUDEP with  generalized tonic-clonic 
seizures, which increases the risk of SUDEP by as much as 4.4% per tonic-clonic seizure 
in a year when compared to other presumed risks (Surges et al. 2010a). Surges et al in 
this study also confirmed detrimental cardiovascular autonomic effects to occur more 
frequently during generalized tonic-clonic seizures. Generalized epilepsy is commonly 
accompanied by urinary incontinence which is sensitive but not specific to generalized 
tonic seizures. Urine loss is seen in the clonic phase of generalized tonic clonic seizures 
when there is generalized relaxation of the vesical sphincter particularly the external 
component and therefore does not occur in the period of increased intravesical 
pressure. This only occurs when there is urine in the bladder, coincident with the 
occurrence of the seizure. In generalized epilepsies, absence seizures may be associated 
with ictal passage of urine. In children with absence epilepsy the passage of urine may 
occur due to high intravesical pressures (Baumgartner et al. 2001; Sinclair et al. 2007). 
 
Generalized tonic clonic status epilepticus is associated with prolonged bilateral 
synchronous brain electrical activity that excites the central autonomic network 
resulting in  a massive sympathetic activation and a host of autonomic symptoms 
including hypertension, tachycardia, hyperglycaemia, neurogenic pulmonary edema, and 
an abnormal thermoregulatory response. These are mediated through a neurogenic 
release of catecholamines, insulin and glucagon. Arterial hypertension is associated with 
increased intracranial pressure and a simultaneous parasympathetic discharge all of 
which can induce fatal cardiac arrhythmias. Hypotension eventually develops during the 
refractory stage of status epilepticus because of the massive metabolic overload, down 
regulation and desensitization of the catecholamine receptors. Cerebral auto-regulation 
which is under autonomic reflex control also becomes dysfunctional creating  pressure 
dependent cerebral blood flow, which as hypotension persists, may result in cerebral 
ischemia (Bennaroch 1997). In addition to the above, several other symptoms 
attributable to the autonomic system occur in generalised tonic clonic seizures; these 
are tabulated below (Table 1) and are illustrated in the classic monograph of Gastaut 
and Broughton (Figure 3). 
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Table 1   Autonomic signs in different body systems during GTCS 
 
System Effects 
 
Cardiorespiratory 
 
Increase in heart rate and blood pressure, Hypoventilation with 
apnoea and hypoxia 
 
Genitourinary 
 
Increase in intravesical pressure culminating in urinary incontinence 
in the clonic phase. 
 
Pupils 
 
Pupils dilate become unresponsive to light and some patients may 
develop hippus. Miosis is extremely rare. 
 
Skin 
 
Skin colour changes cyanosis with apnoea pallor in the immediate 
post ictal phase and piloerection and sweating. 
 
Glandular secretion 
 
 Hypersalivation, Tracheobronchial hypersecretion and marked 
sweating. 
 
 
 
 
 
 
 
 
Figure 3 Figure taken from the Classic monograph of Gastaut and Broughton showing the autonomic 
changes seen in generalised tonic clonic seizures. Source: A clinical Guide to Epileptic Syndromes and Their 
Treatment 2
nd
 Edition. C. Panayiotopoulos, 2007. 
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Autonomic Changes during Partial Seizures 
This form of epilepsy is associated with a variety of auras and signs that clearly indicate 
the involvement of the autonomic nervous system by epileptic activity. Paroxysmal 
activity arising from the amygdalo-hippocampal, orbitofrontal, opercula, cingulate and 
anterior frontopolar regions can produce various autonomic manifestations. The 
majority of these areas are a part of the limbic system and by virtue of their extensive 
connections with the central autonomic centres including the hypothalamus, medulla 
and spinal cord, can affect the peripheral sympathetic and parasympathetic autonomic 
outflows (see figure 5 and 6). Several old stimulation and observational studies helped 
to delineate the localisation of cortical discharges and autonomic function. Jasper and 
Penfield observed that autonomic signs during partial epilepsy vary and depend on the 
brain region involved but were not correlated with the pattern of the  
electroencephalogram (EEG) e.g. slow or fast rhythmic spike wave discharges (Penfield 
et al. 1957). After Penfield’s characterisation of autonomic function and brain areas, Van 
Buren, demonstrated, in  a series of experiments, using both spontaneous and induced 
attacks that bradycardia, reduction in skin resistance, increased oesophageal activity and 
apnoea can occur at the onset of partial epilepsy (Van Buren et al. 1961).  
 
Following this, Van Buren, again used stimulation experiments to show a strong 
correlation of the involvement of the amygdala and neocortical temporal lobe with the 
autonomic nervous system (Van Buren 1961). Later experiments measured the latency 
to the development of autonomic cardiac symptoms after stimulation of specific cortical 
areas and found that, on stimulation of the amygdala, some had short latencies, whilst 
others had much longer latencies to the onset of cardiac symptoms. When prolonged 
the implication is that other cortical areas were being recruited (Lathers et al. 1982; 
Lathers et al. 1987). Stimulation and ablation experiments have also demonstrated that 
autonomic function is related to activity in the septal area, preoptic area and the 
hypothalamus which are modulated by the limbic system structures in the temporal 
lobes (Lathers et al. 1982). The temporal lobe structures, amygdala and hippocampus 
have a role in modulating hypothalamo-pituitary secretions.  Epileptic activity related to 
these areas may therefore cause clinically recognizable peripheral autonomic symptoms. 
The amygdala stimulates and the hippocampus inhibits pituitary ACTH release. When 
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both act together they increase the release of growth hormone and thyroid hormone 
releasing hormone from the pituitary. In stimulation experiments it has been found that 
the amygdala alone increases hypothalamic gonadotropins and prolactin secretion in 
humans (Lathers et al. 1982). It is therefore not surprising for a number of sexual 
function disorders to be present in chronic epilepsy patients (De Vincentiis et al. 2008; 
Demerdash et al. 1991; Hilz 2008; Kuba et al. 2006; Luef 2008; Zelena et al. 2007). 
Autonomic function in partial seizures can be more easily characterised than autonomic 
function in generalised tonic clonic seizures. The systems most commonly affected are 
the cardiovascular system and the gastrointestinal system. Alterations that occur in the 
respiratory system, the genitourinary, the pupils and the skin and integument are not 
uncommon. It is likely that a partial seizure will cause significant disruption to autonomic 
function only when the ictal discharge propagates to areas of the brain that subserves 
the central autonomic network, and this is one of the topics explored in this thesis. 
Autonomic symptoms occurring in partial seizures are usually isolated and restricted to 
particular organ systems and in some cases are  useful in the diagnostic assessment such 
as the epigastric rising sensation commonly described by patients with mesial temporal 
lobe epilepsy (Goodman et al. 2008). The occurrence of autonomic phenomena, 
especially cardiac related autonomic dysfunction during epilepsy, may result in 
difficulties in diagnosis, particularly in differentiating syncope from epilepsy. The rest of 
this section is devoted to autonomic signs in partial epilepsy categorised by the end 
organ. 
 
Autonomic signs of the eye in partial epilepsy 
Autonomic symptoms in epilepsy involving the eye commonly affect the pupils which 
contains effectors subserved by the autonomic nervous system. Bilateral pupillary 
dilatation has been described in both partial and generalised seizures. Unilateral 
pupillary dilatation also occurs but has no significance in lateralising the seizure in focal 
epilepsy syndromes. Sustained pupillary dilatation and hippus (rhythmic contracting and 
dilating pupils) frequently occur in generalised epilepsy (Panayiotopoulos 2007). The 
other autonomic effector in the eye is the lacrimal gland involved in tear generation. 
Ictal crying  has been occasionally reported in the symptomatology of temporal lobe 
epilepsy (Fogarasi et al. 2007; Hogan et al. 2006; Kutlu et al. 2005); crying is a common 
symptom of psychogenic non epileptic attacks(Bergen et al. 1993). Apart from being an 
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ictal manifestation, crying has been recently described to be a precipitant for 
seizures(Yamamoto et al. 2007). This may be an instance where stimulation of the 
autonomic nervous system results in epileptic seizures. However crying is a 
parasympathetic response and it is more usual for the sympathetic arm of the nervous 
system to modify the occurrence of seizures (Nagai et al. 2004). 
 
Autonomic manifestations of the cardiovascular system in partial epilepsy 
Seizure induced autonomic dysfunction of the cardiovascular system is thought to be 
possibly one of the major factors underpinning the excessive mortality of patients with 
epilepsy compared to the general population. Mortality in epilepsy includes seizure 
related deaths, accidents and physical injury and the sudden unexpected death 
syndromes (SUDEP). There is evidence from experimental animal models that intense 
sympathetic stimulation of the heart can result in subtle cardiac lesions; such lesions 
have been found in SUDEP patients and have been hypothesized to act as a nidus for 
fatal arrhythmias after sympathetic stimulation. In addition to these chronic effects 
autonomic dysfunction during seizures can have an acute effect on the heart. Several 
abnormal rhythms occur in epilepsy and include; Atrial premature beats, paroxysmal 
supraventricular tachycardia, enhanced sinus arrhythmia, acceleration and deceleration 
of heart rate, atrioventricular conduction blocks of various degrees, asystole and 
ventricular ectopies (Blumhardt et al. 1986; Howell et al. 1989; Opherk et al. 2002a; 
Tigaran et al. 2002; Zijlmans et al. 2002).  Tachyarrhythmia’s and hypertension are the 
most common cardiac related autonomic symptoms in partial and generalized seizures 
(Keilson et al. 1989). Sinus tachycardia occurs most frequently in 60-100% of epilepsy 
patients during seizures, preceding, following or coinciding with the electrographic 
discharge (Di et al. 2004; Leutmezer et al. 2003). The clinical significance of this for 
SUDEP remains unclear; some authors have suggested that it is a possible diagnostic tool 
to be used in non epileptic seizures (Opherk et al. 2002b). Tachycardia as a symptom of 
seizures is particularly associated with temporal lobe seizures (Keilson et al. 1989). 
Certain features such as dystonic posturing, automatisms, automatic behaviour and 
prolonged duration of seizures are associated with higher incidence of cardiac 
tachyarrhythmia (Garcia et al. 2001; Nei et al. 2000). In a study that assessed 107 
seizures, recording the EEG and the ECG simultaneously, more than 83 % showed 
tachycardia, defined as the heart rate increasing greater than 10 beats per minute from 
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the base line during the ictal phase (Schernthaner et al. 1999). Several authors have 
tried to link ictal tachyarrhythmia with specific anatomical sites (Leutmezer et al. 2003; 
Weil et al. 2005) and the left mesial temporal lobe focus has been the frequently cited 
anatomical region for the induction of tachyarrhythmia in seizures. However, these 
studies used extra cranial scalp electrodes and when intracranial depth electrodes were 
used, there was no significant laterality in tachycardia from the temporal lobe seizures, 
and furthermore the involvement of the amygdala could not explain the source of 
increased heart rate. It is rather the pattern of ictal spread that is important in 
generating the ictal tachycardia (Epstein et al. 1992). Ictal sinus tachycardia also occurs 
in gelastic seizures due to hypothalamic harmatomas, which also causes hypertension 
and peripheral vasoconstriction in addition to the tachycardia (Cerullo et al. 1998).  
 
In childhood epilepsy, available studies on ictal tachycardia are limited, but it has been 
observed that there is a higher percentage of tachycardia in childhood complex partial 
seizures of temporal lobe origin when compared to those in adults (Mayer et al. 2004). 
Angina like pain which may be as a result of indirect autonomic influences has been 
described in the literature as a cardiac manifestation of localization related seizures. 
Devinsky described five such patients of which more than half were admitted to 
coronary care units based on the clinical presentation of sudden onset radiating chest 
pain associated with sweating , dyspnoea and nausea, very typical of acute myocardial 
ischemia but these were accompanied by tell tale signs of complex partial seizure, 
generalized flushing, eye blinking and pupillary dilatation. There was no evidence of 
myocardial ischemia such as elevated cardiac enzymes, and these patients responded to 
antiepileptic drugs instead of anti-angina drugs (Devinsky et al. 1986). Interestingly in 
one case the symptoms were similar to the symptoms of phaechromocytoma which 
further supports the presumed dysfunction of the autonomic nervous system in 
epilepsy. Experiments in animal models of epilepsy demonstrate alterations in 
autonomic inputs to the heart; the cardiac autonomic alterations that were observed in 
this experiment always occurred before any changes could be seen on the scalp 
electroencephalograph (Lathers et al. 1987). Abnormal cardiac autonomic activity is 
observed in the interictal state as well and in some studies, the heart rate variability was 
consistently reduced in patients with temporal lobe epilepsy in the interictal state 
irrespective of the antiepileptic drug used (Ansakorpi et al. 2000; Ansakorpi et al. 
 28
2002b). The heart rate variability can be calculated using R-R intervals analysis from 
simultaneously recorded ECGs, during seizures to determine the predominant 
autonomic input to the heart. In one such analysis it was found that parasympathetic 
activity declined rapidly in the 30 seconds before the seizure whilst the sympathetic 
activity increased exponentially peaking just before the seizure (Toichi et al. 1998). Ictal 
Bradycardia is less common during seizures (Howell et al. 1989). However, occasionally 
the bradyarrythmias may be severe enough to cause sinus arrest and asystole. Cardiac 
asystole is infrequent but there are several recent case reports of this phenomenon 
(Carinci et al. 2007; Howell et al. 1989; Mascia et al. 2005; Novy et al. 2009; Rugg-Gunn 
et al. 2000; Schuele et al. 2008; So et al. 2007; Strzelczyk et al. 2008; Surges et al. 
2009b). There are also  several cases where patients with frequent epileptic induced 
bradyarrythmias have had a cardiac pacemaker inserted (Kiok et al. 1986). Ictal asystole 
and  bradycardia  has been found to be associated with temporal lobe epilepsy 
(Constantin et al. 1990). The left hemisphere is presumed to be the most common site of 
origin of ictal related bradycardia (Tinuper et al. 2001).    
 
There is therefore no doubt that altered cardiac function may occur in epilepsy. The 
disturbances in function are presumed to be due to disturbances of the central 
autonomic network, the peripheral autonomic nervous system and the heart itself. The 
mechanism of these imbalances of sympathetic and parasympathetic function is still not 
clearly understood, and it is not clear whether it is a pure epileptogenic related 
phenomenon or other factors such as drug use and withdrawal or the heightened 
peripheral muscular activity also contribute. 
 
Autonomic manifestations of the respiratory system in partial epilepsy  
Seizures affect the control of respiration as well. Signs of respiratory autonomic 
dysfunction during partial epilepsy are common. Descriptions of ictal autonomic 
respiratory phenomena have been made since the middle of the 19
th
 century. Reynolds 
was the first to mention in 1861, that the breathing of some epileptic patients during 
seizures became irregular. Later in 1885, Gower’s published descriptions of dyspnoea 
and respiratory spasm which he called choking fits of adults. Subsequently several 
descriptions of respiratory related autonomic phenomena during seizures have  been 
mentioned in the literature including apnoea, stridor, coughing, postictal nose wiping 
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and hyperventilation (Baumgartner et al. 2001). Automaticity of respiration is controlled 
by the central respiratory oscillators located in the lower brain stem. These brainstem 
oscillators are under the influence of forebrain cortical areas: hippocampal formation; 
anterior cingulate gyrus; insula; basal forebrain and the motor strip area. These 
structures are extensively involved in localization related epilepsy and partial seizures 
arising from the cortex in these forebrain areas could affect respiration. In early 
stimulation experiments, activation of  these areas resulted in irregular breathing 
patterns, end expiratory apnoea, and hyperpnoea (Van Buren 1958). Temporal lobe 
epilepsy by virtue of the anatomic location of the epileptogenic lesion is commonly 
associated with apnoea and oxygen desaturations (Ives et al. 1996) and in one of the 
patients consented for this study, oxygen desaturations were recorded with ictal events.  
 
The mechanism and clinical correlate of the desaturations are not entirely clear but it 
may be related to the inhibition of ventilation by the forebrain structures described 
above (which include the temporal lobe) and in some cases could result in severe 
compromise of the cardiorespiratory system (Baumgartner et al. 2001). Apnoea during 
partial epilepsy may be the pulmonary equivalent of the ictal bradycardia syndrome. 
Apnea as a manifestation of epilepsy is almost always accompanied by muscle jerks, eye 
twitches, and other tonic body movements without bradycardia in contrast to the 
apnoea that is associated with bradycardia. It is however not difficult to appreciate 
because the cardiopulmonary reflexes will initiate a tachycardia when apnoea occurs 
(Kara et al. 2003). Nevertheless, bradycardia has still been described together with 
apnoea during partial seizures (Coulter 1984; Fenichel et al. 1980). Hyperventilation 
does not readily occur in the autonomic semiology of seizures however it is prominent in 
complex partial seizures in which fear or panic occurs as part of the symptom complex. 
Since it occurs frequently in psychogenic nonepileptic attacks, careful evaluation using 
video and ambulatory EEG, might help in identifying hyperventilation with true partial 
epilepsy (Baumgartner et al. 2001). 
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Autonomic manifestations of the gastrointestinal system in partial epilepsy  
Visceral signs have been long described with partial seizures, probably first described by 
Morgagni in an elderly patient who had paroxysms of right upper quadrant pain, nausea 
and vomiting (Freeman et al. 2008). Whether this was due to paroxysmal dysfunction of 
the central autonomic network (CAN) or arising from his epilepsy was however not 
documented. Panayiotopoulos syndrome is by far the commonest gastrointestinal 
autonomic manifestation of epilepsy. This occurs in childhood. The symptoms of 
Panayiotopoulos syndrome are autonomic and include recurrent nausea, vomiting, 
pallor and flushing. What is striking in this syndrome is the prominent gastrointestinal 
signs related to cortical electrical activity (associated EEG occipital spikes), occipital in 
origin, that are postulated to spread to the vomiting centres’ of the hypothalamus and 
the medulla (Panayiotopoulos 2007). In adult epilepsy, the commonest gastrointestinal 
autonomic signs are the gastrointestinal (GI) auras and these occur more frequently than 
cardiovascular manifestations.  
 
The gastrointestinal signs include: vomiting, retching, cramping abdominal pain, 
diarrhoea, urge to defecate, faecal incontinence, bloating, borborygmi, periumbilical 
pain, butterflies in stomach, feeling of hunger. These symptoms have been obtained by 
stimulating the amygdala, hippocampus and insula cortex. These visceral symptoms are 
not due to dysfunctional GI motility but rather to abnormal sensory percept because 
gastrointestinal smooth muscle is unaffected during these periods (Baumgartner et al. 
2001; Van Buren et al. 1960).  In addition to the above signs, retching and vomiting 
associated with loss of consciousness can occur in the ictal period as the sole 
manifestation seizures (Baumgartner et al. 2001; Catenoix et al. 2008; Mitchell et al. 
1983). Conflicting results have been described with regards to the hemispheric laterality 
of the focus of gastrointestinal signs. Whilst, some studies lateralize to the right 
(Devinsky et al. 1995; Gupta et al. 1983; Kramer et al. 1988), other investigators have 
not found this (Gil-Nagel et al. 1997; Marks, Jr. et al. 1998). However gastrointestinal 
signs generally localize to the  temporal lobes regardless of side (Baumgartner et al. 
2001).  
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Autonomic signs of the genitourinary system in partial epilepsy  
In partial seizures micturation without loss of awareness is rare. Indeed, it is unusual to 
have urinary incontinence during partial seizures, and urinary urgency without 
incontinence is more frequent (Baumgartner et al. 2000; Baumgartner et al. 2001; 
Panayiotopoulos 2007). The autonomic innervations of the bladder and internal bladder 
sphincter are by branches of the peripheral autonomic system located in the sacral 
plexus, functions of which are modulated by the urinary control components of the 
central autonomic network. Whilst parasympathetic stimulation causes detrusor muscle 
contraction and passage of urine, sympathetic stimulation of the urinary bladder 
decreases bladder pressure and filling time so as to limit the number of micturation 
episodes. The basis for the urge to urinate experienced during partial seizures is not 
entirely clear. In healthy individuals the urge to urinate is not automatically followed by 
passage of urine. In addition, fullness of urinary bladder and intense anxiety increases 
the desire to void (Athwal et al. 2001; Holstege et al. 2008).  
 
One postulation has been that the urinary urgency in partial seizures is due to anxiety 
but there is no scientific data to support this. What is clear is that the coordination of 
micturation activity is by interrelation between brain and brainstem structures 
particularly the anterior cingulate gyrus, periaqueductal gray, the hypothalamus and 
several other central structures (Holstege et al. 2008). These constitute the central 
autonomic network and are the same areas involved in the urge to urinate. These 
symptoms also occur in temporal lobe epilepsy which is not surprising because of the 
extensive connections that exist between the components of central autonomic network 
and the temporolimbic pathway. It is not clear why ictal urinary urgency is commoner in 
right hemisphere epilepsy, but it provides evidence to support the presumed asymmetry 
of central autonomic influences on target organ (Adjei et al. 2009; Oppenheimer et al. 
1990; Oppenheimer et al. 1992; Zamrini et al. 1990).  
 
Autonomic signs of sexual function in partial epilepsy  
Human sexual function is affected by autonomic dysfunction. The extent to which sexual 
organs respond to sexual stimulation depends on the integrity of the central autonomic 
network and the innervations of the genitals by the peripheral autonomic nervous 
system. According to the ICD10 and DSM IV, there are four main categories of human 
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sexual dysfunction; arousal disorder, disorder of “sexual desire”, disorder of orgasms 
and pain. All of these disorders are described in patients with chronic epilepsy (Hilz 
2008; Morrell 2008). In epilepsy, the epileptic syndrome, seizure frequency and the 
antiepileptic drugs used influence sexual function. However, the  majority of men and 
women with epilepsy have normal sexual lives (Crawford 2005). There are two broad 
categories of sexual dysfunction; phenomenological and dysfunctional sexual 
behaviours, both of which occur in epilepsy.  Phenomenological sexual behaviours are 
paroxysmal in context and constitute part of the symptom complex in epilepsy described 
as “sexual auras”. They  manifest as deep seated erotic thoughts, sexual arousals, sexual 
orgasms, genital sensations, erections, ejaculations, increased vulvovaginal secretory 
activity and “genital automatisms” which may not be related to autonomic function but 
are sexual in context and include:  exhibitionism, fondling, grabbing, manipulation of the 
external genitalia, rhythmic and controlled movement of the legs, pelvic thrusting and 
even masturbation (Freeman et al. 2008). Whilst Janszky reported the auras to be 
common  in women patients with epilepsy and mostly associated with right temporal 
lobe epilepsy (Janszky et al. 2004), Dobesberger, in the same year, described genital 
automatisms to be common in male patients without the right sided laterality but 
temporal lobe in origin (Dobesberger et al. 2004). The significance of these observations 
is the involvement of the temporal lobe in the sexual semiology of partial seizures. 
Abnormal sensations in genital and pelvic areas constituting sexual auras can be 
mistaken for infantile masturbation, a rather rare condition that may be misdiagnosed 
as epilepsy, occasionally resulting in antiepileptic drug prescription (Fleisher et al. 1990; 
Otaigbe 2008; Wulff et al. 1992). 
 
Dysfunctional sexual behaviour, on the other hand is reported interictally (Kutlu et al. 
2005; Luef 2008). Human sexual behaviour is controlled by three main factors; libido, 
arousal and orgasm. Whilst libido is modulated mostly by psychological factors, arousal 
and orgasms remains a function of the autonomic nervous system. The mechanisms 
underpinning sexual function abnormalities reported in epilepsy are unknown but 
probably  involve especially the emotional circuitry of the amygdala, increased prolactin 
levels and the antiepileptic drugs (Bennaroch 1997; Hilz 2008). The progression to 
orgasm in a seizure is extremely rare but spread to the hypothalamus in temporal lobe 
epilepsy can be associated with unpleasant or even painful orgasms.  
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Report is made of the great Russian writer, Dostoevsky, who had a rare form of temporal 
lobe epilepsy in which he would have sexual fantasies and orgasms during attacks 
(Morgan 1990). Older female patients with epilepsy have impaired vaginal lubrication 
and dyspareunia that causes them to have hyposexuality. This leads to a difference in 
sexual behaviour when compared to adolescents and younger women with epilepsy. The 
latter group have been found to have similar sexual behaviours as their non epileptic 
counterparts (Zelena et al. 2007). Autonomic contribution to female sexual function 
depends entirely on the integrity of the central autonomic structures (amygdala and 
hypothalamus) and the peripheral autonomic innervations of the female genital organs.  
 
Stimulation of the central autonomic network will cause activation of the two arms of 
the peripheral autonomic nervous system. The effects of the parasympathetic and 
sympathetic nervous system on the female sexual response are controversial but 
evidence available is  that sympathetic stimulation causes reduced vaginal blood flow, 
secretions, vaginal moistening and dyspareunia whilst the converse is true for 
parasympathetic stimulation (Hilz 2008).  In the male patient with epilepsy, 
hyposexuality, characterized by erectile failure and normal libido has been reported 
(Kuba et al. 2006; Molleken et al. 2009; Pritchard, III et al. 1983; Siniscalchi et al. 2008). 
Apart from a presumed autonomic disturbance, the reason for some male patients to 
experience erectile failure and dysfunction is not fully understood. Many factors, not 
necessarily autonomic in nature may be at play: including depression, psychosocial 
deficits such as a low self esteem, endocrinological effects of antiepileptic drugs  and 
restricted social opportunities (Morrell 2008).    
 
Autonomic signs manifest in the skin in partial epilepsy 
Seizures generate skin flushing and pallor as well as pilomotor erection, diaphoresis and 
feelings of warmth and cold, and may modify the generation of sweat which is the basis 
for the skin resistance. The most described skin manifestations is the “Goose flesh” 
which is due to pilomotor erection and is always accompanied by other autonomic 
symptoms in partial epilepsy of dominant.  The cutaneous signs, which are temporal 
lobe in origin, are commonly bilateral. However, on many  occasions they can lateralize 
to a side contra lateral to seizure focus (Drake 1984).  
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2.2.2 The effects Autonomic Nervous System has on Epilepsy. 
A number of clinical observations indicate the level of autonomic nervous system 
activity may be significant in providing an appropriate environment for the precipitation 
and occurrence of seizures (Nagai et al. 2004). The evidence alluding to the potential 
influence of the autonomic nervous system on cortical epileptogenic foci is quite small; 
however heightened levels of excitement in the autonomic nervous system particularly 
under extreme forms of stress seem to contribute to seizure susceptibility at least in 
mesial temporal lobe epilepsy (Koe et al. 2009). Abnormal cardiac rhythms can cause 
reduced cerebral perfusion and lead to convulsive activity but rarely causes cortical 
epilepsy. The rare condition, primary eating epilepsy is an example of how 
gastrointestinal activity (increased motility during eating which is a purely autonomic 
mechanism) might precipitate a seizure (Rosenzweig et al. 2008). Mechanisms are not 
fully clear as the bulk of gastric peristalsis associated with eating is parasympathetic and 
increased sympathetic arousal is rather involved in seizure precipitation. Yoko Nagai, 
working at the National Hospital for Neurology and Neurosurgery in London, 
demonstrated an inverse relation between peripheral sympathetic arousal and cortical 
arousal activity such that in extremely relaxed states when the skin resistance was high 
enough there was an associated reduction in cortical stimulation. By using behavioural 
modifications, the authors were able to suggest a management for treatment resistant 
epilepsy based on relaxation techniques (Nagai et al. 2004).  
 
Stimulation of vagal afferents has been associated with inhibition of  several types of 
experimental seizures (Rutecki 1990). The inhibition is bi-hemispheric, seizures are 
suppressed within seconds, which lasts for a long time and remains bi hemispheric 
whether the stimulation is bilateral or unilateral. The neurobiological basis for vagal 
nerve stimulation and autonomic modulation in the treatment of refractory epilepsy is 
said to be related to the extensive connections of the main relay station of the vagus 
nerve, the nucleus of the tractus solitarus,  to the hippocampus and other cortical areas 
involved in the propagation of seizures (Castle et al. 2005), however the exact 
mechanism is not yet characterised. It has been suggested that it is the release of 
noradrenalin from the locus coeruleus following stimulation of the vagal nerve that 
results in seizure suppression (Schachter 2009). As vagal nerve stimulation is now widely 
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used, further insights may be uncovered for the significant role the autonomic nervous 
system plays in epilepsy. 
2.2.3 Clinical effects of Autonomic abnormalities in epilepsy 
Autonomic abnormalities and SUDEP 
An early statistical report of unexplained death in patients with epilepsy was by WP 
Spratling, the eminent American epileptologist and future President of the ILAE, in 1902 
who described that up to 4 percent of deaths in a population of epileptic patients 
occurred without any identifiable explanation. Subsequently several retrospective and 
prospective studies on unexplained death in epilepsy has been conducted and overall, 
sudden death has been found to be increased in patients with epilepsy by as much as 
24-40 times the general population (Freeman 2006; Langan et al. 1998; Langan 2000; 
Langan et al. 2005; Opeskin et al. 2003; Timmings 1998; Walczak et al. 2001). Mortality 
among epilepsy patients is of 2-3 times higher than the general population. SUDEP 
account for as much as 10- 15 % of mortality in epileptics and this exceeds that due to 
status epilepticus. In people with epilepsy, the annual incidence of SUDEP is of the order 
of 1 in every 500 to 1000 patients depending on the population under investigation 
(Leestma et al. 1989).  
 
The term SUDEP has been defined by Nashef (1997) and this definition is now universally 
accepted. According to this definition, SUDEP is: The sudden, unexpected, witnessed or 
unwitnessed, non traumatic, and nondrowning, death in patients with epilepsy with or 
without evidence of seizure and excluding documented status epilepticus , in which 
post-mortem does not reveal a structural or toxicology cause for the death (Nashef 
1997). The cause for SUDEP may be multifactorial but it is presumed in most instances to 
be due to unexplained respiratory failure, cardiac arrhythmia during or in the immediate 
aftermath of a seizure in most cases. The mechanism of the cardiac and respiratory 
disturbances have an  autonomic response (Blum et al. 2000; Kiok et al. 1986; Lathers et 
al. 1982; Lathers et al. 1987; Nashef et al. 1996; Rugg-Gunn et al. 2000).  The occurrence 
of generalized tonic clonic seizures is the most important risk factor for SUDEP but this is 
not to say that SUDEP only occurs in patients with chronic uncontrolled epilepsy who 
may have the supposed risks but occurs even in patients with rare seizures as well 
(Opeskin et al. 2003).  The pathological findings in SUDEP have been reviewed by Thom 
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(2003) (Thom et al. 2003). Most striking is pulmonary edema which is a common finding 
at autopsy in patients who have had SUDEP (Colice et al. 1984; Malik et al. 1994) but is 
not usually severe. Such oedema is thought to be neurogenic due to excessive ictal 
sympathetic discharge to the pulmonary vasculature during generalized tonic clonic 
seizures. Interictal and ictal arrhythmias occur in epilepsy, as well as a marked ictal 
catecholamine surge during a fit and if high enough can itself cause cardiac arrhythmias 
and sympathetic myocardial injury in patients with epilepsy (Legriel et al. 2008). 
Sakamoto (2008), in an animal model experiment, found simultaneous over-activity in 
the peripheral divisions of the autonomic nervous system during experimental 
generalized tonic clonic seizures. He attributed death to a form of asphyxiation where 
respiratory distress occurring in an epileptic seizure led to profound parasympathetic 
discharge. This and the ensuing bradycardia compounded with the mechanical failure of 
the heart due to simultaneous over activity in the parasympathetic and sympathetic 
nervous system led to sudden cardiac death (Sakamoto et al. 2008).  
Autonomic abnormality during seizures and syncope 
Loss of consciousness is a frequent clinical presentation. It forms a spectrum, which at 
one end has patients with acute loss of consciousness due to cardiac arrhythmias during 
a seizure and at the other extreme, loss of consciousness due to an acute cardiovascular 
failure. Loss of consciousness in most patients and even in some cases of epilepsy may 
warrant autonomic function evaluation. The differential diagnosis of loss of 
consciousness includes syncope and epileptic seizures. Syncope refers to the abrupt loss 
of postural tone and consciousness’ followed by an extremely rapid recovery, due to a 
sudden and reversible cerebral hypoperfusion (Cook 2009). Syncope has an entirely 
different pathophysiology and should not be confused with seizures but difficulties arise 
if there is an increased predisposition to syncope and when syncope occurs in unusual 
circumstances. Syncope is common but the real cause for more than a quarter of cases 
of syncope cannot be identified (Mathias et al. 2001). The importance of syncope in 
epilepsy lies in the extent to which ictal autonomic phenomena particularly “ictal 
arrhythmia syndrome” can cause syncopal like events during seizures. Syncope may be 
evident in central nervous system disease and syncope due to sinus arrest during 
temporal lobe seizures may occur. In fact, Ghearing and Schuele both have suggested 
that sudden loss of tone during seizure semiology in patients with temporal lobe 
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epilepsy to represent ictal asystole (Ghearing et al. 2007; Schuele et al. 2007). There is 
no doubt that patients with epilepsy have abnormalities in autonomic function (Chroni 
et al. 2009; Devinsky et al. 1994; Devinsky 2004; Dutsch et al. 2006; Hilz et al. 2002; 
Persson et al. 2007a; Tomson et al. 1998; Tomson et al. 2008) and because of this some 
patients with epilepsy may have symptoms similar to syncope. Loss of consciousness 
during a cardiac event may be associated with myoclonic jerks, tonic spasm and 
incontinence of urine similar to an epileptic event. These symptoms are due to the 
release of inhibitory motor phenomenon in the upper brainstem by the transient 
cerebral hypoperfusion. If these patients are evaluated electrophysiologically, the EEG is 
usually always normal except when done simultaneously with head up tilt test, which 
will show gradual slowing of cerebral activity and eventual attenuation typical of cardiac 
syncope (Brenner 1997). Autonomic evaluation in such patients also reveals reduced 
heart rate variability.  
 
The most common concomitant of syncope in patients with epilepsy may be the “ictal 
bradycardia syndrome”. This syndrome is undoubtedly an abnormal autonomic cardiac 
reflex response due to epileptic seizure when it occurs in the absence of any cardiac 
conduction defects. Several mechanisms has been proposed for ictal bradycardia but the 
underlying principle  involves activation of the cardiac autonomic reflexes that activates 
the medullary reflex centres to cause increased vagal discharge and hence bradycardia 
(Schuele et al. 2008).  Some other authors have described the cause to be an excessive 
vagal discharge from an autonomic reflex triggered by a sudden increase in arterial 
blood pressure associated with increased catecholamine release during a seizure 
(Bennaroch 2007), whilst others yet still have attributed it to an uncontrolled peripheral 
autonomic discharge (Sakamoto et al. 2008). Whatever the mechanism is, it is clear that 
seizure induced influences on the autonomic nervous system could be the mechanism of 
ictal asystole in patients with epilepsy.  As mentioned above, it has been suggested that 
bradycardia and subsequent asystole may be a crucial part of the ictal phenomenology 
of suddenly slumping to the floor due to atonia (Ghearing et al. 2007; Schuele et al. 
2007). Reflex syncope is worth mentioning. It is a common presentation at epilepsy 
clinics that warrants autonomic function evaluation to differentiate from cardiac 
syncope. The consistent finding in reflex syncope is the existence of prolonged 
prodromal symptoms rightly confused with the auras of epilepsy, a young age of onset, 
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usually less than 50 years and the association with orthostatic stress as seen in 
prolonged sitting or standing. Whilst epileptic syncope may occur unprovoked, cardiac 
syncope on the other hand will occur during heightened physical exertion even though 
in some cases it has been reported to occur in the resting supine position. Palpitations at 
rest will not help to differentiate cardiac syncope from epileptic syncope, because in 
young patients with epilepsy, palpitations occur as a common symptom (Calkins et al. 
1995). Prolonged confusion, usually greater than five minutes and clonic jerks before 
and during the event may help in establishing epilepsy as the cause of syncope but it is 
also worthwhile to note that some syncopal episodes may be associated with longer 
lasting confusion (Panayiotopoulos 2007).  
Autonomic abnormalities and interictal alterations of behaviour  
There are distinctive interictal behavioural patterns in patients with epilepsy, particularly 
temporal lobe epilepsy, that are ascribed to be related to the dysfunction of the 
autonomic nervous system. The central autonomic network controls and coordinates 
autonomic function with behavioural nociceptive and hormonal response to various 
environmental stimuli. This is made possible by the reciprocal connections that exist 
between the cholinergic and monoaminergic centres of the septal area and the brain 
stem that controls sensorimotor, autonomic and neuroendocrine function depending on 
the behavioural state of the individual.  The significance of these reciprocal connections 
is that the central autonomic network can influence the processing of emotion and 
cognitive responses from viscerosensory information. The latter may also influence the 
central autonomic networks coordination of autonomic and other motor responses 
(Bennaroch 1997). A review of the limbic system anatomy and physiology supports the 
key role it plays in processing both internal and external sensory percept to determine 
through memory, the adequate emotional, autonomic and directed motor responses 
intended for survival. The temporal lobe is an integral part of the limbic system and it is 
not surprising that temporal lobe epilepsy is particularly associated with disruptions in 
behaviour but because of the connections of the limbic system to other cortical areas, 
extratemporal epilepsy can affect limbic function as well (McLachlan 2009). Alterations 
in behaviour have been related to the autonomic nervous system. The exact autonomic 
mechanism remains unknown and the association of autonomic function and interictal 
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alterations of behaviour at this stage is at best, speculative (Bear et al. 1981; Devinsky et 
al. 1994). 
2.2.4 Antiepileptic drugs and Autonomic Function 
Experimental studies indicate an intact noradrenergic system may be required for the 
anticonvulsant actions of some antiepileptic medications including carbamazepine, 
phenytoin, phenobarbitone, and valproate and (Quattrone et al. 1978; Schank et al. 
2005; Waller et al. 1985). Antiepileptic medications that have a stabilization effect on 
the neuronal cell membrane have a series of indirect effects on the autonomic nervous 
system (table 2). Carbamazepine is very much implicated in this sense and a study by a 
Swedish group (Tomson et al. 1998), identified that carbamazepine tends to  decrease 
the heart rate variability. Carbamazepine has several unwanted effects including QT 
interval prolongation and in patients with epilepsy, even at therapeutic doses, 
carbamazepine can produce severe prolongation of atrioventricular conduction and 
result in severe bradycardia (Ide et al. 2007; Johnson et al. 1997; Kumada et al. 2005; 
Labrecque et al. 1992; Ladefoged et al. 1982; Parihar et al. 1996; Takayanagi et al. 1998). 
Carbamazepine has other non autonomic effects and may cause hyposexuality in 
epileptic patients by reducing serum concentration of di-hydroepiandosterone sulphate 
(Zelena et al. 2007). The  sudden withdrawal of carbamazepine has been found to 
enhance autonomic sympathetic function in patients with epilepsy (Hennessy et al. 
2001). Valproate apart from its effect on the GABAergic system and NMDA receptors is 
said to increase levels of noradrenalin in hippocampal and brainstem tissue which has 
been found to suppress epileptiform activity (Weinshenker 2008). 
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Table 2 Autonomic features of common antiepileptic drugs 
Antiepileptic 
Drug 
Autonomic Effects 
HypT RD CA CAb AchE GID 
 
Diazepam 
 
yes 
 
yes 
 
- 
 
- 
 
- 
 
- 
Lorazepam yes yes - - - - 
Ethosuximide - - - - - Yes 
Felbamate - - - - - Yes 
Phenobarbitone Yes Yes - - - - 
Phenytoin Yes - Yes - - - 
Valproate Yes - - - - Yes 
Carbamazepine - Yes Yes Yes Yes - 
 
HypT; Hypotension, RD; Respiratory depression, CA; Cardiac Arrhythmia, CAb; Conduction abnormalities, 
AchE; Anticholinergic effects, GID; Gastrointestinal disturbance. 
 
 
2.3 Cardiac Enzymes, Troponin T and I in Epilepsy 
 
There are published reports to support myocardial damage during epileptic seizures 
(Woodruff et al. 2003). Factors responsible could be apnoea and increased myocardial 
oxygen consumption during seizures. There is however evidence against increased 
troponin during epileptic seizures (Hajsadeghi et al. 2009; Woodruff et al. 2003). These 
markers in epilepsy could have relevance to the understanding of the mechanism of 
SUDEP. Various mechanisms that have been proposed include cardiac related sudden 
death that may be ischemic, arrhythmic or both (Surges et al. 2009c).  
 
2.4 Electrolytes (Na
+
, Ca
2+
, Mg
2+
 and K
+
) in Epilepsy. 
 
The change in the serum concentration of electrolytes affects neuromuscular excitability 
in the normal healthy individual. Modifications in the serum levels of these ions occur 
readily during seizures particularly generalized epileptic seizures. The electrolyte balance 
is easily disturbed in patients with epilepsy as during seizures there is the tendency for 
alkalosis to develop from an unapparent sympathetically mediated hyperventilation 
usually at the onset of seizures. The changes in serum electrolytes that are apparent in 
epileptics are: 1) unaffected  serum level of sodium (Na+) in both partial and generalized 
seizures but with prolonged seizure activity occurring especially in the generalized 
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epilepsy group, elevated serum sodium is likely to be encountered (White et al. 1992). 2) 
The retention of salt and water which can be associated with the development of 
convulsions might be one cause for the catamenial exacerbation of epilepsy in women. 
This is not an absolute observation because earlier reports on the  measurement of the 
serum sodium of non epileptic controls and epileptics in one study showed no significant 
difference (Reynolds 1970). Magnesium is essential to the maintenance of neuronal 
stability in excitable membranes; nerve and muscle and it also maintains an allosteric 
voltage dependent inhibition of glutamate NMDA receptors. Studies that have measured 
the serum magnesium have found it to be unaffected during all forms of seizures 
(Hamed et al. 2004; Hurd et al. 1984; Kurekci et al. 1995; Smith et al. 1982). 
Nevertheless hypomagnesaemia, hypocalcaemia  and hypokalaemia have been 
previously reported in patients with epilepsy (Ilhan et al. 1999). The total serum calcium 
in epileptics remain normal in between attacks but during attacks there is a decrease in 
the serum levels of calcium to the low normal, which  occurs just before the onset of the 
seizure activity (Nzeh et al. 1994). As the seizure progresses’ and acidosis develops, a 
gradual increase in the serum calcium occurs (Natelson et al. 1979a). Another 
contributory factor to calcium dyshomeostasis in seizures is increased catecholamine 
secretion. This can  contribute to hypocalcaemia by increasing intracellular loading  of 
calcium (Natelson et al. 1979a). Abnormal kinetics of serum potassium (K)
 
also occur in 
epilepsy. During the interictal period, serum levels of K
+   
are normal. However, during 
and after attacks the serum levels of potassium (K
+
) increase and stay elevated for some 
time especially when the seizure activity is, particularly intense or prolonged as for 
generalised tonic clonic seizures (White et al. 1992). These dynamic changes of the 
electrolytes can generate electrical instability of the myocardium and could contribute 
to SUDEP. 
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2.5 General overview of the autonomic nervous system 
 
The autonomic nervous system controls visceral functions required for the maintenance 
of homeostasis of the organism. The heart muscles, respiratory smooth muscle,  
gastrointestinal smooth muscle, secretory glands  of the eyes respiratory tract, the skin, 
neurohormonal  secretion and control are all under autonomic control (Goldstein et al. 
2007). Anatomically the autonomic nervous system consists of two main systems; 
sympathetic nervous system and parasympathetic nervous system. These two divisions 
together with the central autonomic network and their connections in the brain stem 
constitute the autonomic nervous system (Barron et al. 1993; Fitzgerald et al. 2007a; 
Harati 1993). 
2.5.1 Sympathetic nervous system 
The sympathetic nervous system nerve cell bodies are located in the intermediolateral 
cell columns of the spinal cord segments from T1 to L3. Axons from these cell bodies 
course with the ventral rami of the segmental nerves and exit with these nerves via the 
short myelinated preganglionic fibres to form the paravertebral sympathetic trunk which 
consists of synaptic ganglia   and run alongside the vertebral bodies. Long post ganglionic 
fibres exit the sympathetic ganglia to innervate the target organs (Figure 5). Target 
organs have specific adrenergic receptors, alpha and beta receptors. All the 
preganglionic neurons in the sympathetic system release acetylcholine at nerve endings 
in their respective ganglia and noradrenalin is released by   the postganglionic neurons 
at their respective target organs (Barron et al. 1993; Fitzgerald et al. 2007a; Harati 1993). 
2.5.2 Parasympathetic nervous system 
Includes special nuclei of  the cranial nerves III, VII, IX and X nuclei and special  cell 
columns located in the sacral spinal cord segments S2 – S4 (Figure 5). The synaptic 
ganglia are located in or close to the effector organ giving rise to long preganglionic 
nerves. The receptors involved in neurotransmission are two types: muscarinic and 
nicotinic with acetylcholine being the main neurotransmitter at both the ganglia and 
effector organ. Not all body organs are innervated by the two divisions of the peripheral 
autonomic nervous system and in cases where both are found, the end organ is 
responsive to only one at anytime due to a high level of autonomic interaction at the 
ganglia (Figure 4). Peripheral autonomic activation results in various opposing clinical 
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effects which are tabulated in Table 3 (Barron et al. 1993; Fitzgerald et al. 2007a; Harati 
1993). 
 
 
 
 
 
 
Figure 4    Interaction at the Autonomic nerve effector junction. Adrenergic neurones and cholinergic 
neurones exist together at nerve effector junctions and there is reciprocal inhibition of a specific neurone 
following neurotransmitter release through specific pre and post junctional neurotransmitter receptors. 
This forms the general basis for antagonism in the peripheral autonomic nervous system. Also whilst 
efferent activity in the parasympathetic system is specific, activity in the sympathetic system is very 
diffuse affecting several sympathetic effectors simultaneously, in response to afferent stimulation. 
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α1 
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Figure 5 Overview of the sympathetic Innervations in different   organs and organ systems. The 
sympathetic ganglia are located a good distance from the target organ with long postganglionic nerve 
fibres. Source: Clinical Autonomic Disorders 3rd edition 2007. 
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Figure 6 Overview of the parasympathetic innervations of different organs. Autonomic ganglia are located 
near to or in target organs and the post ganglionic fibres are short. The sacral segments S2-S4 of the spinal 
cord and Cranial nerves 3, 7,9and 10, form the peripheral parasympathetic system.    Source: Clinical 
Autonomic Disorders 3rd edition 2007. 
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Table 3 Clinical signs on stimulation of the peripheral autonomic nervous system.  
 
System/Organ 
 
Parasympathetic Sympathetic 
Pineal gland  
 
No effect  Increase melatonin  secretion  
Brown Adipose Tissue (Infants)  
 
No effect  Heat production  
Glands (Exocrine, Salivary, Lacrimal, 
Nasopharyngeal, Sweat, Digestive 
and Mucosal)  
Increase secretions except for 
sweat glands where it has no 
effect  
Increases sweat gland activity via a 
cholinergic sympathetic action but 
Decreases all other gland 
secretion  
Lymphoid tissue  
Adrenal medulla  
No effect 
No effect  
Decreases ability of NK cells 
Increases release of NA and AD  
Metabolism liver 
 fat cells 
 Pancreas  
No Effect 
No effect 
Increased secretion  
Glycogenolysis and 
Gluconeogenesis  
Lipolysis &Decreased secretion  
Piloerection muscles No effect 
 
Contraction 
 
Tracheobronchial muscles 
 
Contraction Relaxation 
Eye  Contracts sphincter pupillae 
and contracts ciliary muscle 
only  
Contracts all other smooth muscle 
and the tarsal (lifts eyelid) and 
orbital  (protrusion) muscle  
Blood vessels 
Arteries       skin face 
                       skin trunk & limbs 
                       viscera 
                       skeletal muscle 
                       heart 
                       erectile tissue 
Veins  
Effect (vasodilatation) 
 
 
 
 
 
 
Effect (vasodilatation)  
Vasoconstricts all excepts skeletal 
where there is cholinergic 
sympathetic activity causing 
vasodilatation 
vasoconstriction  
GI sphincters 
GI Long and Circ muscle 
Spleen capsule  
 
Contraction, all. 
Contraction 
 
contraction  
 
NA: noradrenalin; AD: adrenaline; NK: natural killer. Adapted from Clinical Autonomic Disorders; 
Evaluation and management. Phillip A Low. First Edition 1993  
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2.5.3 Central Autonomic Network and the Control of Autonomic Function 
This is  a complex of neuronal interconnections of specific cortical and brainstem areas 
which has an adaptive and tonic reflex control on the peripheral autonomic system 
(Figures 7 and 8). The central autonomic network also controls endocrinological, 
emotional, and behavioural and pain responses in the intact organism. Central 
autonomic network activity is state dependent and is affected by the sleep and wake 
cycle, arterial blood pressure, respiration and a host of other physiologic functions. 
Neural transmission in the central autonomic network  is controlled by the principal 
central nervous system neurotransmitters Glutamate, GABA, Monoamines, 
Neuropeptides and Nitric oxide (Bennaroch 2007). 
 
 
Figure 7 Components of the Central Autonomic Network from the cerebral neocortex to the lower 
brainstem. The lower segments of the central autonomic network are regulated by the higher centres. 
Other areas not seen in this diagram are the hippocampus, septal and olfactory areas. Source: Continuum 
– Autonomic Disorders Volume 13 Number 6 December 2007 
 
The components of the central autonomic network (CAN) are: orbitofrontal, insular, 
anterior cingulate cortex, amygdala and the hypothalamus constitute the telencephalic 
components of the central autonomic network. These regions control the peripheral 
autonomic function through both direct and indirect connections with centres in the 
lower brainstem (NTS, VLM and Medullary Raphe Nuclei). The nucleus of the tractus 
solitarus (NTS) is the first relay station of autonomic function subserved by the cranial 
Thalamic Visceral 
Relay nuclei 
Hypothalamic nuclei 
Mid Brain 
Pons 
Medulla 
Spinal cord 
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parasympathetic nuclei to the cerebral cortex and it also responsible for all 
cardiovascular, respiratory, and gastrointestinal autonomic reflexes. Ventolateral 
nucleus of the medulla (VLM) provides the major excitatory output for vasomotor tone 
and the medullary raphe nuclei is responsible for sympathetic outputs involved in 
thermoregulation and emotional responses (Bennaroch 2007). Stimulation of the insula 
and other areas of the central autonomic network have helped to delineate the specific 
functions of the rostral components of the CAN (Reis et al. 1964), interestingly these are 
the areas commonly involved in the propagation of seizures (Mameli et al. 1988).  
 
Septal Area 
This area is adequately described as the ventromedial forebrain. It is a small area 
merging with the cortex directly in front of the anterior commissure and comprises of 
the septal nuclei and extends slightly into the septum pellicidum. There are extensive 
connections from the septal area to other parts of the cortex through the fornix and also 
to specific areas of the central autonomic network. Activation of this area causes varied 
autonomic responses including tachycardia. 
 
Anterior Cingulate Cortex 
This forms a part of the medial frontal lobe and by means of the papez circuitry connects 
with the parahippocampal gyrus to form the mesolimbic lobe. It has  functional areas 
that are concerned with autonomic responses (Fitzgerald et al. 2007c). The specific role 
in the autonomic nervous system is  not so clear but bradycardia, hypotension and 
micturation  have been observed from the simulation of this area  in rats (Cechetto et al. 
1988).  
 
Hippocampal Complex 
This is a medial temporal lobe structure consisting of the subiculum, dentate gyrus and 
hippocampus proper. These structures of the mesial temporal lobe are particularly 
affected in temporal lobe epilepsy. Clinically, the medial temporal lobe includes the 
amygdala, hippocampal complex and parahippocampal gyrus. This is  connected to the 
cingulate cortex and the hypothalamus through the interconnections of the papez circuit 
and epileptic activity in this region can affect autonomic control (Fitzgerald et al. 2007c). 
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Amygdala 
The amygdala is located in the anterior temporal region where it merges with the cortex 
on the medial side of temporal pole and serves to initiate autonomic responses that are 
critical for expression of emotions. It’s a principal subcortical component of the limbic 
system with extensive connections to the hypothalamus (Fitzgerald et al. 2007b; 
Fitzgerald et al. 2007c). 
 
Insular Cortex 
This the deep cortical area that includes the temporal, parietal and frontal lobe recesses 
on the lateral parts of the cerebral hemispheres on either side. Stimulation of this area 
has been shown to increase the heart rate, blood pressure, the respiratory rate, 
gastrointestinal activity, epinephrine secretion by the adrenal medulla, piloerection and 
pupillary dilatation (Penfield et al. 1957). There is an inconsistent body of evidence 
suggesting that there is lateralisation of autonomic activity in the insula and that right 
and left insula stimulation results in sympathetic and parasympathetic activity 
respectively (Oppenheimer et al. 1990; Zamrini et al. 1990). 
 
Olfactory Cortex 
This is continuous with the olfactory bulb and it is connected ventrally and laterally to 
the hippocampus and thus influenced by hippocampal discharges. By means of the 
medial forebrain bundle the olfactory area connects to the hypothalamus, and the 
brainstem solitary nucleus and reticular formation (Fitzgerald et al. 2007c). When 
stimulated there is increased salivation, gastric contraction and erotic arousal responses 
(Bennaroch 2007; Penfield et al. 1957) . 
 
Hypothalamus 
This thermostat organ of the brain is strictly speaking not a cortical structure but one 
which serves to integrate all cortical inputs to the brainstem components for autonomic 
regulation particularly the cardiovascular and respiratory centres in the brainstem. It is 
divided into anatomic functional units; anterior, medial, posterior and lateral areas all 
sub serving specific functions (Bennaroch 2007; Fitzgerald et al. 2007b). Anterior and 
posterior hypothalamic activity is associated with parasympathetic and sympathetic 
function respectively. The fibres for autonomic control in the brainstem section of the 
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central autonomic neural network remain largely uncrossed as they descend to the 
lower autonomic centres. The paraventricular nucleus in the hypothalamus has an 
overall impact on the autonomic nervous system because it has connections to all 
central autonomic centres. Cardiorespiratory, micturation and vomiting centres in the 
brainstem are independent of the descending autonomic pathways and can still  
function even after pontine section (Fitzgerald et al. 2007b). Central autonomic network 
dysfunction has not been documented in epilepsy patients but cases of paroxysmal 
disturbance in components of the central autonomic network have been reported in the 
literature which could be confused for seizures (Uluc et al. 2004). The high volume of 
interaction (Figures 8, 9a and 9b) that is apparent in the central autonomic nervous 
system (CAN) is completely absent in the peripheral autonomic nervous system (ANS).  
 
 
Left
Central Autonomic
Network ( CAN)
Right
Central Autonomic
Network (CAN)
Sympathetic Nervous
System (L)
Parasympathetic Nervous
System  (L)        
Left side
Right side
Sympathetic Nervous
System (R)
Parasympathetic Nervous
system (R) 
To various Autonomic ganglia (L) To various Autonomic ganglia (R)
 
 Figure 8 A schematic representations of the complex interconnections of the CAN in the two 
cerebral hemispheres and also the specific organisation of the peripheral section of the autonomic 
nervous system into sympathetic and parasympathetic branches which remain lateralised on each 
side. 
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Figure 9a: Ascending Projections of the Central Autonomic Network. Together with the descending 
projection form a reflex arc for integration of inputs of the autonomic reflexes such as the baroreceptor 
reflexes and the other medullary reflexes.  Source: Clinical Autonomic Disorders, 3rd edition 2007. 
 
 
MID BRAIN 
PONS 
MEDULLA 
SPINAL CORD 
 52
 
 
Figure 9b: Descending Projections of the Central Autonomic Network. Injury to the descending pathways 
innervating the sympathetic ganglia in the spinal cord can result in severe autonomic dysreflexia. The most 
serious autonomic dysreflexia is an accelerated hypertension that occurs with bladder distension in 
patients who have developed lesions to the descending pathways above the T5 level in the spinal cord. 
Source: Clinical Autonomic Disorders, 3rd edition 2007. 
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The composite structures of the cerebral cortex in the central autonomic network (CAN) 
have a supervisory role on autonomic control. Many autonomic phenomena arise from 
stimulation of these structures due to the high level of interconnectivity.  
Central nervous system and cardiovascular function  
Cardiovascular autonomic control is a function of neuronal activity in the cerebral cortex 
and other components of the central autonomic network (Talman et al. 1993). 
Reciprocal connections that exist between the higher and lower centres of the central 
autonomic network are essential to the integration of this control (Figures 8, 9 and 
10).The cardiac pacemaker located to the right of the midline is innervated by the right 
peripheral autonomic nervous system and the atrioventricular node on the left of the 
midline has innervations from the ipsilateral peripheral autonomic nervous system 
(Fitzgerald et al. 2007a). Because of the reciprocal connections in the central autonomic 
network on both sides of the cerebral hemispheres, asymmetric simulation of one 
cerebral hemisphere may not be associated with significant changes in cardiac 
autonomic function. However, direct stimulation of the left and right cardiac nerves 
have significantly different effects. Where the left cardiac nerve is associated with 
ventricular and supraventricular tachyarrhythmia’s, the right cardiac nerve is associated 
with cardiac conduction abnormalities. Stimulation of the amygdala, hippocampus, 
anterior cingulate gyrus, temporal pole, and subiculum produce cardiac arrhythmias 
which are independent of the spread of current in the cortex (Anand et al. 1956; 
Delgado et al. 1960).   
 
In  addition stimulation of the hypothalamus increases sympathetic nervous activity and 
the risk of cardiac arrhythmias (Verrier et al. 2004). Abnormal cardiac sympathetic 
activation mediated by the central nervous system does not depend only on gross 
cerebral lesions but also on naturally occurring central events such as occurs in 
emotional or physical stress. During stress, overwhelming central activation induces 
arrhythmias  and may cause sudden cardiac death  from an uncontrolled release of 
catecholamine (Cannon 2002) which at the cellular level results in the influx of calcium, 
potassium and magnesium into the cardiac myocytes (Billman et al. 1991). This increases 
cardiac myocytic contractility and dysfunction, and can precipitate arrhythmias. Lesions 
of the central nervous system may cause significant electrocardiographic changes and 
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arrhythmias. Abnormal cardiac rhythms evident on the electrocardiogram are 
particularly seen in hemorrhagic strokes, subarachnoid haemorrhage and in epilepsy 
(Cropp et al. 1960; Eisalo et al. 1972; Oppenheimer 1993; Oppenheimer 2006; 
Oppenheimer 2007). The central nervous system through the modulation of 
neurohumoral secretion is also critical in regulating cardiovascular autonomic function. 
In the intact organism adrenergic stimulation causes cardiac sinoatrial depolarization 
and increased ventricular propensity to develop arrhythmias’. Vagal stimulation 
however abolishes sinoatrial depolarization, increases ventricular electrical stability and 
decreases the risk to developing arrhythmias.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 10 Schematic presentations of central cardiovascular autonomic control. Central oscillators 
are shown in the midline. Epilepsy excites the cortical components to initiate a series of cardiovascular 
reflexes. 
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2.6 Evaluation of autonomic nervous system function 
 
This section describes the various methods that are available to evaluate the autonomic 
nervous system function. The effective evaluation of the autonomic nervous system 
depends on an expert medical history and physical examination. There are tests for 
autonomic function which can be classified as being physiological, neurochemical, 
pharmacological, imaging and genetical tests. Components of the first two were used to 
assess autonomic function in this study. 
2.6.1 Physiological Tests of Autonomic function 
Physiological tests provide reliable methods for detecting abnormalities in the 
autonomic reflex arcs. The description of these test are beyond the scope of this study 
and mention will be made of various specific tests with  further descriptions of the 
methods used in this study under the specific sections. Available physiological tests 
include; The Head up Tilt test,  Valsalva manoeuvre, isometric  handgrip and cold pressor 
tests, postural change in heart rate and blood pressure, liquid meal challenge test, 
exercise testing, carotid sinus massage and the heart rate variability which has been 
used as non invasive test for the evaluation of cardiovascular autonomic function (Malik 
1996).  
The heart Rate variability and its measurement 
This is a conventionally accepted term used to describe the variations in both the 
instantaneous heart rate and the normal to normal RR intervals associated with each 
QRS complex of each successive heart beat using segments of the recorded 
electrocardiogram. The heart rate variability was first described in 1965 by Hon and Lee 
when they observed that alterations in interbeat intervals occurred in foetal distress 
before any meaningful change occurred in the heart rate of the fetus. After about a 
decade later, Sayers and other group of researchers found the beat to beat heart rate to 
be a function of other physiologic rhythms particularly respiration and diurnal pattern 
changes. The association of high risk mortality in the post myocardial infarction period 
with reduced heart rate variability was first described by Wolf in 1977. By the end of the 
1970s, Askelrod had utilized the power spectral analysis to determine heart rate 
variability which had hitherto been evaluated with only time domain methods. This 
contributed to the understanding of the autonomic background of the beat to beat 
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fluctuations in the heart rate recording. It was however, not until the late eighties that 
the usefulness of the heart rate variability as an independent predictor of cardiovascular 
mortality in the post myocardial infarction period was established and since then  
reduced heart rate variability has been reported in several diseases including epilepsy 
(Adjei et al. 2009; Ansakorpi et al. 2000; Ansakorpi et al. 2002a; Devinsky et al. 1994; 
Harnod et al. 2009; Malik et al. 1990; Malik et al. 1994; Sathyaprabha et al. 2006). RR 
interval measurement is a measure of the control mechanisms of the heart rhythm 
which  are determined by activity in the efferent limbs of the cardiac branches of the 
peripheral autonomic nervous system (Malik 1996).  
 
These two branches are finely tuned and stimulation of the vagal efferent results in 
suppression of sympathetic efferent activity and vice versa (refer figure 5). The 
peripheral autonomic activity is intricately synchronous with the cardiac cycle and 
modulated by the central and peripheral oscillators of the cardiac function. Central 
oscillators consist of the medullary respiratory and vasomotor centres, whilst the 
peripheral oscillators are the changes in arterial pressure related to the general state of 
the individual and respiratory movements. These oscillators generate the rhythmic 
fluctuations in the efferent autonomic neural discharge to the heart. Analyzing these 
fluctuating rhythms using the variation in RR interval measurement associated with each 
heart beat allows inference to be made on the state of the efferent sympathetic and 
parasympathetic neural activity directed to the heart from the central oscillators to the 
sinus node.  
 
The standard electrocardiographic equipment is used to acquire raw 
electrocardiographic data which are digitized by computer programs that detect QRS 
complexes on a continuous strip of ECG over specified time periods into the RR intervals 
data. HRV is then calculated from the interval data using two categories of methods: 
time domain and frequency domain methods. HRV variables determined by time domain 
methods of HRV are generally simple to calculate. Simple arithmetic variables are the 
mean RR intervals, mean instantaneous heart rate, difference between day and night 
heart rates and the difference between the longest and shortest RR intervals. The 
changes in these variables can be determined secondary to manoeuvres that may result 
in increased demand on the autonomic nervous system e.g. exercise and valsalva 
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manoeuvre. Statistical time domain methods are usually done on two types of 
measurements; 1) direct RR interval measurements and 2) from RR interval differences. 
The simplest statistical variable to calculate from direct RR interval measurement is the 
standard deviation of the RR intervals (SDNN). This may be calculated over short or long 
term period recordings the former allowing one to compare HRV between set time 
points during various activities (Malik 1996). The standard deviation of the normal to 
normal RR intervals measures all the components of the heart rate variability. Since 
standard deviation is a measure of variance, it is arithmetically proportional to the total 
power of spectral analysis. The variance of a recording is dependent on the recording 
length and if the recording length increases the variance and SDNN will increase with it. 
This property of the SDNN makes it inappropriate to compare unequal durations from 
arbitrarily selected recordings and it is recommended that durations of recordings 
should be standardized to allow uniform comparison of (SDNN) HRV. In addition to the 
SDNN other commonly determined statistical parameters using directly derived 
measurements are 1) standard deviation of the mean RR interval (SDANN) calculated 
from short 5 minutes periods; 2) average SDNN determined by measuring the SDNN in 5 
minute segments of a 24 hour period (SDNN index).  
 
These methods determine changes in heart rate in cycles less or longer than 5 minutes   
respectively. Using data from RR interval differences, the statistical time domain 
measures usually calculated are; 1) the square root of the mean squared differences of 
successive RR intervals (RMSSD); 2) interval differences of successive RR intervals that 
are greater than 50 milliseconds (NN50); and 3) (pNN50), which is the ratio of NN50 to 
the total number of RR intervals in a giving segment of ECG.  These are measurements of 
short term variation and they estimate the high frequency components of the heart rate 
variability (parasympathetic function) (Malik 1996).  Frequency domain measures of RR 
intervals involve performing power spectral analyses.  Power spectral density analysis 
provides useful information on the distribution of variance as a function of frequency. 
The methods for calculating spectral density may be parametric autoregressive models 
(least squares method; Yule-Walker method; maximum entropy method) or non 
parametric (fast Fourier Transformation). The results from both methods are 
comparable but the main disadvantage of the former over the latter is the need to 
specify the order of calculation. Three main spectral components are separated in the 
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frequency spectrum calculated from RR interval segments usually 2-5min recordings; 
high frequency spectrum (HF) which  is a measure of parasympathetic activity, low 
frequency spectrum (LF) and very low frequency spectrum(VLF) (Malliani et al. 1991). 
Low frequency power is observed to increase during situations that demand sympathetic 
activity e.g. head up tilt test at 90° mental stress, and moderate exercise and it is 
generally accepted as marker of sympathetic activity but this is disputed by some 
investigators because LF power decrease during these activities but when LF power is 
measured in normalized units, then it is seen to increase (Malik 1996). 
 
Traditionally HRV has been calculated using 2mins to 24 hour segments of ECG but short 
10 seconds segments have been evaluated and found to have similar properties as the 
longer segments (De Bruyne et al. 1999; Hamilton et al. 2004; Karp et al. 2009; 
Salahuddin et al. 2007). The main advantage of the latter is the practicality (easier to 
record and analyze) and the cheap costs involved. There are no convincing 
disadvantages when compared to the long segment ECG measures. In this study the 
heart rate variability was measured from 10 second segments mainly because of the 
above mentioned reasons. Heart rate variability is influenced by a number of factors; 1) 
Age of individual is inversely proportional to the HRV, the latter showing a linear decline 
with increasing age. This prevents the use of single normative values in all ages and 2) 
Timing of testing. There is a well established circadian variation in heart rate variability 
that is characterized by low HRV during the day especially in the morning hours and 
increased high HRV at night. In addition to these, other potential confounders which 
may influence  
HRV measures (albeit usually only having a small effect) are hypocapnia, medications 
with anticholinergic side effects including carbamazepine and body habitus (i.e. weight 
and height). Body position has also been suggested to influence HRV but the results are 
conflicting and this is generally not considered an important confounding factor when 
measuring HRV (Cooke et al. 1998; Ewing et al. 1991; Freeman 2008; Hennessy et al. 
2001; Hirsch et al. 1991; Malpas et al. 1990; Ten Harkel et al. 1990; Vallejo et al. 2005). 
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Heart Rate Variability in Epilepsy   
Where epileptic seizures can cause acute autonomic dysfunction such as arrhythmias, 
chronic changes in epilepsy may lead to chronic autonomic dysfunction and abnormal 
heart rate response to stimuli. There are published standards of the heart rate variability 
in cardiovascular diseases (Kamath et al. 1993; Malik et al. 1994; Malik 1996) but the 
application of heart rate variability in epilepsy and other cerebral disease are still a focus 
of new research (Flachenecker et al. 1997; Persson et al. 2007a; Tomson et al. 1998). 
Reduced heart rate variability has been found in previous HRV studies in epilepsy 
patients (Persson et al. 2007b; Tomson et al. 1998). In epilepsy the clinical significance of 
the reduced HRV is not entirely clear. However, since it is dependent on an increase in 
cardiac sympathetic tone, it may be relevant to the pathophysiology of SUDEP (Langan 
2000; Langan et al. 2005; Mukherjee et al. 2009). Most HRV studies in epilepsy have 
been done on interictal ECG. There were none prior to this study in the ictal phase and a 
few in the peri-ictal phase (Assaf et al. 2008; Toth et al. 2010). In the study of Toth et al 
(2010), HRV, which was evaluated 20 minutes after the seizure offset was reduced and  
persisted for as long as 6 hours. This implies epileptic seizures significantly reduce the 
HRV. It is fashionable to associate increased heart rate during seizure with an automatic 
reduction in HRV.  
 
However there is no clear  correlation between HRV and heart rate and very significant 
HRV changes can underlie normal heart rates and vice versa (Sztajzel et al. 2008). Given 
that sudden unexplained death in epilepsy (SUDEP) occurs mainly at night (Langan et al. 
2005; Opeskin et al. 2003) and assuming this is associated with night time seizures, then 
either a nocturnal abnormality of the HRV (Ronkainen et al. 2005) or a seizure related 
reduction in HRV or both may be related to the mechanism of SUDEP.  Knowledge on the 
influence of epilepsy on circadian rhythms is incomplete. There are some minimal data 
suggesting that an  abnormal HRV circadian rhythm exists in epilepsy and elucidating this 
could provide useful insights into the mechanisms of SUDEP (Chokroverty 2008). 
Seizures are unpredictable and the tendency for artefacts to be introduced in 
simultaneously recorded ECG during seizures has complicated the measurement of HRV 
changes with seizures.  In this thesis, I have used  standardised 10seconds ECG 
 60
recordings (De Bruyne et al. 1999) to evaluate heart rate variability changes during 
epileptic seizures and this proved a robust method.  
2.6.2 Neurochemical Tests 
The measurement of serum concentrations of noradrenalin, adrenalin, 
noradrenalin/adrenalin response to tyramine and edrophonium, urine catecholamines, 
plasma renin activity, aldosterone and plasma dihydroxyphenylglycol helps to establish 
autonomic reflex failure, deficient neurotransmitter release and synthesis, and abnormal 
target organ responses. Plasma levels of noradrenalin, derived from sympathetic nerve 
endings that surround arterioles can be used as an index of sympathetic activity 
however this  serum concentration is dynamic and it is affected by several factors 
including the rate of uptake after release, other endogenous biochemical and postural 
changes (Schofl et al. 1997). The site of sampling which is usually the antecubital vein  
may not be suitable for determining norepinephrine activity elsewhere in the body since 
the local sympathetic discharge at this site will bias the sample result (Bannister et al. 
1999). The contribution by adrenal gland to the levels of serum noradrenalin is minimal 
in the resting state but this increases significantly under conditions of stress and other 
conditions that cause excess sympathetic discharge including anoxic ischemia associated 
with generalised epilepsy and the excessive muscular activity of tonic clonic seizures. 
Circulating adrenaline on the other hand is derived from the chromaffin secreting cells 
of the adrenal medullar and it is a direct index of the sympathoadrenal axis.  This organ 
is more or less a postganglionic neurone of the sympathetic nervous system. The several 
other neurochemical tests for evaluating autonomic function are beyond the scope of 
this project. 
Epinephrine and Norepinephrine in Epilepsy 
Increase in plasma catecholamine is as a result of the spill over from sympathetic 
postganglionic nerve endings and the supine measurement is a reflection of the total 
sympathetic nerve activity. The main aim in determining the levels of these substances 
in epilepsy is to assess the degree of sympathetic stimulation following seizures rather 
than to establish sympathetic preganglionic or postganglionic failure. An elevation of 
noradrenalin and adrenaline after seizures has been demonstrated (Khatun et al. 1997). 
In epilepsy, the focus on noradrenalin/adrenalin is partly because of their possible 
involvement in SUDEP through the modulation of cardiovascular autonomic function and 
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overall sympathetic tone. Cardiac rhythm abnormalities can result from abnormal 
impulse generation or propagation or both. Abnormal sympathetic stimulation occurring 
during seizures may cause uncoordinated impulse initiation and propagation and the 
lowering of the threshold for ventricular fibrillation (Doba et al. 1975; El-Sayed et al. 
2007). Beside the described cardiovascular effects, noradrenalin has a role in the control 
of epilepsy. The anti epileptic mechanism of vagal nerve stimulation and some 
antiepileptic drugs requires an intact noradrenergic system for their anticonvulsant 
actions (Giorgi et al. 2004; Schank et al. 2005). 
 
There is some reason to believe that epilepsy itself can affect the urinary excretion of 
catecholamines. The urinary excretion of dopamine, adrenaline and noradrenalin in 
epilepsy has been compared to that of their nonepileptic controls.  With the exception 
of dopamine which had lower rates of excretion in epileptic patients, there was no 
statistical difference for adrenalin and noradrenalin between the two groups. Because 
dopamine is a precursor during the biosynthesis of noradrenalin and adrenalin, the 
authors concluded that chronic epilepsy might affect catecholamine synthesis 
particularly dopamine (Kapustecki et al. 2000).   
2.6.3 Pharmacological Tests 
These are tests that assess the target organ response to autonomic neurotransmitter 
release. They may not necessarily determine the receptor integrity or mutations in 
receptors at the effector organ. Several are available and typical examples are the 
edrophonium test in myasthenia gravis and intracarvernosal papaverine injections into 
erectile tissue in patients erectile dysfunction (Goldstein et al. 2007). 
2.6.4 Neuroimaging Tests 
Several imaging techniques help to visualize the sympathetic innervations of the heart 
and the autonomic controlled functions of the gastrointestinal system. Barium studies, 
endoscopy, videoflouroscopy and gastric emptying studies are utilised to evaluate some 
gastrointestinal autonomic function whilst other imaging studies such as intravenous 
urography and pelvic ultrasonography can be used in the in the urogenital system. 
Iodine labelled metaiodobenzylguanidine (MIBG) scintigraphy has been used extensively 
in the evaluation of sympathetic cardiac dysfunction in the post myocardial infarction 
period and also in other forms of autonomic failure such as pure autonomic failure, 
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Parkinson’s disease, multisystem atrophy and epilepsy (Druschky et al. 2001). Positron 
emission tomography (PET) scans after systemic administration of perfusion and 
sympathoneural imaging agents have helped to evaluate the cardiac autonomic 
function. This technique has been shown to have good spatial resolution which helps to 
rapidly visualise the sympathetic innervations of the heart (Goldstein et al. 2007). 
Recently a group in Germany used methyl-iodo-benzyl guanidine (MIBG) to delineate a 
cardiac sympathetic dysfunction in epilepsy patients who develop ictal asystole (Kerling 
et al. 2009). 
2.6.5 Genetic Tests 
Genetic testing in autonomic evaluation is not readily available but can be used to 
establish the cause of autonomic dysfunction in conditions like familial amyliodotic 
polyneuropathy.  
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Chapter 3 
 
General Methodology and Procedures  
 
This section outlines the general procedures and statistical model used for the whole 
study. The subsequent results chapters dedicated to each hypothesis will refer to 
sections in this chapter for description of methodology used. The study was conducted 
at the Jules Thorn video telemetry unit (Dedicated EEG monitoring unit) in the 
Department of Clinical and Experimental Epilepsy under the auspices of the National 
Hospital for Neurology and Neurosurgery, Queen square London. 
 
3.1 Methodology for Literature Review 
 
Data for the review were identified by searches of Pubmed using the following search 
terms  
• “Autonomic symptoms epilepsy ”,  
• “Heart rate variability epilepsy and epileptic seizures”, 
•  “Catecholamines in epilepsy ” , 
• “Serum electrolytes epilepsy”,  
• “Cardiac Troponin epilepsy”, 
• “Corrected QT interval seizures and epilepsy”. 
Only articles in English were selected. No time limit or any other limits were set. I 
reviewed all the articles identified from the Pubmed searches and selected, from these 
articles, only those which provided a systematic evaluation of the various autonomic 
signs and symptoms in epilepsy and during epileptic seizures.  Additional data was 
obtained from selected textbook chapters:   
• Epilepsy; A Comprehensive Textbook  
• A Clinical guide to Epileptic Syndromes and their Treatment 
• Clinical Autonomic Disorders 
• The Central Autonomic Network: Functional Organisation and Clinical 
correlation. 
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3.2 Subjects 
 
The subjects were recruited from patients who have chronic medically intractable 
epilepsy which is defined as ; More than two disabling seizures per month, lasting longer 
than 2 years, and has not been controlled by two or more antiepileptic drugs at their 
maximum tolerable dose (Radhakrishnan et al. 1998). All subjects were studied during 
their admission for video EEG telemetry at the National Hospital for Neurology and 
Neurosurgery and unless otherwise indicated all patients had extra cranial video EEG 
monitoring. Research ethics approval was provided by the National Hospital for 
Neurology and Neurosurgery research ethics committee and strict adherence to the 
principles of clinical research was adhered to. The study was in three parts each 
addressing one of the specific aims. Informed consent (Appendix 9.1a and 9.1b) was 
sought from all willing participants who satisfied both inclusion and exclusion criteria.  
 
The principal inclusion criteria were: 
• Patients with epilepsy admitted for localization and characterization of their 
seizures at the video−EEG telemetry unit of the National Hospital for Neurology 
and Neurosurgery 
• Age range 18 to 65 years 
• Ability to give informed consent 
• No co morbidities such as diabetes mellitus, hypertension and no documented 
evidence of autonomic nervous system dysfunction. 
And the exclusion criteria were: 
• Patients without epilepsy including pseudoseizures 
• Unconscious and very ill patients 
• Mentally insufficient patients or psychological disease patients such as 
schizophrenia who were not able to give informed consent. 
• History of diabetes mellitus, hypertension or any autonomic nervous system 
abnormality. 
• History of myocardial infarction. 
• History of type I and type II pulmonary disease.  
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Gender, race and ethnicity of participants did not affect inclusion or exclusion from this 
study. Overall a total of 207 patients (191 in HRV Study and 16 patients in the Electrolyte 
study) were included in this project. The number of participants for each part of the 
study was derived using power calculations based on conventional size estimate using a 
standard of power of 80% and significance level of 0.05. All the patients satisfied the 
inclusion criteria described above, and underwent greater than 92 hours of continuous 
EEG and ECG monitoring. Up to 40 participants were excluded from the study because 
there were no recorded seizures during the period of admission or the seizures recorded 
on admission were found to be non epileptic episodes.  
 
3.3 Methodology  for Heart Rate Variability  Studies 
  
There were three time periods of interest used in evaluating the HRV for the first 
hypothesis;  
• The immediate pre-seizure period – within 20 seconds before the onset of both 
clinical and EEG seizure  
• The ictal period – the period of the electrographic seizure activity corresponding 
to precisely the midsection of the discharge. 
• The immediate postictal period – 20 seconds after the cessation of the 
electrographic discharge.  
 
ECG was standardized for uniform comparison of HRV by using 10 second segments of 
ECG recordings (Karp et al. 2009; Salahuddin et al. 2007). These segments were free of 
artefacts. ECGs corresponding to the first three ictal seizures for each subject were 
analysed.  
 
To test the second hypothesis, 24 hour day period was equally divided into 12 hour 
blocks from 20:00 pm to 07:59am, and from 08:00am to 19:59pm, representing night 
time and day time respectively. Five minute segment of ECG at the beginning of each 
hour was used to represent and evaluate the hourly HRV in each patient. 
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Electrophysiology data acquisition  
Electroencephalograph (EEG) were mainly  acquired using scalp electrodes which were 
placed according to the 10-20 system in almost all patients with additional special 
electrodes (10-10 system and sphenoidal electrodes) being used in specified patients. 
For patients who had intracranial studies (n=26), the electrodes which were subdural 
grids, subdural strips and depth were inserted stereotactically under                      
general anaesthesia by the neurosurgical team. Up to 64 channels of EEG including 
superficial sphenoidal electrodes were recorded. Disposable Ag/AgCl EEG electrodes 
were used for all extracranial recordings. Commercially available skin preparation gel 
(Nuprep ECG/EEG abrasive skin prep GEL, D.O Weaver &Co) and electrolyte gel 
(Redux®Gel, Parker Lab Inc) were used to prepare the scalp electrodes which were then 
secured with porous adhesive tape. Electrodes were routinely checked and electrode gel 
reapplied to maintain electrode impedance at less than 5 kohm. Amplifier settings were: 
Filters set at 0.5Hz LFF and 70Hz HFF; Recording sensitivity set at 7µV and sampling rate 
of greater then 250Hz in all channels including the ECG channel. Activation methods 
used were mainly antiepileptic drug withdrawal and in some cases sleep deprivation.  
 
Electrocardiograph (ECG) was recorded using two disposable skin contact adhesive 
electrodes attached to the chest on each side below the clavicle and connected to the 
Nicolet One digital recording amplifier (The Modified Lead I ECG). Amplifier was set 
similar to the EEG acquisition channels. 2 channels of ECG were recorded using this 
modification. The sampling rate for the ECG signal was 256 Hz. Because ECG and EEG 
were recorded simultaneously I was able to accurately correlate the ictal EEG onset and 
clinical onset with the ECG. Video was recorded using NicOne LTM systems (VIASYS 
Healthcare Inc, Madison Wisconsin) which had motion sensor detectors for night time 
video recordings.  
 
RR Interval Analysis and Computer programs Used 
The ECG/EEG recordings once acquired were stored on data CDs and reviewed using 
Nicvue systems (Modular Neurodiagnostic Software system, version 5.3, registered to 
VIASYS Health Care™). In the peri-ictal heart rate variability study video recordings and 
EEG for all recorded seizures were reviewed simultaneously. For purposes of localization 
and classification, seizures were viewed in more than one montage; mainly “the 
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montage in which it was recorded” (referential) and bipolar “double banana” montage. 
Electrographic seizure duration was noted by marking the start and end time, and 
correlated with the video recording to rule out non epileptic events. The seizure was 
then equally divided into 3 time segments based on the duration of the electrographic 
discharge; thus there was an initial section of seizure, mid section of seizure and late 
section of seizure that was close to the termination of electrographic activity.  Ten 
seconds of the ECG/EEG signal in the midsection was selected to represent the ictal time 
period. After identifying the ictal period, 10 seconds of ECG/EEG signal were identified in 
a time period, 20 seconds after the end of electrographic discharge and in the period 
just before the onset of electrographic discharge to represent the “postictal” and 
“preictal” time periods respectively.   
 
In the diurnal heart rate variability study, ECG in the interictal period was reviewed from 
the onset of telemetry monitoring till 24hrs afterwards. 5 minute durations of ECG were 
analysed taken from the beginning of every hour for 24 hours, starting from the onset of 
investigation. These sections were generally devoid of movement artefacts. All ECG/EEG 
signal data were acquired in EDF (European Data Format) and underwent further 
computer digitization of the ECG signal to eventually  sequence the RR intervals (Figure 
11, 12 and 13). This process was done for all patients. After exporting data in EDF, a 
custom made software(EDF to ASCII Converter, figure 13) was then used to manually 
select only the ECG signal channel at sampling rate  256 Hz from the complete data set 
and converted into an ASCII(American standard code for Information Interchange) 
format file. A second custom made software (ECG_Analysis_32 program), consisting of a 
programme which utilizes an amplitude threshold applied to a channel of selected ECG 
(bandwidth 10Hz to 20Hz, sampling rate 256Hz) in ASCII format to detect QRS 
complexes, was used. Using the same software, The ECG signal marked with QRS 
complex detections, was then reviewed visually, spurious detections were removed and 
missed detections inserted manually for every segment of ECG analysed. This method of 
measuring RR intervals has been recommended by the HRV task force because manual 
editing of RR intervals as opposed to automatic filter editing, which tends to exclude RR 
intervals differing by more than 20% from the previous RR interval, is highly accurate 
and leads to minimal errors in the RR interval analysis. Also the RR interval analysis done 
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at a sampling rate greater than 250 Hz was in accordance with the HRV task force 
recommendations (Malik 1996).  
 
The time domain parameters; mean instantaneous heart rate (mHR), square root of the 
mean squared differences of successive RR intervals (rMSSD) and standard deviation of 
RR intervals (SDNN) were determined for each segment of ECG analyzed using Microsoft 
Excel. Instantaneous heart rate was determined for each segment by mathematically 
dividing 60 by the numerical value of each successive RR interval measured in seconds to 
obtain the heart rate in beats per minute. SDNN is a measure of variance of the whole 
segment and thus reflects all the cyclic components responsible for heart rate variability 
A reduced SDNN is a sign for increased cardiac sympathetic tone (Riediker et al. 2005). 
Frequency domain analysis was carried out on the 5 minute ECG segments using a 
custom made software that utilised mathematical fast Fourier transformation to 
separate the signal into its component power spectra (low frequency =0.04-0.15 and 
high frequency =0.15-0.40) (see figure 12) and automatically determines the ratio of low 
frequency power to high frequency power. This ratio has been described to be a 
measure of the cardiac sympathetic/vagal balance (Malik 1996). Only the mean heart 
rate and sdnn were computed on the short 10 seconds segments whilst all HRV indices 
mentioned above were computed on the longer 5 minute segments. 
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Figure 11 Flow diagrams that summarize the steps used in processing raw ECG signal to obtain data for 
HRV analysis. The ECG signal is extracted and by series of computer software processes the signal is 
digitised then the RR series manually edited before being converted to time frequency domain measures. 
RR data editing signifies the series of events that is mentioned in figure 13. SDNN standard deviation of RR 
intervals; RMSSD square root of the mean squared RR interval difference; mHR mean heart rate; LF low 
frequency power; HF high frequency power. 
 
 
 
 
 
 
Figure 12 Graphical display of power spectral analysis from a section of ECG used in the study. Two 
spectra are seen in which the larger spectrum corresponds to the low frequency band (0.04-0.15) and the 
smaller spectrum corresponds to the high frequency power (0.15-0.40). The area under the curve in each 
peak is the corresponding power and this is estimated by integrating between frequency limits. 
 
ECG SIGNAL 
 
COMPUTER DIGITISING of ECG SIGNAL 
RR DATA EDITING  
(ARTIFACT IDENTIFICATION AND RR 
INTERVAL REJECTION)  
 
RR DATA SEQUENCE  
 
TIME DOMAIN HRV 
SDNN 
Mean HR RMSSD 
FREQUENCY 
DOMAIN HRV 
LF/HF 
FFT 
(Interpolation and 
resampling) 
 70
  
 
 
 
    
      
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 13 Computer programs involved in the stepwise digitization of raw electrophysiological data (ECG) 
for the analysis of RR intervals. Apart from the Nicvue software used for reviewing the raw EEG/ECG data, 
other software’s were required to extract and analyze the RR intervals as shown in this diagram. 
Step 1 EEG and ECG are run in Nicvue review systems and data corresponding to time of interest is 
selected to be analyzed by the ASCII converter. ECG signal appears in bright red.  
Step 2  This programme manually selects the ECG signal converts to ASCII data from EDF.  
   
Step 3  ECG_ Analysis 32 programs detects QRS complexes and measures RR intervals by applying an 
amplitude threshold to a single channel of filtered ECG (sample rate 256Hz). The ECG signal, marked 
with QRS complex detections (vertical red lines), are then visually inspected, and spurious detections 
are removed whilst missed detections inserted manually. 
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Figure 14 A picture of the very relaxed atmosphere of a typical investigation cubicle at the Sir Jules 
Thorn Video Telemetry Ward in the National Hospital for Neurology and Neurosurgery. On screen 
display of recordings and the video camera are displayed in the top pictures. Recording Amplifier (Blue 
box) is strung across investigator. Electrodes have been placed in a typical 10-20 electrode placement 
system in a longitudinal double banana montage on the investigator. White patches are the cut pieces 
of porous adhesive tape used to secure the electrodes. This was done for all patients and has been 
described in the text. Courtesy: Sir Jules Thorn Video Telemetry Unit, National Hospital for Neurology 
and Neurosurgery, Queen Square, London WC1N 3BG. 
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3.4 Catecholamines, Serum Electrolytes and Cardiac Enzymes 
 
Peri-ictal measurements for serum catecholamines, electrolytes and the QT time were 
made for patients with medically intractable epilepsy who had complex partial seizures 
and also those who had secondary generalization during presurgical video-telemetry 
evaluations. Only those patients who had obvious clinical seizures, (Secondarily 
generalised tonic clonic seizures and complex partial seizures) correlated by video 
recording were included in this study. 
 
Catecholamine and Electrolyte estimation 
Blood samples were taken at 3 different time points  
• Within 5 minutes after an observable seizure for catecholamine estimation 
• 12 hours after the seizure to measure change in Troponin.  
• At the end of recording, on the morning of discharge from the ward for patients 
who had blood withdrawn immediately after observed seizures. 
  
The rationale for choosing these time periods for this study were: 1) Adrenalin/ 
Noradrenalin when released are rapidly hydrolysed from the blood stream within 10 
minutes (Goldstein et al. 2007) through various biochemical processes and any time 
beyond this would have missed crucial peaks in the plasma levels. 2) Serum markers of 
myocytic damage (Troponin T&I), begin to rise 3-4 hours after onset of ischemia and 
peaks in plasma after 12 hours persisting for up to 14 days. 3)  Withdrawing baseline 
samples at the onset of recording when no seizures had been ascertained, could have 
led to discarding and wastage of human tissue in the situation where no seizures 
occurred during the investigation or if the 5 minute benchmark was missed. 
 
Ten mls Venous blood was obtained from the antecubital fossa using 21G sterile Terumo 
needle syringes under aseptic conditions and separated into two plastic SST gel (Serum 
Separating Tube, silica gel)containing blood collection tube and labelled for electrolyte 
and catecholamine analysis for each patient accordingly. Each arm was used 
interchangeably. By virtue of study design, all the patients had seizures on different time 
of day and week, allowing for the crucial 5 minute post seizure sample to be taken with 
minimal time bias. The first SST gel bottle, containing 5 mls of venous blood for 
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determination of the electrolytes; Na
+
, K
+
, Ca
2+
, Mg
2+
 and the serum cardiac myocytic 
damage marker; Troponin T and I, was immediately sent for laboratory analysis to 
reduce risk of autolysis’ of red blood cells which is likely to affect potassium (K
+
 ) plasma 
estimations. To prevent and reduce catecholamine decay, 0.1 mls of the catecholamine 
preservative EGTA-Glutathione was added to the second sample bottle containing the 
other 5 mls of whole venous blood earmarked for catecholamine estimation and the 
bottle tipped over gently to ensure adequate mixing of preservative and sample, and 
activation of the anticoagulant. The sample was then spun in refrigerated centrifuge at 
4°c and speed of 1800rpm for 12 minutes. The plasma was then separated into a clean 
sample tube and immediately frozen in a minus 70 degrees celsius industrial freezer 
before being sent for estimation of catecholamines. Catecholamine measurement was 
done in collaboration with the Autonomic unit of the National Hospital for Neurology 
and Neurosurgery. The catecholamines were expressed in units of pg/ml, electrolytes 
expressed as mmol/L and Troponin, ug/L. Calcium was estimated as corrected calcium 
after adjusting for serum albumin. In addition, peri-ictal QT interval was determined 
from the period before the seizure; and 5 minutes after the seizure. Interaction between 
QT interval electrolytes and catecholamine levels at the base line and 5 minutes post 
seizure time points was evaluated. QT interval was manually measured with callipers 
from the start of the Q wave to the end of the T wave on the modified lead one ECG for 
three successive beats within the time periods. RR intervals for these successive beats 
were determined and used to calculate the corrected QT using Bazetts formula [QTc = 
QT*(RR)
-1/2
](Luo et al. 2004).  
 
3.5 Additional Sources of Data 
 
Age, gender and duration of epilepsy were obtained from the patient records using 
computerized hospital database and patient notes for all subjects. In addition the yearly 
seizure frequency and the antiepileptic drug polytherapy in which carbamazepine was 
inclusive at the time of telemetry were determined. Duration of epilepsy was 
determined as the years of uncontrolled epilepsy from the time of confirmation of 
epilepsy diagnosis to time of telemetry i.e. when patients were consented for this study. 
For purposes of statistical analysis lobar localisation were grouped into temporal and 
extratemporal lobe epilepsy. 
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3.6 Statistical Analysis  
 
Multilevel model analysis has been used to analyse the data in this study using STATA 10 
intercooled statistical software programme (StataCorp LP, Texas 77845, USA) registered 
to the UCL:   
 
• To test the primary hypothesis, comparisons of heart rate variability were made 
in the time periods: before; during and after a seizure and the effects of 
hemispheric laterality of seizure and lobar location were adjusted on the 
response variable which in this case was the difference in time points; before 
during and after. This statistical analysis was done using linear mixed model 
analysis, a multilevel mixed linear regression analysis, which allows within 
individual and between individuals’ variation to be accounted for and makes 
straight forward adjustment for the predictions of the effects of the explanatory 
variables: seizure duration, hemispheric and lobar location, age and epilepsy 
duration on the response variable. All outcome variables were tested for 
normality by using normal plots after transforming the data within each patient 
to have a zero mean and unit variance. For inclusion in the multiple regression 
models all the explanatory variables were first considered one at a time using 
univariate analysis to select the confounders with the highest association to the 
various response variables, i.e. p value less than 1. The final models have been 
presented in the chapters 4 and 5 of this thesis. Population averaged models 
were fitted in Stata 10 using linear mixed model analysis with the xtmixed 
command.   
 
• To test the second hypothesis, four summary statistics were produced for each 
outcome variable: rMSSD, sdnn, mHR, and LF/HF.  The data was multilevel in 
structure with time points nested within patient.  The four outcome variables 
were tested for normality by using normal plots after transforming the data 
within each patient to have a zero mean and unit variance.  The variable LF/HF 
was extremely skewed to the left and a log transformation was applied.  It should 
be noted that back transformation of a mean on the log scale results in a 
geometric mean on the original scale. Each of the four outcome variable was 
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plotted against the 24hour time period to show the diurnal pattern graphically. 
Explanatory variables considered at the patient level were age, sex, number of 
years since diagnosis, number of seizures per year, Antiepileptic drug 
polytherapy with carbamazepine, location and laterality of the seizure focus.  The 
explanatory variable at the time point level was whether the reading was taken 
between 8 am to 7pm (day) or 8pm to 7 am (night). First single variable models 
and then multivariable models were fitted to the data. In order to take account 
of data collected sequentially over time the within patient correlation structure 
was assumed to be autoregressive of order one. Two way interactions between 
the variables were investigated and the models were re-parameterized to 
investigate any significant interactions found. Population averaged models were 
fitted in Stata 10 using generalized estimating equations with the xtgee 
command. The final models for each outcome are presented in chapter 5 of this 
thesis.   
 
• To test the third hypothesis, sodium, potassium, calcium, magnesium, 
noradrenalin and adrenaline levels results were obtained from 16 patients. The 
corrected QT interval (QTc) was recorded from electrocardiogram (ECG) traces 
before seizure and 5 minutes after the seizure.  All outcomes were tested for 
normality by using normal plots and no transformations were required. The data 
were analyzed for each electrolyte separately with multilevel mixed effects linear 
regression in Stata 10 with the xtmixed command.  An initial analysis included 
the time the recordings were taken as a categorical fixed effect and patient as a 
random effect.  The results was declared statistically significant at the 5% level 
and the before seizure level was used as the baseline category for comparison.  
Seizure duration and the seizure type were included in a secondary multivariable 
analysis as explanatory variables at the patient level.  These analyses are 
presented in chapter 6 of this thesis. 
 
These statistical methods were recommended by Dr Constantinos Kallis and Mrs Pauline 
Rogers, statisticians at the Institute of Neurology, who instructed me in the planning and 
application of the statistical methods. 
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Chapter 4 
 
Heart rate variability during subclinical seizures in partial 
epilepsy 
 
Subclinical seizures are defined as electroencephalographic seizure patterns without any 
disturbance of motor, sensory and conscious functions in the awake patient and without 
any movement or arousal in the sleep patient (Zangaladze et al. 2008). They must not be 
confused with subclinical rhythmic electrographic discharge of adults which is a rare 
monophasic sharply contoured theta frequency discharge, usually diffuse but with 
temporal lobe dominance and occurs in the drowsy or restful awake individual also with 
no associated clinical symptoms as well. The defining feature of the latter is the “state 
restriction”, lack of post ictal slowing and preservation of posterior dominant rhythms.  
Long term video monitoring in epilepsy provides means by which subclinical seizures can 
be observed and studied. Subclinical seizures are closely related to the clinical seizures 
itself and may be indicative of the location of the epileptogenic zone. The lack of clinical 
symptoms during subclinical seizures is probably due to insufficient propagation or 
synchrony of the electrographic discharges (Zangaladze et al. 2008). I have used the 
above definition, although there is a “grey area” between the terms “subclinical” and 
“clinical” and with the use of more sophisticated neurological testing, it is possible that 
subtle movements and cognitive dysfunction may be detected during these 
electrographic discharges. Moreover, it is well recognised that even interictal 
epileptiform discharges can produce subtle impairment of cognition (Binnie 2003). It 
should be noted that in this study patients with spike wave discharges in Idiopathic 
Generalised Epilepsy were not included and the results obtained in partial epilepsy may 
well not apply in other forms of epilepsy. 
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4.1 Aim 
  
The aim in this  study was to test the hypotheses that changes in heart rate variability 
(HRV, as an index of cardiac autonomic function) occur in partial epilepsy without 
clinically overt seizures, (i.e. during subclinical electrographic seizure patterns), and that 
changes observed can help localise or lateralise the seizure discharge focus.  
 
4.2 Methodology 
 
Only patients who had intracranial video EEG were recruited for this study.  The 
electrodes which were either 64 contact subdural grids or10 contact subdural strips or 6 
contact depth had been inserted stereotactically under general anaesthesia. Details 
discussed in Chapter 3, section 3.3. 
 
4.3 Statistical Analysis 
 
Ictal and postictal HRV were compared with the preictal HRV (baseline) using linear 
mixed model analysis. Details discussed in chapter 3 sections 3.6.  
 
 
 
 
 
 
 
 
 
 
 78
4.4 Results 
Summary of Clinical features  
26 patients with medically refractory partial epilepsy were included in this study. One 
TLE patient without underlying cardiac disease had had an episode of ictal asystole in 
previous video-EEG telemetry, and a DDDR cardiac pacemaker had been implanted. A 
total of 74 subclinical seizures (2-3 per patient) were analysed. Twelve patients displayed 
left hemisphere subclinical seizures (7 patients TLE, 5 patients FLE) and 14 patients’ right 
hemisphere subclinical seizures 7 TLE, 7 FLE). The mean (SD) duration of subclinical 
seizures was 72(14) s (range 10 - 964 s). The most common neuropathological finding 
was hippocampal sclerosis (Table 4.1). The subclinical events were highly localised 
electroencephalographically with minimal spread to adjacent contacts of respective 
electrodes or grids (Table 4.2). Table 4.3 shows the overall data in the three time 
periods, whilst tables 4.4 and 4.5 depict HRV in temporal and frontal lobes respectively. 
 
Table 4.1 Summary of the clinical features of patients (n=26) 
Clinical characteristics Observation 
 
Duration of epilepsy 
mean(SD) (range) years 
 
28(12)(7-47) 
Duration of Subclinical Seizures 
mean(SD)(range) s 
 
72(14)(10-964) 
Age  
mean(SD)(range) years 
 
38(10)(21-54) 
Gender  13 males  
13 females 
Aetiology of seizures 9 HS 
1FCD 
3 Tumours 
3 Trauma 
9 Cryptogenic  
Epilepsy Type 14 TLE 
12 FLE 
Total number of subclinical seizures 74 
 
TLE temporal lobe epilepsy; FLE frontal lobe epilepsy; HS hippocampal sclerosis; FCD; focal cortical 
dysplasia; S; seconds. 
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Table 4.2 Electrode placement and type, Total number of Electrode contacts and 
the total number of contacts involved during spread. 
 
 
Patient Lesion type Intracranial Electrode type Total Number 
 of 
Electrode contacts 
No of contacts 
involved 
during spread 
 
1 
 
Hippocampal sclerosis 
 
Depth and Subdural strip 
 
40 (20 left, 20right ) 
 
3 
2 Hippocampal sclerosis Depth, Subdural grid and 
strip 
44 7 
3 Hippocampal  sclerosis Depth, Subdural grid and 
strip  
38 6 
4 Hippocampal sclerosis Depth, Subdural grid and 
strip  
68 14 
5 Hippocampal sclerosis Subdural strip 12 (6 left, 6 right) 3 
6 - Depth, Subdural grid and 
strip  
66 3 
7 Hippocampal sclerosis Subdural grid and strip 48 4 
8 Hippocampal sclerosis Depth and Subdural grid 24(12 left, 12 right) 6 
9 Trauma (contusion) Subdural grid 12 3 
10 Hippocampal sclerosis Subdural grid 30 (18 right, 12 left) 4 
11 Hippocampal sclerosis Depth and Subdural grid 30(18 right, 12 left) 1 
12 Focal cortical dysplasia Subdural grid and strip 50 1 
13 Hippocampal sclerosis Depth and Subdural grid  24(12 left, 12 right) 2 
14 Hippocampal sclerosis Subdural grid and strip  30(18 right, 12 left) 4 
15 DNET(WHO G1) Depth and Subdural strip  54 6 
16 Rasmussen 
Encephalitis 
Depth and Subdural strip  48 16 
17 - Depth and Subdural strip 48 7 
18 - Subdural grid and  strip 60 11 
19 - Depth and Subdural strip  66 2 
20 Focal cortical dysplasia Depth, Subdural grid and 
strip  
58 1 
21 - Depth and Subdural strip  70 6 
22 Cavernous 
hemangioma 
Depth, Subdural grid and 
strip  
60 14 
23 Oligodendroglioma Depth and Subdural strip  54 10 
24 Frontal lobe cystic 
lesion 
Depth and Subdural strip 40 9 
25 - Depth, Subdural grid and 
strip  
54 12 
26 - Depth, Subdural grid and 
strip  
56 10 
 
Electrode placements, Electrode type and the contacts involved in spread. The seizures remain highly 
localised as can be seen from the number of electrode contacts involved in spread. RFL right frontal 
lobe; LTL left temporal lobe; RTL right temporal lobe; LFL left frontal lobe. 
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Table 4.3 Comparison of sdnn and mHR in the 3 time periods in all patients 
Variables Time1 
(Before Seizure) 
Mean (SD) range 
Time 2 
(During Seizure) 
Mean (SD) range 
Time 3 
(After Seizure) 
Mean (SD) range 
 
Sdnn 
 
overall 
 
28.41(20.26)2.73-83.23 
 
27.32(16.57)1.83-64.12 
 
29.30(21.23)2.31-87.97 
 between (17.57)3.43-70.93 (14.63)2.86-51.07 (20.29)3.18-70.94 
 within (10.63)3.59-64.61 (8.45) 8.91-50.22 (8.09)12.09-54.51 
     
mHR overall 80(10)63-108 82(11)61-105 81(10)65-100 
 between (10)63-100 (10)63-99 (9)66-98 
 within (4)72-94 (4)65-101 (4)72-94 
 
 
Table shows overall mean and standard deviation in addition to the between and within patient standard 
deviations. Within patient variation is low compared to between patient variation. Sdnn standard 
deviation of normal to normal RR intervals; mHR mean instantaneous heart rate; Seizure subclinical 
seizure; Italicised figures represent the range and the figures in brackets’ are the standard deviations.  
 
Table 4.4 Comparison of sdnn and mHR in temporal lobe epilepsy 
variables Left hemisphere 
mean(SD) range 
 Right hemisphere 
mean(SD) range 
 
sdnn/ms 
 
overall 
 
12.79(5.99)3.08-27.39 
  
34.47(17.08)6.9-87.97 
 between (3.97)7.24-18.31  12.34)25.02-59.61 
 within (4.56)3.34-27.58  (13.43)13.74-67.86 
     
mHR/bpm overall 90(9)68-108  78(6)66-90 
 between (7)79-99  (5)72-85 
 within (5)75-101  (4)68-87 
 
.  
 
 
 
 
Table 4.5 Comparison of sdnn and mHR in frontal lobe epilepsy 
variables Left hemisphere 
mean(SD) range 
 Right hemisphere 
mean(SD) range 
 
sdnn/ms 
 
overall 
 
38.39(20.73)5.50-85.41 
  
29.67(20.18)1.83-79.14 
 between (19.84)11.21-63.18  (16.38)3.16-42.09 
 within (10.37)8.32-61.73  (13.18)1.29-71.68 
     
mHR/bpm overall 78(10)64-96  78(11)61-100 
 between (10)67-94  (9)64-93 
 within (3)72-83  (6)67-102 
 
 
Table shows overall mean and standard deviation in addition to the between and within patient standard 
deviations. There is lower within patient variation as compared to between patient variations. Sdnn and 
mHR values recorded from the left are lower than the right. Sdnn: standard deviation of normal to normal 
RR intervals, mHR: mean instantaneous heart rate. Italicised figures represent the range and the figures in 
brackets’ are the standard deviations 
The difference is not significant between left and the right side: sdnn (P=0.42), mHR (P=0.90). Sdnn: 
standard deviation of normal to normal RR intervals, mHR: mean instantaneous heart rate. Italicised 
figures represent the range and the figures in brackets’ are the standard deviations 
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Sdnn during subclinical seizures 
On average, there is no significant change in HRV from preictal to ictal (P= 0.57) and 
between the preictal and postictal HRV (P=0.64). After adjusting for all the other 
variables, HRV is lower by 27ms in patients with temporal lobe epilepsy (P=0.003, 95%CI 
9.37ms to 45.39ms). Within patients with temporal lobe epilepsy, Right hemispheric 
epileptogenic region increases the HRV by about 24ms (P=0.001, 95%CI 9.91ms to 
37.96ms). The effects of age (P=0.067), gender (P=0.68), duration of seizures (P= 0.17), 
number of seizures (P=0.27) and spread to adjacent brain regions (P=0.27) on the HRV 
during subclinical seizures are not statistically significant.  
 
Table 4.6 Results of sdnn analysis 
Sdnn/ms coefficient standard 
error 
P 
value 
95% CI 
 
 
Time period1(preictal vs. ictal 
 
-1.09 
 
1.93 
 
0.57 
 
-4.87 to 2.69 
Time period2(preictal vs. postictal) 0.89 1.93 0.64 -2.88 to 4.67 
Gender(female vs. males) 2.35 5.77 0.68 -8.95 to 13.67 
seizure duration/secs 0.01 0.009 0.17 -0.005 to 0.03 
epilepsy duration/years 0.25 0.22 0.26 -0.18 to 0.69 
Age/years -0.59 0.32 0.067 -1.23 to 0.04 
Lobar location(TLE vs. FLE) -27.38 9.18 0.003 -45.39 to -9.37 
TLE  (Right vs. Left) 23.94 7.15 0.001 9.91 to 37.96 
FLE(Right vs. Left) -6.34 7.89 0.42 -21 to 9.12 
Spread to adjacent contacts -0.75 0.68 0.27 -2.08 to 0.58 
Seizures 1.15 1.04 0.27 -0.91 to 3.21 
 
 
A negative coefficient means the outcome variable decreases by that amount when the explanatory 
variable is adjusted for. FLE: frontal lobe epilepsy, TLE: temporal lobe epilepsy. 
 
Mean heart rate during subclinical seizures 
On average, mean instantaneous heart rate increases during subclinical events by about 
2bpm (P= 0.023, 95% CI 0.24bpm to 3bpm) after adjusting for all the other variables. 
Overall the rise in mean heart rate is higher in patients with temporal lobe epilepsy 
compared to those with frontal lobe epilepsy by about 15bpm (P=0.016, 95% CI 3bpm to 
27bpm) after adjusting for the effects of all the other variables. Within the patients with 
temporal lobe epilepsy, right hemispheric epileptogenic region decreases the mean 
heart rate by about 11bpm (P=0.026, 95%CI 1bpm to 20bpm).  The effects of age 
(P=0.85), gender (P=0.79), seizure duration (P=0.52), epilepsy duration (P=0.38), spread 
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to adjacent brain regions (P=0.34) and the number of successive seizures (P=0.09) on the 
mean heart rate during subclinical seizures are not significant. 
 
Table 4.7 Results of MHR analysis 
mHR/bpm coefficient standard 
error 
P 
value 
95% CI 
 
 
Time period1(preictal vs. ictal 
 
2 
 
1 
 
0.023 
 
0.24 to 3 
Time period2(preictal vs. postictal) 1 1 0.15 -0.4 to 3 
Gender(female vs. males) -1 4 0.79 -9 to 7 
seizures -1 0.42 0.09 -2 to 0.4 
seizure duration/secs -0.003 0.004 0.52 -0.01 to 0.005 
epilepsy duration/years -0.13 0.15  0.38 -0.43 to 0.16 
Age/years 0.04 0.22 0.85  -0.4 to 0.5 
Lobar location(TLE vs. FLE) 15 6 0.016 3 to 27 
TLE (Right vs. Left) -11 5 0.026 -20 to -1 
FLE (Left vs. Right) 0.64 5 0.90 -10 to 11 
Spread to adjacent contacts 0.43 0.45 0.34 -0.45 to 1 
 
 
A negative coefficient means the outcome variable decreases by that amount when the explanatory 
variable is adjusted for. FLE: frontal lobe epilepsy, TLE: temporal lobe epilepsy. 
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Figure 15 Box plots of the overall sdnn (a) and the mean instantaneous heart rate (b) in the three 
experimental time periods. No significant differences (pooled data) in HRV, whereas HR was slightly 
increased (p= 0.023) during the subclinical seizure. The values are presented as medians (horizontal bars) 
with the interquartile range at the end of the boxes. The vertical capped bars represent the maximum and 
minimum values above and below the interquartile ranges. The dots are the outliers. 
15a Standard deviation of normal to normal RR intervals (sdnn) 
15b Mean instantaneous Heart rate (mHR) 
Before  Subclinical seizure After 
Before  Subclinical seizure After  
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4.5  Discussion 
 
In summary, HRV does not change during subclinical seizures. Mean heart rate increases 
slightly during subclinical seizures. Patients with temporal lobe epilepsy have reduced 
HRV and increased mean heart rate. This is particularly so with left temporal lobe 
epilepsy. In this study, I have used data from short 10 seconds ECG recordings and  
observed, in contrast to a previous study which included mostly patients with scalp EEG 
recordings (Weil et al. 2005), only minor changes in HR independent of the duration of 
the subclinical pattern. This difference might be due to the limited extent of the 
electrographic pattern in these subclinical seizures in the study, and it may be the case  
that clear changes in mean heart rate  occur only when there is more extensive spread 
of electrographic seizure activity (Epstein et al. 1992). Furthermore, HRV did not
 
change 
during or after subclinical patterns; these findings are in accordance with those from 
recent studies that investigated HRV during epileptiform activity and subclinical 
generalised spike and wave activity in children (Assaf et al. 2008; Longin et al. 2007). I 
have also found that the influence of the frontal and temporal lobes on the mean heart 
rate and heart rate variability are different. Temporal lobe epileptogenicity, in particular, 
is associated with a low HRV and high mHR. These findings suggest that neuronal 
networks within temporal and frontal lobes have a differential impact on autonomic 
function. However, I cannot rule out the possibility that the observed differences in 
autonomic function in the frontal and temporal lobes are, to some extent, due to 
differences in lesion anatomy or cerebral volume that is covered with different electrode 
types (grid versus depth and subdural strip).  
 
In addition, temporal lobe epilepsy can cause extensive cortical dysfunction. Insula 
underfunctioning releases the inhibition provided to the brainstem autonomic centres 
and result in increased sympathetic function (Oppenheimer 2006; Oppenheimer 2007),  
reflected as reduced HRV. The finding that cardiac sympathetic tone is increased in 
patients with left temporal lobe epilepsy is consistent with the presumed asymmetric 
representation of autonomic function (Oppenheimer et al. 1990; Oppenheimer et al. 
1992; Swartz et al. 1994; Zamrini et al. 1990), i.e. that inactivation of right hemisphere 
leads to decrease in HR whereas left-sided inactivation to an increased HR. Likewise, PET 
imaging and neuropsychological studies indicated interictal dysfunction of the affected 
brain regions; a lesion in the left-sided temporal lobe structures may lead to impaired 
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parasympathetic activity and a right-sided lesion to an impaired sympathetic activity. 
The finding of autonomic dysfunction with impaired parasympathetic activity and 
predominant sympathetic activity in left temporal lobe epilepsy is also consistent with 
earlier reports on interictal autonomic dysfunction in chronic epilepsy (Diehl et al. 1997; 
Evrengul et al. 2005; Hilz et al. 2002).  
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Chapter 5 
 
Heart rate variability during clinical seizures in partial epilepsy 
 
Abnormal cortical activity during overt epileptic seizures (“clinical seizures”) recruits 
regions of the central autonomic network. It has been proposed that seizures modify 
cardiovascular autonomic function by the involvement of these areas during seizure 
propagation. Several studies in epilepsy suggests that there is an interictal autonomic 
disturbance in patients with epilepsy (Adjei et al. 2009; Devinsky et al. 1994; Devinsky 
2004; Hilz et al. 2002; Mukherjee et al. 2009) however only a few describe ictal or peri-
ictal cardiac autonomic dysfunction using the HRV (Toth et al. 2010).  Abnormal cardiac 
autonomic function is thought to be one possible mechanism of SUDEP and as SUDEP 
occurs mainly in the ictal or immediate peri-ictal period of a seizure (Langan et al. 2005; 
Nashef et al. 1997; Nieminen et al. 2010), one could hypothesise that this is also the 
time of maximal cardiac autonomic change. However, the extent and severity of 
autonomic dysfunction during this period is unknown. Several different patterns of 
autonomic dysfunction have been postulated to occur in the peri-ictal period, and 
common to all is the potential for the autonomic disturbance to result in peri-ictal 
arrhythmia, a known risk for sudden death and a potential mechanism for SUDEP 
(Nilsson et al. 1999; Rugg-Gunn et al. 2000; Surges et al. 2009c). 
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5.1 Aim  
 
The aim in this study was to test the hypothesis that changes occur in the heart rate 
variability (as an index of autonomic function) during clinically overt complex partial 
seizures. Also, if these changes do occur, to determine whether they can be used to 
localise the seizure focus within the cerebral cortex.  
 
5.2 Methodology 
 
Only patients who had complex partial seizures during video telemetry were included in 
this study. SDNN and mean heart rate were done on 10 second periods of ECG which 
were free of artefacts. See chapter 3 section 3.3 for comprehensive description of 
methods. 
 
5.3 Statistical Analysis 
 
Ictal and postictal HRV were compared to the preictal HRV using linear mixed model 
analysis. See chapter 3 section 3.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 88
5.4 Results 
Summary of Clinical Characteristics 
A total of 109 chronic epilepsy patients (56 males and 53 females) who were under 
evaluation for epilepsy surgery were included in this study. The mean duration of 
epilepsy was 21(12) years and about 47% of these patients were on carbamazepine in 
addition to other antiepileptic drugs. 70 patients had temporal lobe epilepsy and 39 had 
extra temporal lobe epilepsy. 217 seizures were studied, 105 and 112 seizures localized 
to the right and left hemisphere respectively. 88 seizures emanated from the 
extratemporal lobe focus and 129 from a temporal lobe focus. The most common 
pathological finding on MRI was hippocampal sclerosis and in 40 patients no cause for 
the epilepsy was known and there was no abnormality on MRI. All patients had up to 96 
hours of video EEG telemetry and between 1- 3 successive seizures were recorded from 
each patient. The mean seizure duration was 76(55) seconds. 
 
Table 5.1 Patients clinical characteristics (n=109) 
Clinical features  Observation(n) 
 
Epilepsy duration/years 
mean(SD) range 
 
21(12); 2 to 58 
Seizure duration/secs 
mean(SD) range 
76(55); 12 to 283 
Age of patients/years 
mean(SD) range 
35(11); 18 to 65 
Gender/n Male 56 
Female 53 
Carbamazepine related polytherapy/n Yes 51 
No  58 
Hemispheric location of Epileptic focus/n Left 57 
Right 52 
Lobar Location of Epileptic focus/n TLE 70 
exTLE 39 
Total number of seizures/n 217 
 
 
 
n number; exTLE extratemporal lobe epilepsy; TLE temporal lobe epilepsy; SD standard 
deviation 
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Table 5.2 MRI findings for all patients (n=109) 
MRI pathology Number of Patients 
 
Normal MRI 
 
40 
Hippocampal sclerosis 35 
Malformations of cortical development 11 
Dysembryoplastic Nerve Cell Tumor 5 
Tumors (not DNET) 5 
Vascular Malformations 7 
Traumatic Lesions 3 
Ischaemic Lesions 2 
Neurocutaneous syndromes 1 
   
 
 
Summary of HRV indices 
Overall characteristics of the measured HRV indices are presented in the following tables 
(5.3 to 5.5). The time domain indices; sdnn and mean instantaneous heart rate were 
analyzed from 10 second ECG segments. 
 
Table 5.3 Comparison of sdnn and mHR in the three time periods 
Variables Time1 
Preictal 
mean(SD) range 
Time 2 
Ictal 
mean(SD) range 
Time 3 
Postictal 
mean(SD) range 
 
Sdnn 
 
overall 
 
34.02(19.55)6.08-96.35 
 
18.88(12.92)2.58-113.64 
 
33.11(20.38)2.86-98.73 
 between (17.14)9.41-96.35 (13.22)5.74-113.64 (18.18)4.00-86.15 
 within (11.53)3.67-70.25 (6.81) 1.09-57.86 (12.11)8.73-74.34 
     
mHR overall 74(13)50-143 112(30)60-197 89(22)58-192 
 between (12)51-117 (26)71-187 (19)56-142 
 within (6)39-110 (15)56-161 (14)30-153 
 
 
 
 
 
 
 
 
 
Heart rate variability compared in the periods before during and after the seizures showing the overall, 
between and within patient variation. Within patient variation remains smaller than between patient 
variation. Overall there is a marked reduction in sdnn during the seizure (P=0.0001) which returns to 
around preictal levels in the period 20 seconds after the seizure offset. Mean instantaneous heart 
increases during the seizure (P=0.0001) but remains fairly high after the seizure (P=0.0001). Sdnn: 
standard deviation of the normal to normal RR intervals over 10 seconds, mHR: mean instantaneous heart 
rate.   
Up to 36 % of the patients had normal pathology on MRI and had probably cryptogenic 
partial epilepsy. 
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Table 5.4 Comparison between left and right hemispheric sides in TLE in the peri-
ictal period 
 
variables Left hemisphere 
mean(SD) range 
 Right hemisphere 
mean(SD) range 
 
sdnn/ms 
 
overall 
 
26.94(19.45)2.58-113.64 
  
27.95(17.71)4.07-98.73 
 between (13.43)10.49-67.20  (11.28)10.85-70.01 
 within (15.46)12.15-89.66  (14.44)11.83-82.77 
     
mHR/bpm overall 95(27)51-187  88(23)58-188 
 between (15)62-128  (14)66-121 
 within (24)46-184  (18)71-165 
 
 
 
 
Table 5.5 Comparison between left and right hemispheric sides in exTLE in the peri-
ictal period. 
 
variables Left hemisphere 
mean(SD) range 
 Right hemisphere 
mean(SD) range 
 
sdnn/ms 
 
overall 
 
28.93(20.14)2.86-89.9 
  
32.12(19.64)6.71-86.67 
 between (11.34)13.26-51.45  (10.87)18.90-55.92 
 within (16.67)5.92-86.18  (16.81)4.01-76.50 
     
mHR/bpm overall 93(9)50-197  91(30)52-187 
 between (17)61-128  (16)70-124 
 within (27)40-172  (24)40-171 
 
 
 
 
Sdnn during complex partial seizures 
On average, HRV decreases during seizures by about 15ms (P<0.001, 95%CI 12.24ms to 
18.04ms) after adjusting for the effects of gender, age, number of successive seizures, 
seizure duration, epilepsy duration, lobar and hemispheric location of the epileptic focus 
and that due to carbamazepine polytherapy. There is no statistical difference between 
the postictal and preictal HRV (P=0.54). Overall, for every additional seizure after a first 
seizure, HRV decreases by about 4.7ms (P=0.012, 95%CI= 1.03ms to 8.34ms). Age 
Heart rate variability is compared in the left and right hemispheric region in patients with temporal lobe 
epilepsy. The difference in sdnn (P=0.62) and mHR (P=0.29) is not significant. TLE: temporal lobe epilepsy. 
HRV of the left and right hemispheric sides in patients with extratemporal lobe epilepsy is compared. 
There is no clear difference between the two sides in both sdnn (P=0.62) and mHR (P=0.29). Sdnn: 
standard deviation of normal to normal RR intervals, mHR: mean instantaneous heart rate, and exTLE: 
extratemporal lobe epilepsy.  
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(P=0.79), gender (P=0.95), duration of seizure (P=0.39) hemispheric or lobar location 
(P=0.62 and P=0.09 respectively), carbamazepine treatment (P=0.20) and the duration of 
epilepsy (P=0.70) have no effects on the HRV during seizures. 
 
Table 5.6 Results of sdnn analysis during complex partial seizures 
sdnn/ms coefficient standard 
error 
P 
value 
95% 
Confidence interval 
 
Time period1(preictal vs. ictal 
 
-15.14 
 
1.48 
 
<0.001 
- 
18.04 to -12.24 
Time period2(preictal vs. postictal) -0.90 1.48 0.54 -3.80 to 1.99 
Gender(female vs. males) 0.14 2.29 0.95 -4.34 to 4.63 
seizures -4.68 1.87 0.012 -8.34 to -1.03 
seizure duration/secs 0.013 0.02 0.39 -0.02 to 0.04 
epilepsy duration/years -0.05 0.13 0.71 -0.29 to 0.20 
Age/years -0.04 0.15 0.78 -0.34 to 0.25 
Lobar location(TLE vs. exTLE) -4.05 2.41 0.09 -8.77 to 0.67 
Hemispheric Location(Left vs. Right) -1.19 2.40 0.62 -5.91 to 3.51 
CBZ related treatment -2.97 2.32 0.20 -7.52 to 1.59 
 
 
 
 
 
Mean heart rate during complex partial seizures  
On average, mean heart rate increases during seizures by about 39bpm (P<0.001, 
95%CI=35bpm to 42bpm) and in the postictal state, the mean heart rate is high when 
compared to the preictal state by about 15bpm (P<0.001, 95%CI=12bpm to 19bpm) after 
the effects of age, sex, seizure duration, epilepsy duration lobar and hemispheric 
location of epileptic focus and carbamazepine related polytherapy have been adjusted 
for. Overall female patients with epilepsy have higher mean heart rates of about 6bpm 
more than their male counterparts (P=0.041, 95%CI=0.24bpm to 13bpm). On average 
every 1 second increase in the seizure duration will increase the peri-ictal mean heart 
rate by 0.04 bpm (P=0.024, 95%CI=0.01bpm to 0.08bpm). Both epilepsy duration and 
the age of the patient have significant effects on the peri-ictal mean heart rate. Overall 
every one year increase in the age of patient, decreases the peri-ictal mean heart rate by 
1bpm (P=0.001, 95%CI= 0.3bpm to 1bpm) and for every additional year of epilepsy, peri-
ictal mean heart rate increases by 0.34bpm (P=0.035, 95%CI=0.02bpm to 0.7bpm) after 
adjusting for the effects of all the other variables. Finally, hemispheric location (P=0.29), 
Multiple regression analysis tables showing the explanatory variables included in the final mixed model 
analysis for the sdnn. Coefficients represent the mathematical weighting of the explanatory variables on 
the outcome variable. Negative coefficients represent a decreased effect. CBZ carbamazepine; TLE 
temporal lobe epilepsy; exTLE extratemporal lobe epilepsy 
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lobar location (P=0.79), number of successive seizures (P=0.78) and carbamazepine 
related polytherapy (P=0.22) do not influence the mean heart rate. 
 
Table 5.7 Results of mHR analysis during clinical seizures 
mHR/bpm coefficient standard 
error 
P 
value 
95% 
Confidence interval 
 
Time period1(preictal vs. ictal 
 
39 
 
2 
 
<0.001 
 
35 to 42 
Time period2(preictal vs. postictal) 16 2 <0.001 12 to 19 
Gender(female vs. males) 6 3 0.041 0.24 to 13 
seizures -1 2 0.78 -5 to 3 
seizure duration/secs 0.04 0.02 0.024 0.01 to 0.08 
epilepsy duration/years 0.34 0.2 0.035 0.02 to 0.7 
Age/years -1 0.2 0.001 -1 to -0.3 
Lobar location(TLE vs. exTLE) -1 3 0.79 -7 to 5 
Hemispheric Location(Left vs. Right) 3 3 0.29 -3 to 9 
CBZ related treatment 4 3 0.22 -2 to 9 
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Multiple regression analysis tables showing the explanatory variables included in the final mixed model 
analysis for the mHR. Coefficients represent the mathematical weighting of the explanatory variables on 
the outcome variable. Negative coefficients represent a decreased effect whereas a positive coefficient 
refers to increased effect of the explanatory variable on the outcome variable. CBZ carbamazepine; TLE 
temporal lobe epilepsy; exTLE extratemporal lobe epilepsy; mHR mean instantaneous heart rate 
 
Preictal Ictal Postictal 
Figure 16 Box graphs of the sdnn and mHR.  Values are presented as medians (horizontal bars) 
with the interquartile range at the end of boxes. The vertical capped bars represent the maximum and 
minimum values above the upper and lower quartiles respectively. The dots represent the outliers. On 
the average, sdnn decreases (P<0.001) during the ictal phase and returns to preictal levels at the end of 
the seizure (P=0.54). However the mean heart rate increases during the ictal phase (P<0.001) and 
decreases after the seizure but remains significantly higher than the preictal level (P<0.001). 
Postictal Ictal Preictal 
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5.5 Discussion 
 
In summary, I have found that HRV decreases during clinical seizures and decreases with 
every additional seizure after a first seizure.  The mean heart rate increases during 
seizures. The age of patient and duration of epilepsy decreases and increases the peri-
ictal mean heart rate respectively. Neither the hemispheric location nor lobar location of 
the epileptic focus has any significant effect on the changes of the heart rate variability 
during seizures. In this study, I have evaluated heart rate variability in the immediate 
preictal phase (20 seconds before seizure onset), mid ictal phase and the immediate 
postictal (20 seconds after the seizure offset in complex partial seizures from patients 
with chronic medically refractory epilepsy. In addition, I have demonstrated that the 
HRV is reduced whereas the mean heart rate is increased during epileptic seizures. I 
have also found HRV to decrease with successive seizures not particularly seizure 
clusters. About half of the patients in this group were on carbamazepine and since all 
the patients had drug reduction during telemetry, this may be related to the 
enhancement of cardiac sympathetic tone following sudden withdrawal of 
carbamazepine (Hennessy et al. 2001). Ictal tachycardia was observed to be the most 
common cardiac rhythm change during  epileptic seizures, as has been reported before 
(Jansen et al. 2010; Leutmezer et al. 2003; O'Regan et al. 2005).  
 
The findings suggest that an epileptic seizure irrespective of the localization of the 
epileptic focus causes reversible increase in cardiac sympathetic activity which may be 
further compromised when seizures are repetitive. This is the first study to have looked 
at the ictal autonomic changes of HRV. An earlier study evaluated peri-ictal rather than 
the ictal HRV and the results suggested postictal decrease of HRV which persisted for as 
long as 6 hours after seizure offset (Darbin et al. 2002; Mayer et al. 2004; Naritoku et al. 
2003; Toth et al. 2010) and my findings provide confirmation of this and show that the 
change in HRV is triggered during the ictus itself. One possible significance of these 
findings is that the timing of the reduction in HRV during the seizure, starting ictally and 
extending into the immediate postictal period, is similar to that of the occurrence of 
SUDEP. During epileptic seizures, the reduced HRV is due to an ictally-induced increase 
in sympathetic tone. Similar findings of increased sympathetic tone during seizures have 
been found in animal models of epilepsy (Lathers et al. 1982; Sakamoto et al. 2008). The 
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marked reduction in the HRV during the seizure and the persisting reduction in 
successive seizures are interesting. There are many studies that have linked epileptic 
seizures with abnormal function in the autonomic nervous system (Baumgartner et al. 
2001; Sakamoto et al. 2008; Surges et al. 2010a; Toth et al. 2010), but none have 
previously been able to determine that this is direct consequence of ictal activity.  
Propagation of the electrical component of seizures in the cortex is associated with the 
recruitment of contiguous areas in the cortex - central autonomic network and 
disinhibition of the cardiovascular control centers in the lower brainstem. The increase 
in the sympathetic tone may result in tachyarrhythmia typically ventricular and atrial 
fibrillation (Oppenheimer 1993; Oppenheimer 2007; Zhang et al. 2000b) and several 
clinical studies have described tachyarrhythmia, bradyarrythmias and asystole during 
epileptic seizures (Opherk et al. 2002a; Rugg-Gunn et al. 2000; Standridge et al. 2010; 
Zijlmans et al. 2002). This is clearly a potential mechanism for SUDEP (Nilsson et al. 1999; 
Sakamoto et al. 2008). The findings from all these studies and from my study can be 
taken to imply that during an epileptic seizure a major increase in cardiovascular 
sympathetic tone (decreased HRV) occurs which may overwhelm the autonomic reflex 
mechanisms.  
 
Hemispheric and lobar location of the epileptic focus did not influence the HRV in 
contrast to the findings of an earlier study (Toth et al. 2010). In that study the timing for 
HRV sampling at 20 min postictal made it more interictal than peri-ictal and the former 
has been found to be associated with asymmetry of autonomic function. Increased 
cerebral metabolism occurs in the epileptogenic zones, as can be demonstrated for 
instance by ictal SPECT (Adjei et al. 2009; Kazemi et al. 2010; Lamusuo et al. 1997; Wong 
et al. 2010). Also there is evidence for interhemispheric spread of electrical activity 
during complex partial seizures (Eross et al. 2009; Seyal et al. 2009). These and the 
findings in this study show that there is disruption of the interictal hemispheric 
localization of autonomic function in the cerebral cortex during the ictal period. The 
effects of age and epilepsy duration on the mean heart rate, mirrors the global changes 
to mean heart rate with these parameters (Devinsky et al. 1994; Earnest et al. 1992; 
Opeskin et al. 2000) and the fact that the peri-ictal HRV is not affected by these factors 
may be because of the lack of correlation between the HRV and heart rate (Sztajzel et al. 
2008).  
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Chapter 6 
 
Interictal and circadian rythm of heart rate variability in partial 
epilepsy  
 
The autonomic tone in the cardiovascular system is maintained under a distinct circadian 
rhythm by the hypothalamo-pituitary pineal network and the adrenergic system (Singh 
et al. 2003). It has been established in previous studies that the heart rate variability 
(HRV) is higher during the night time than during the day time. However, a detailed 
analysis and the significance of this phenomenon are still under investigation 
(Bonnemeier et al. 2003; Carrington et al. 2003; Malpas et al. 1990). It has been shown 
that when there is vagal nerve dysfunction, the diurnal pattern of the HRV is unaltered 
(Malpas et al. 1990).  Thus, the increase in HRV at night observed in normal individuals is 
not related to increased vagal activity but to a withdrawal or reduced cardiac 
sympathetic tone during the night. Using conventional heart rate variability measures 
several investigators have been able to confirm that there is reduced sympathetic 
modulation during the night in healthy individuals (Furlan et al. 1990; Sapoznikov et al. 
1992; Yamasaki et al. 1996). This normal diurnal fluctuation of the HRV is disrupted in 
patients with myocardial infarction, angina pectoris, diabetes mellitus and epilepsy 
(Chokroverty 2008; Ewing et al. 1991; Ronkainen et al. 2005; Tomson et al. 1998; 
Tomson et al. 2008). Bearing in mind that there is a diurnal pattern in the onset for both 
ischemic cardiac events and sudden cardiac death in the general population 
(Bonnemeier et al. 2003; Korpelainen et al. 1997), and the fact that abnormal diurnal 
HRV dynamics has been previously suggested in epilepsy (Ronkainen et al. 2005), it is 
possible that  epilepsy  may  disrupt the heart rate variability and its circadian rhythm. 
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6.1 Aim 
 
This study was done to evaluate heart rate variability, in normal day and night cycles in 
patients with epilepsy in order to test the hypothesis that intractable epilepsy can 
disrupt the heart rate variability and its circadian rhythm.  
 
6.2 Methodology 
 
HRV indices were done on 5 minute sections of ECG taken at the beginning of each hour 
in the interictal period in patients with chronic medically intractable epilepsy. Details in  
chapter 3, section 3.3. 
 
6.3 Statistical Analysis 
 
Generalised estimation equations were used to evaluate the effect of patient factors on 
the HRV indices. See chapter 3 section 3.6 for details. 
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6.4 Results 
Summary of clinical characteristics  
A total of 66 patients with chronic epilepsy, 34 males and 32 females, were included in 
this study. 40 patients had temporal lobe epilepsy, 20 lateralised to the left hemisphere 
and 20 lateralised to the right hemisphere. Of the 26 with extratemporal lobe epilepsy, 
the focus was in the left hemisphere in 12 and in the right hemisphere in 14. One subject 
had both an hypothalamic hamartoma and right frontal lobe cortical dysplasia. However, 
the epileptogenic zone was found to be in the right frontal lobe, there was no record of 
gelastic seizures and therefore this subject was included in the frontal lobe epilepsy 
group. All patients were on more than one antiepileptic drug with up to 45% patients 
receiving carbamazepine as part of polytherapy at the time of inclusion in this study. 
Drug reduction was carried out in all 66 patients. A few patients were sleep deprived. 
However, heart rate variability data was sampled at the onset of recording in the first 24 
hours before sleep deprivation and drug withdrawal had taken place.  
 
Table 6.1 Summary of clinical characteristics of the group (n=66) 
Clinical Characteristic Observation 
Epilepsy duration 
mean (SD) (range)years 
 
22(11)(5-59) 
Age 
mean(SD) (range) years 
36(9)(19-61) 
 
Epilepsy Type 
40 TLE 
25 FLE 
1 PLE 
Gender 
 
34 males 
32 females 
Yearly Seizure Frequency 
median ( interquartile range) 
72(28 to 156) 
Carbamazepine polytherapy 30 
 
 
 
 
TLE: Temporal lobe epilepsy, FLE: Frontal lobe epilepsy, PLE: Parietal lobe epilepsy. 
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Summary of HRV  
Data has been summarised showing the overall, between and within individual variation. 
These are presented in tables 5.2-5.4. Figure 17 summarises the overall Night vs. Day 
differences for all the measured HRV indices. 
 
17a Vagal efferent activity (RMSSD) 17b Overall HRV (sdnn)  
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17c mean heart rate (mHR)   17d Sympathovagal balance log (LF/HF) 
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Figure 17 The Box graphs show summary of night (left hand side) and day (right hand side) of all the 
measured HRV indices in all patients with epilepsy (n=66). Values are presented as medians (horizontal 
bars) with the interquartile range at the end of boxes. The vertical capped bars represent the maximum 
and minimum values above the upper and lower quartiles respectively. The dots represent the outliers. 
Note LF/HF has been analysed as the log transformation because of skewness of data (positively 
skewed). Day values are significantly different from corresponding night values except for the sdnn heart 
rate variability. RMSSD (P=0.02), sdnn (P=0.94) mHR (P=0.0001) and Log (LF/HF) (P=0.002). RMSSD 
Square root  of mean squared RR interval differences; sdnn Standard deviation of RR intervals in a given 
segment of ECG; mHR Mean instantaneous heart rate; Log(LF/HF) Logarithmic transformation of Low to 
High frequency ratio. 
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Table 6.2 Comparison of Day and Night HRV in all patients  
 Day   Night 
Variable Mean SD Range  Mean SD Range 
 
RMSSD/ms 
 
Overall 
 
70.02 
 
27.50 
 
9.95 to 301.83 
  
74.45 
 
23.73 
 
29.54 to 227.74 
 Between  18.13 40.51 to 142.64   17.02 49.68 to 137.61 
 Within  20.78 7.76 to 229.22   16.65 24.70 to 164.57 
         
Sdnn/ms Overall 65.96 28.50 9.61 to 214.80  65.53 31.94 10.72 to 200.96 
 Between  19.04 30.23 to 123.29   18.85 33.97 to 121.69 
 Within  21.32 0.17 to 159.89    25.89 9.35 to 171.39 
         
mHR/bpm Overall 74 11 49 to 149  66 10 43 to 104 
 Between  8 57 to 90   7 50 to 87 
 Within  7 54 to 139   7 49 to 99 
         
Log(LF/HF) Overall 1.04 1.12 -2.53 to 4.17  0.81 1.15 -2.41 to 4.02 
 Between  0.69 -0.33 to 2.68   0.70 -0.42 to 2.78 
 Within  0.89 -1.53 to 4.19   0.92 -1.84 to 3.73 
 
 
There is higher within individual variation as compared to between individual variations. Night time values 
for heart rate variability differ from the day time. Sdnn Standard deviation of RR intervals; RMSSD square 
root of the mean squared RR interval differences; mHR mean instantaneous heart rate, SD standard 
deviation.                  
 
 
Table 6.3 Comparison of HRV in extratemporal lobe epilepsy patients 
 Left hemisphere    Right hemisphere  
Variable Mean SD Range  Mean SD Range 
 
RMSSD/ms 
 
Overall 
 
69.64 
 
20.42 
 
29.54 to 145.45 
  
86.71 
 
34.83 
 
30.27 to 301.83 
 Between  11.02 50.87 to 85.01   24.46 50.34 to 130.58 
 Within  17.51 27.98 to 134.67   25.67 28.97 to 257.96 
         
Sdnn/ms Overall 64.21 28.62 16.22 to 192.5  78.04 33.49 10.82 to 214.8 
 Between  12.97 40.95 to 78.23   22.52 46.79 to 120.45 
 Within  25.82 18.63 to 184.21   25.53 15.25 to 172. 40 
         
mHR/bpm Overall 70 11 46 to 103  64 12 43 to 109 
 Between  7 59 to 80    9 55 to 87 
 Within  9 47 to 93   7 53 to 92 
         
Log(LF/HF) Overall 0.91 1.08 -2.52 to 4.03  0.60 1.01 -2.04 to 3.87 
 Between  0.64 -2.50 to 1.92   0.51 -0.10 to 1.58 
 Within  0.90 -2.03 to 3.15   0.88 -1.71 to 3.13 
 
 
In the extratemporal lobe epilepsy group, heart rate variability indices recorded from the right hemisphere 
are indicative of an enhanced parasympathetic tone. Sdnn Standard deviation of RR intervals; rMSSD 
square root of the mean squared RR interval differences; mHR mean instantaneous heart rate, SD 
standard deviation.                  
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Table 6.4 Comparison of HRV in Temporal lobe epilepsy patients 
 
 Left hemisphere    Right hemisphere  
Variable Mean SD Range  Mean SD Range 
 
RMSSD/ms 
 
Overall 
 
67.89 
 
22.30 
 
9.95 to 212.34 
  
68.94 
 
21.52 
 
29.82 to 233.24 
 Between  11.91 46.02 to 90.47   12.71 51.48 to 102.37 
 Within  19.37 4.85 to 220.22   17.59 34.01 to 213 .8 
         
Sdnn/ms Overall 61.85 30.01 10.72 to 188.55  62.77 27.14 9.61 to 160.59 
 Between  16.65 35.30 to 96.89   13.81 37.33 to 87.81 
 Within  25.13 3.79 to 171.00   23.56 8.85 to 150.14 
         
mHR/bpm Overall 70 11 46 to 149  70 10 46 to 110 
 Between  7 56 to 84   7 58 to 81 
 Within  9 50 to 144   8 52 to 101 
         
Log(LF/HF) Overall 1.16 1.17 1.96 to 4.17  0.89 1.18 -2.04 to 4.12 
 Between  0.70 0.06 to 2.45   0.79 -0.13 to 2.54 
 Within  0.97 1.54 to 4.17    -1.58 to 3.74 
 
 
In the temporal lobe epilepsy patients excepting the (LF/HF), which shows a left to right sympathetic 
predominance, there are no obvious left to right difference in the other indices. Sdnn Standard deviation 
of RR intervals; RMSSD square root of the mean squared RR interval differences; mHR mean instantaneous 
heart rate, SD standard deviation.                  
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Diurnal Patterns of HRV indices  
The diurnal patterns of the measured HRV indices are similar to that described in normal 
healthy adults (Bonnemeier et al. 2003). 
 
The sympathovagal balance curve for all patients (figure 18a) shows the sympathovagal 
index to gradually increase from midnight through the night, staying high throughout 
the day with a peak at around midday. This is followed by a gradual decrease reaching 
lowest level at around midnight. 
 
Instantaneous heart rates curve for all patients (figure 18b) shows the mean heart rate 
to gradually decline from midnight. It is at a nadir between 4 and 6 am (just before 
waking up), peaks at between 8-9 am and then decreases gradually, remaining fairly 
constant during the day. At 6pm it begins to fall again to the low night time levels.  
 
Overall heart rate variability curve for all patients (figure 18c), begins to increase from 
the midnight and shows a peak at around 7am (waking up). This is followed by the drop 
between 8-9 am and a sustained decrease throughout the day decreasing to low levels 
around midnight, and then the cycle begins again.  
 
Vagal efferent activity curve (figure 18d), shows a night time high compared to the day 
time. It is highest between 4-6 am (just before waking) and then begins to fall after wake 
up, but remains fairly constant at a relative low throughout the day and rises again by 
midnight.    
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Figure 18a 
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Figure 18 Overall, measured HRV indices show a diurnal trend.  
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Diurnal and interictal Cardiac Vagal activity (RMSSD)  
RMSSD is an HRV measure that determines cardiac vagal activity. On average, the day 
time HRV are 4.15ms (P=0.02, 95% CI= 0.79ms to 7.52ms) lower than the night time 
when the effects of age, gender, yearly seizure frequency, duration of epilepsy, lobar 
location and the hemispheric laterality of epileptic focus are adjusted for. On average, 
the HRV goes down by 0.43ms (P<0.001, 95% CI= 0.20ms to 0.65ms,) for every one year 
increase in the duration of uncontrolled epilepsy. There is no statistical significant 
difference between patients with temporal and extratemporal lobe epilepsy (P=0.91) 
and also within the left and right hemispheric side for patients with temporal lobe 
epilepsy (P=0.93). However within patients with extratemporal lobe epilepsy, HRV was 
higher on the right hemispheric side than on the left by about 19 ms (P<0.001, 95% 
CI=12.06ms to 25.22ms).  
 
Table 6.5 Effects of the Day vs. Night and other epilepsy factors on RMSSD  
RMSSD/ms Coefficient Standard 
Error 
P  
value 
95% 
 Confidence Interval 
 
Day  vs. Night 
 
-4.15 
 
1.71 
 
0.02 
 
-7.52 to – 0.79 
Gender(Females vs. males) 0.31 2.01 0.87 -3.62 to 4.28 
Age 0.09 0.15 0.55 -0.19 to 0.37 
CBZ  tx vs. Non CBZ tx   -0.49 2.11 0.82 -4.62 to 3.63 
Yearly seizure frequency 0.002 0.004 0.53 -0.0052 to 0.01 
epilepsy duration -0.43 0.11 <0.001 -0.65 to -0.20 
Location(TLE vs. exTLE) -0.35 2.99 0.91 -6.21 to 5.51 
 exTLE(Right vs. Left) 18.64 3.36 <0.001 12.06 to 25.22 
TLE(Right vs. Left) 0.22 2.43 0.93 -4.55 to 4.99 
 
 
RMSSD Square root of the mean squared differences of successive RR intervals is a measure of vagal 
efferent activity. Negative coefficients signify a decrease of the RMSSD (response variable) by that figure 
for any change in the determined variables (explanatory variable). Thus, RMSSD decreases by 0.43ms for 
every additional year of uncontrolled epilepsy (P<0.001, 95%CI 0.20 to 0.65). In patients with 
extratemporal lobe epilepsy (right compared to left hemispheric localisation of epileptic focus), RMSSD is 
higher by about 19ms (P<0.001, 95%CI 12.06 to 25.22). Extra temporal lobe epilepsy here refers to frontal 
lobe epilepsy. TLE, temporal lobe epilepsy, exTLE, extratemporal lobe epilepsy, CBZ tx, polytherapy with 
carbamazepine, Left, left hemispheric side and Right, right hemispheric side. 
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Diurnal and interictal mean heart rate (mHR) 
On average, the day time mean heart rates are higher than the night by about 6bpm 
(P<0.001, 95% CI=4bpm to7bpm). On average for every additional year a patient has 
uncontrolled epilepsy, mean heart rate goes up by 0.3 bpm (P<0.001, 95% CI=0.2bpm to 
0.5bpm). Overall, the mean heart rate decreases by 0.3bpm for every year increase in 
the patients age (P<0.001, 95% CI=0.2bpm to 0.5bpm). When the interaction between 
the age and duration epilepsy was evaluated, it was found that the overall effect of the 
two is to increase the mean heart rate by 0.002bpm for every additional increase in 
patient age and epilepsy duration (P=0.006, 95% CI 0.0007 to 0.004). In female patients, 
the mean heart rate increases by about 5 bpm (P<0.001, 95% CI=3bpm to 7bpm). On 
average, patients with temporal lobe epilepsy have lower mean heart rate of about 3 
bpm (P=0.046, 95% CI= 0.1bpm to 6bpm,). There is no statistical difference between the 
left and right hemispheric side in patients with both temporal and extratemporal lobe 
epilepsy (P=0.21 and 0.063 respectively).  
 
Table 6.6   Effects of the Day vs. Night and other epilepsy factors on mHR 
mean  heart rate/bpm Coefficient Standard 
Error 
P  
value 
95% 
 Confidence Interval 
 
Day  vs. Night 
 
5.47    
 
0.74 
 
<0.001 
 
4.02 to 6.92 
Gender(Females vs. Males) 5.22    1.04 <0.001 3.18 to  7.27 
Age -0.33    0.08 <0.001 -0.48 to -0.18 
CBZ tx  vs. Non CBZ tx  -1.64    1.09 0.13 -3.78 to 0.49 
Yearly seizure frequency 0.001    0.002   0.54 -0.003 to 0.005 
epilepsy duration 0.33    0.06 <0.001 0.22 to 0.45 
Location (TLE vs. exTLE) -3.00 1.51 0.046 -5.95 to -0.05 
exTLE(Right vs. Left) -3.20    1.72 0.063 -6.58 to 0.17 
TLE(Right vs. Left) 1.56    1.25 0.21 -0.90 to 4.03 
 
 
 
 
 
 
 
 
 
 
 
CBZ tx, polytherapy with carbamazepine, exTLE, extra temporal lobe epilepsy, TLE Temporal 
lobe epilepsy. Negative coefficients imply the explanatory variables decreases the response 
variable. The resultant interaction between the patient age and epilepsy duration is an increase 
of the mean heart rate by about 0.002bpm (P=0.006, 95% CI 0.0007bpm to 0.005bpm) for every 
additional year. 
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Diurnal and interictal sdnn   
On average, the difference between day and night time sdnn heart rate variability is not 
significant (P=0.94). The effects of gender (P=0.70), age (P=0.22), treatment with 
carbamazepine (P=0.74), yearly seizure frequency (P=0.43) and of location in either 
temporal or extratemporal lobe (P=0.98) on the sdnn were not significant. However, 
within the patients with extratemporal lobe epilepsy, sdnn is higher on the right 
hemispheric side compared to the left hemispheric side by 16.9ms (P<0.001, 95% CI= 
9.61ms to 24.19ms).  Finally, on the average, for every additional year the patient has 
epilepsy and after adjusting for the effects of the other variables, sdnn heart rate 
variability decreases by 0.49ms (P<0.001, 95% CI= 0.25ms to 0.74ms).  
 
Table 6.7 Effects of Day vs. Night and other epilepsy variables on sdnn 
SDNN/ms Coefficient Standard 
Error 
P  
value 
95% 
 Confidence Interval 
 
Day  vs. Night 
 
-0.15 
 
1.95 
 
0.94 
                       
-3.98 to 3.67 
Gender(Female vs. Male) 0.84 2.23 0.70 -3.52 to 5.22 
Age -0.19 0.16 0.22 -0.5 to 0.11 
CBZ  tx vs. Non CBZ tx   0.75 2.32   0.74 -3.81 to 5.31 
Yearly seizure frequency -0.003 0.004 0.43 -0.012 to 0.005 
epilepsy duration -0.49 0.12 <0.001 -0.74 to -0.25 
Location (TLE vs. exTLE) 0.07 3.32 0.98 -6.42 to 6.58 
exTLE(Right vs. Left) 16.90 3.71    <0.001 9.61 to 24.19 
TLE(Right vs. Left) 0.53 2.69 0.84 -4.74 to 5.82 
 
 
 
 
 
 
 
 
 
 
 
 
SDNN, Standard deviation of normal to normal RR intervals, CBZ tx, polytherapy with 
carbamazepine, exTLE, extra temporal lobe epilepsy, TLE Temporal lobe epilepsy. Negative 
coefficients imply the explanatory variables decreases the response variable. Therefore, the 
SDNN decreases by 0.49ms for every additional year of epilepsy (P<0.001, 95%CI 0.25 to 0.75). 
In addition the right hemisphere localisation of the epileptogenic region is associated with 
increased SDNN (P<0.001, 95%CI 9.61 to 24.19).  
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Diurnal and interictal Cardiac sympathovagal balance (LF/HF) 
On average, day time cardiac sympathovagal balance (LF/HF) is higher than the night 
time by about 0.21points (P=0.002, 95% CI 0.08 to 0.35). On average, in female patients 
with epilepsy sympathovagal balance is lower by about 0.51points (P<0.001, 95% CI 0.36 
to 0.66). On average, every additional year increase in the epilepsy duration, cardiac 
sympathovagal balance increases by 0.01 points (P<0.001, 95% CI 0.001 to 0.018). 
Antiepileptic drug polytherapy with carbamazepine increases cardiac sympathovagal 
balance by 0.15 points (P=0.05, 95% CI 0.001 to 0.31). Overall for every additional year in 
age of patient, sympathovagal balance increases by 0.02 points (P=0.023, 95% CI 0.01 to 
0.03). Sympathovagal balance is high in patients with temporal lobe epilepsy by 0.53 
points (P<0.001, 95% CI 0.31 to 0.76). However, within the patients with temporal lobe 
epilepsy, right hemisphere location decreases the sympathovagal balance by 0.28 points 
(P=0.003, 95% CI 0.10 to 0.46). On average, a one point increase in the yearly seizure 
frequency will increase the sympathovagal balance by 0.0004 points (P<0.001, 95% CI 
0.0002 to 0.0008).  
 
Table 6.8 Effects of Day vs. Night and other epilepsy factors on LF/HF 
Log(LF/HF) Coefficient Standard 
Error 
P  
value 
95% 
 Confidence Interval 
 
Day vs. Night 
 
0.21 
 
0.07 
 
0.002 
 
0.08 to 0.35 
Gender(Female vs. Male) -0.51 0.08 <0.001 -0.66 to -0.36 
Age of Patient 0.02 0.006 <0.001 0.01 to 0.03 
CBZ tx vs. Non CBZ tx  0.15 0.08   0.05 0.001 to 0.31 
Yearly seizure frequency 0.0004 0.0001 0.001 0.0002 to 0.0008 
epilepsy duration 0.01 0.004 0.023 0.001 to 0.018 
Location (TLE vs. exTLE) 0.53 0.114 <0.001 0.31 to 0.76 
ExTLE (Right vs. Left)   0.01 0.13 0.934 -0.24 to 0.26 
TLE (Right vs. Left) 
 
-0.28 0.09 0.003 -0.46 to -0.10 
 
 
 
 
 
 
 
 
 
 
CBZ tx, polytherapy with carbamazepine, exTLE, extra temporal lobe epilepsy, TLE Temporal lobe 
epilepsy. Negative coefficients imply the explanatory variables decreases the response variable. 
Epilepsy duration increases the LF/HF ratio (P=0.23, 95%CI 0.001 to 0.18).  
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19a Vagal efferent activity (RMSSD/ms)  19b Overall HRV (sdnn/ms) 
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 19c Sympathovagal balance (LF/HF)              19d mean heart rate (mHR/bpm) 
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Figure 19   Scatter plots, the corresponding regression line and its 95% confidence interval or prediction 
bands of all the heart rate variability variables and epilepsy duration. These plots show the epilepsy 
duration increases mean heart rate and sympathovagal balance but reduces the vagal efferent activity and 
the overall heart rate variability. This means a prolonged medical history of epilepsy could increase cardiac 
sympathetic tone. However the prediction lines do not fit the data well, therefore other factors including 
the prolonged medical history of epilepsy affects cardiac sympathetic tone in epilepsy patients.  
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6.5 Discussion 
 
In summary, the diurnal pattern of the HRV is preserved in patients with epilepsy. 
However, every additional yearly increase in epilepsy duration increase the cardiac 
sympathetic tone in patients with epilepsy. Even though the mean heart rate decreases 
with age, the combined effect of age and prolonged medical history of epilepsy is to 
increase the mean heart rate over time. Higher mean heart rates are seen in female 
epileptic patients. Carbamazepine polytherapy, high yearly seizure frequency and 
temporal lobe epilepsy increase cardiac sympathetic tone. Left and right hemisphere 
epileptogenicity control sympathetic and parasympathetic cardiac function respectively. 
The reduced cardiac vagal activity increased mean heart rate and an elevated cardiac 
sympathetic tone with the duration of active epilepsy means that epilepsy may depress 
heart rate variability. Antiepileptic drug use and seizure frequency were also found to 
reduce HRV independently of the effects of duration of epilepsy. A prolonged medical 
history of uncontrolled epilepsy is a risk factor for SUDEP (Devinsky et al. 1994; Earnest 
et al. 1992; Opeskin et al. 2000) and the finding in this study provide a potential 
pathophysiological explanation for this and a mechanism for cardiac arrhythmogenesis 
in chronic epilepsy patients.  
 
But ageing in healthy individuals also results in decreased HRV and reduced cardiac vagal 
tone (Bonnemeier et al. 2003; Freeman et al. 2008; Hunt et al. 2001) and because the 
results have not been compared to non epileptic controls, the extent to which these 
HRV changes can be attributed to prolonged medical history of epilepsy cannot be 
readily ascertained. However, the statistical model adjusted for the effects of age in the 
study group and found it to be independent of the effects of duration of epilepsy. 
Therefore, it is possible to speculate that the findings of reduced HRV could be related to 
epilepsy as seen in this study.  Reduced heart rate variability is a reliable predictor of 
death due to arrhythmias in other patient groups because of increased cardiac 
sympathetic tone (Jons et al. 2010; Smilde et al. 2009), and  by  extension, it is thus 
plausible that the increased cardiac sympathetic tone found in epilepsy will increase the 
risk for fatal cardiac arrhythmias and SUDEP. One recent case control study on SUDEP 
failed to identify unequivocal changes in HRV in SUDEP patients to allow for such 
predictions (Surges et al. 2009a) but this study had a small sample size and a more 
adequately powered study is required to study this possibility. An increase of 
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sympathetic tone in patients with intractable epilepsy has been suggested.  Some 
studies mention heightened anxiety levels and others, decreased heart rate variability 
(Lee et al. 2009; Mukherjee et al. 2009). In addition, antiepileptic drug use and 
frequency of seizures have been identified to alter sympathetic cardiac autonomic 
function (Langan et al. 2005; Nei et al. 2010; Nilsson et al. 1999; Walczak et al. 2001). 
These are factors that are linked to prolonged medical history of epilepsy and 
substantiate the findings in this study. Normal diurnal variation in heart rate variability is 
characterized by the sleep related withdrawal of sympathetic tone (Bonnemeier et al. 
2003; Cysarz et al. 2008; Hofstra et al. 2009). It has been suggested that this normal 
pattern would be disrupted in epilepsy patients (Persson et al. 2007b; Ronkainen et al. 
2005), but this is not what I found in this study. Also previous studies in other patient 
groups in whom abnormal peripheral autonomic function was already established 
similarly did not find the HRV diurnal rhythm to be disrupted (Burger et al. 1999; Burger 
et al. 2001; Ewing et al. 1991; Kardelen et al. 2006; Malpas et al. 1990). In this study, 
with the exception of the sdnn (overall heart rate variability) I have shown a normal 
diurnal pattern of heart rate variability (Singh et al. 2003) in patients with epilepsy and 
this could mean that the night time occurrence of SUDEP may not be related to 
abnormalities in the  HRV diurnal rhythm as has been suggested previously in epilepsy 
patients (Persson et al. 2007b; Ronkainen et al. 2005).  
 
The lack of a statistical significant difference between mean day and night sdnn even 
though there is a normal diurnal pattern (see figure 18c), might be due to the large inter 
individual variability of heart rate variability. Furthermore, in the previous studies only 
patients with temporal lobe epilepsy on their full complement of antiepileptic drugs 
were investigated therefore the confounding effects on the HRV due to anticonvulsants 
and lobar location of epileptic focus (Hennessy et al. 2001; Tomson et al. 1998) could 
have affected the results. In this study I have found carbamazepine related polytherapy 
and left temporal lobe epilepsy to increase cardiac sympathetic activity independently of 
the day or night effect in line with the findings from earlier studies (Gelvan et al. 2001; 
Hennessy et al. 2001; Ide et al. 2007; Kenneback et al. 1997; Persson et al. 2003; Persson 
et al. 2007b; Ronkainen et al. 2005). A lower sympathetic tone is found in females in 
child bearing age group which approximates to the high levels in the male when the 
menopause is reached. Several explanations have been put forward including 
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methodological issues, cardioprotective female reproductive hormones and muscularity 
in the male (Bonnemeier et al. 2003; Kuo et al. 1999; Sztajzel et al. 2008). In this study 
also, the female patients were seen to have a lower sympathetic tone (Lower LF power). 
However they were seen to have higher mean heart rate. This discrepancy has been 
reported. The mean heart rate is often elevated when low frequency power HRV, a 
measure of sympathetic tone was reduced (Fitzgerald 2010; Sztajzel et al. 2008) and this 
may be the reason. Additionally in epilepsy, this could be due to the loss of the 
cardioprotective nature of estrogens (Verrotti et al. 2010). These and the other study 
findings show that HRV and the mean heart rate are not correlated and clinically 
significant changes in the HRV can occur without overt changes in the mean heart rate 
or vice versa. Increasing age has been known to decrease the HRV and increase 
sympathetic activity to the heart. It has been shown to be due a multitude of factors 
that include loss of vascular compliance, impaired integration of autonomic neural 
conduction and cardiac reflexes as well as sinoatrial node unresponsiveness. Impaired 
cardiovascular reflexes with aging are associated with increased serum norepinephrine 
levels. There is also evidence that with increasing age, an associated decrease of the 
intrinsic heart rate occurs because of impaired cardiac conduction and respiratory 
influences (Bonnemeier et al. 2003; Freeman et al. 2008; Hunt et al. 2001). These 
changes, the combined effects of increased serum levels of catecholamine in epilepsy 
and the apparent lack of correlation between HRV and the mean heart rate means that 
decreased HRV with prolonged history of epilepsy may be greater than the age related 
decrease of the HRV. 
 
Hemispheric asymmetry of cardiac autonomic function in epilepsy has been previously 
described (Adjei et al. 2009; Assaf et al. 2008; Diehl et al. 1997; Evrengul et al. 2005; 
Oppenheimer et al. 1992). Right hemisphere related epilepsy enhances cardiac 
parasympathetic activity and left hemisphere related epilepsy enhances cardiac 
sympathetic function. The frontal lobe areas; ventromedial prefrontal area, orbitofrontal 
and anterior cingulate gyrus together with medial temporal lobe regions and insula; a 
deep cortical structure which is continuous with the temporal, parietal and frontal lobes 
represents cortical areas involved in central autonomic function and are also involved in 
epilepsy (Critchley et al. 2000).  The insular cortex is of particular importance because it 
has been found to exert significant visceral autonomic function including heart rate 
 111
control and laterality in cardiac autonomic function. The insula is reciprocally connected 
to the temporal, frontal and parietal lobes as well as brainstem cardiovascular control 
centers.  The inputs from the adjacent cortical areas are generally inhibitory to the 
ipsilateral insula functions and projections of the insula to the brainstem cardiovascular 
control centers (nucleus of the tractus solitarus) are also inhibitory. Cardiovascular 
sympatho-excitatory control is a right insula function and cardiac parasympathetic 
regulation is limited to the left insula (Oppenheimer 1993; Oppenheimer 2006; 
Oppenheimer 2007; Oppenheimer et al. 1996; Zhang et al. 2000a; Zhang et al. 2000b).  
Also FDG-PET studies have outlined interictal hypometabolism of the affected lobes in 
epilepsy (Lamusuo et al. 1997; Nelissen et al. 2006; Wong et al. 2010). The findings in 
this study are that there are asymmetries in cardiac autonomic control, and this may be 
explained by ipsilateral cortical dysfunction due to a right hemispheric epileptic focus 
which could lead to an enhanced inhibition of the ipsilateral insula and unopposed 
activity in the contra lateral parasympathetic insula and vice versa. Interestingly, in 
patients with temporal lobe epilepsy, there was no asymmetry between the HRV indices 
except in the LF/HF ratio. This may be one explanation for the difficulties in determining 
cortical representation of cardiac autonomic function in patients with epilepsy (Ahern et 
al. 2001; Jokeit et al. 2000).  Furthermore, large inter individual variability in the location 
and in the extent of cortical representation of cardiac autonomic function, together with 
the extensive temporolimbic connections  may underlie this finding.  
 
The findings from these studies show that the impact of temporal lobe epilepsy on 
autonomic function is more marked than that of extratemporal lobe epilepsy as found 
by others (Harnod et al. 2009). Patients with temporal lobe epilepsy were found to have 
higher cardiac sympathetic tone. Interictal PET studies in temporal lobe epilepsy have 
shown extensive intratemporal and extratemporal hypofunction that involves the insula 
(Wong et al. 2010). Insula dysfunction releases inhibition on brainstem cardiovascular 
centers leading to unopposed cardiac sympathetic function (Oppenheimer 2006; 
Oppenheimer 2007). In light of this observation and as seen in this study, temporal lobe 
epilepsy may elevate cardiac sympathetic activity. This is not surprising given that 
autonomic symptoms in epilepsy are described most frequently in patients with 
temporal lobe epilepsy (Baumgartner et al. 2001).  
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Chapter 7 
 
Catecholamines, electrolytes and cardiac troponin in seizures 
 
Epileptic seizures are characterised by both systemic and central nervous system 
physiological changes that include generalised autonomic nervous system activation, a 
metabolic acidosis, and an increased central nervous system metabolism. During 
epileptic seizures, the accelerated release of adrenalin and noradrenalin affects the 
maintenance of electrolyte homeostasis. This favours the intracellular shift of potassium, 
calcium and magnesium. Catecholamine surge of such magnitude is a risk factor for 
cardiac myocardial dysfunction due to direct adreno-receptor vasoconstriction and 
myocardial toxicity (Clutter et al. 1980; Shimizu et al. 2008; Simon et al. 1984; Whitted et 
al. 2010). The intracellular shift of calcium creates hypocalcaemia. This stimulates 
parathormone which further worsens the intracellular loading. In cardiac myocytes, the 
accumulation increases oxidative stress and necrosis. Catecholamine based myocytic 
damage may  release Troponin and eventual myocardial fibrosis which may serve as a 
nidus for arrhythmia (Lee et al. 2003; Ueshima et al. 2004; Whitted et al. 2010).   
 
There are conflicting reports on the changes in serum sodium during epileptic seizures 
and in the interictal period (Hamed et al. 2004; Natelson et al. 1979a).  Catecholamine 
induced hypokalaemia and hypomagnesaemia will prolong the QT interval and 
predispose to development of atrial fibrillations. Serum sodium is not known to be 
associated with QT interval changes; however a recent study identified significant QT 
interval prolongation with increased serum sodium (Lee et al. 2003; Sohaib et al. 2008). 
Therefore it is possible that the metabolic burden associated with epileptic seizures may 
facilitate the development of arrhythmias and myocardial ischemic injury.  This is an 
area in epileptology that could help unravel the mechanisms of SUDEP. 
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7.1 Aim  
 
The aim in this study was to test the hypothesis that epileptic seizures affect the serum 
concentration of adrenalin and noradrenalin, and the electrolytes (sodium, calcium, 
magnesium and potassium) and that these changes could impact on the corrected QT 
interval (QTc). 
 
7.2 Methodology 
 
Serum catecholamines, electrolytes and the corrected QT interval (Bazetts formula) 
were measured after seizures in chronic epilepsy patients. Refer chapter 3 section 3.4 
for details. 
 
7.3 Statistical Analysis 
 
Linear mixed model analysis was used to evaluate the interaction between the 
electrolytes and QTc and between catecholamines and QTc.  Refer to chapter 3 section 
3.6 for details 
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7.4 Results 
Summary of clinical characteristics 
16 patients were included in this study.  Three patients had secondary generalised tonic 
clonic seizures. All patients had drug reduction at the onset of the of the video telemetry 
investigation and were confused but not obviously agitated after cessation of the 
seizure.  Clinical characteristics of all patients are presented in the table 7.1. Cardiac 
Troponin levels did not change in all seizure types after 12 hours. The changes in serum 
electrolytes are shown in tables 7.2-7.4. The changes in catecholamine levels are shown 
in tables 7.5-7.7. The interaction of catecholamines, electrolytes and the QTc interval 
during seizures is shown in table 7.8. 
 
Table 7.1 Summary of Clinical characteristics (n=16) 
Clinical characteristic Observation 
 
Age mean(SD) range/years 
 
38(9)18-49 
Gender M/F 12/4 
Epilepsy duration mean(SD) range/years 24(11) 5-46 
Seizure duration mean(SD) range /seconds 121(47) 50-190 
Epileptic Focus      Hemispheric location L/R 8/8 
                                 Lobar location TLE/FLE 9/7 
Carbamazepine Polytherapy YES/NO  10/6 
  
 
TLE temporal lobe epilepsy; FLE frontal lobe epilepsy 
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Electrolytes changes during seizures  
 
Table7.2 Electrolytes data in the 3 time periods for all patients 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Age Epilepsy Sex Seizure Na0 
mmol/l 
Na1 
mmol/l 
Na2 
mmol/l 
K0 
mmol/l 
K1 
mmol/l 
K2 
mmol/l 
Ca0 
mmol/l 
Ca1 
mmol/l 
Ca2 
mmol/l 
Mg0 
mmol/l 
Mg1 
mmol/l 
Mg2 
mmol/l 
1 47 LTLE M CPS 141 140 139 3.7 4.1 3.9 2.23 2.21 2.24 0.95 1.12 0.96 
2 31 LTLE M CPS 135 138 138 4.2 4.1 4.3 2.41 2.39 2.41 0.99 1.14 1.09 
3 32 RTLE F CPS 141 142 140 3.7 4.1 4.3 2.27 2.19 2.27 0.86 1.01 0.95 
4 29 LTLE F CPS 144 141 141 4 3.7 3.9 2.38 2.29 2.29 0.86 0.91 0.88 
5 37 LFLE M CPS 141 140 140 4.3 3.8 3.7 2.38 2.36 2.37 0.91 0.91 0.94 
6 40 RTLE M CPS 138 141 141 4.9 3.9 4.6 2.34 2.26 2.42 0.93 0.91 0.86 
7 43 LFLE M CPS 138 141 143 3.8 4.4 4.3 2.32 2.33 2.37 0.92 0.92 0.95 
8 49 RFLE M CPS 140 141 140 4.4 4.5 4.2 2.23 2.20 2.27 0.91 0.89 0.86 
9 46 RFLE M CPS 142 145 142 3.6 3.5 3.4 2.13 2.08 2.07 0.78 0.82 0.79 
10 38 RFLE M CPS 138 142 140 4.2 3.9 4.6 2.26 2.21 2.30 0.82 0.9 0.87 
11 26 LTLE M CPS 143 139 143 3.9 3.5 4.2 2.41 2.27 2.35 0.84 0.77 0.87 
12 49 LTLE F GTCS 143 141 143 3.6 4.6 3.9 2.15 2.32 2.25 0.85 0.84 0.83 
13 39 LFLE F GTCS 139 142 145 3.9 4.4 4.4 2.23 2.35 2.29 0.85 0.87 0.84 
14 18 RFLE M GTCS 144 143 142 3.1 4.0 4.0 2.15 2.29 2.32 0.85 0.78 0.80 
15 44 RTLE M CPS 141 145 144 4.4 4.2 4.6 2.27 2.32 2.27 0.82 0.80 0.90 
16 43 RTLE M CPS 134 137 140 4.3 4.0 4.0 2.16 2.25 2.30 0.80 0.89 0.87 
 
Na, K, Ca and Mg represent sodium, potassium, calcium and magnesium respectively. The numbers 0, 1 and 2 are the time periods: 0= baseline, 1= 5minutes postictal 
and 2= 12hours postictal. RTLE and LTLE: left and right frontal lobe epilepsy. RFLE and LFLE: right and left frontal lobe epilepsy. GTCS secondary generalized tonic clonic 
seizures CPS complex partial seizures. This shows very minor changes in the electrolytes which were not significant statistically (Table 7.3). All electrolytes were 
measured in mmol/l. The standard laboratory reference ranges of the electrolytes provided by the laboratory were: (Na
+
=135mmol/l−145mmol/l, 
K
+
=3.3mmol/l−4.7mmol/l, Ca
2+
=2.12mmol/l – 2.62mmol/l and Mg
2+
= 0.75mmol/l−1.0mmol/l). 
 
 116
The change in electrolytes from the baseline and 12 hours postictal was not statistically 
significant (Table 7.3).  
 
Table 7.3 Change in electrolyte concentration with seizures 
Electrolyte Baseline serum level 
mmol/l 
5 min postictal serum 
level/mmol/l 
P 
Value 
12 hours postictal 
serum level/mmol/l 
P 
Value 
 
Na
+ 
 
140(3) 134-144 
 
141(2) 137-145 
 
0.12 
 
141(2) 138-145 
 
0.062 
K
+ 
4(0.4) 3.1-4.9 4.04(0.33) 3.5-4.6 0.69 4.14(0.34) 3.4-4.6 0.20 
Ca
2+ 
2.27(0.1)  2.13-2.41 2.27(0.08) 2.08-2.39 1.0 2.30(0.08) 2.07-2.42 0.12 
Mg
2+ 
0.87(0.06) 0.78-0.99 0.91(0.11) 0.77-1.14 0.034 0.89(0.07) 0.79-1.09 0.21 
      
 
Overall there are no significant changes in the serum concentration of the electrolytes between the three 
time points. However, there is some evidence that there may be a change between the baseline and the 
5minute postictal for mg (P=0.034). Results are reported as the mean (SD) range. The standard laboratory 
reference ranges of the electrolytes: (Na
+
=135mmol/l−145mmol/l, K
+
=3.3mmol/l−4.7mmol/l, 
Ca
2+
=2.12mmol/l – 2.62mmol/l and Mg
2+
= 0.75mmol/l−1.0mmol/l). 
 
 
 
Overall, magnesium increases from base line by about 0.034mmol/l (P=0.034, 95%CI 
0.002mmol/l to 0.065mmol/l). On average every second increase in the duration of the 
seizure decreases the serum concentration of the electrolytes magnesium by     
0.0008mmol/l (P=0.018, 95%CI-0.0001mmol/l to -0.0015mmol/l) and potassium by 
0.003mmol/l (P=0.039, 95%CI -0.0001mmol/l to -0.005mmol/l) after seizure type and 
change in time points have been adjusted for.  On average, every second increase in the 
seizure duration, will increase the serum sodium by about 0.02 mmol/l (P=0.008, 95%CI 
0.006mmol/l to 0.04mmol/l). The serum level of calcium is unaffected by seizures 
(P=1.00), seizure type (P=0.75) and seizure duration (P=0.25). The effect of seizure type 
on the serum concentration of the electrolytes are not statistically significant (Na
+
: 
P=0.09), (K
+
: P=0.77), (Ca
2+
: P=0.75) and (Mg
2+
: P=0.17). 
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Table 7.4 Results of electrolyte analysis 
   
 Baseline vs. 5minute postictal Baseline vs. 12 hours postictal Generalised vs. Complex partial 
seizures 
Seizure duration 
Variable Coef P value 95% CI Coef P value 95% CI Coef P value 95% CI Coef P value 95% CI 
 
Na
+
 
 
1.00 
 
0.12 
 
-0.24 to 2.24 
 
1.18 
 
0.062 
 
-0.06 to 2.43 
 
1.59 
 
0.09 
 
-0.28 to3.47 
 
0.02 
 
0.008 
 
0.006 to 0.4 
K
+ 0.04 0.69 -0.17 to 0.26 0.14 0.20 -0.77 to 0.36 -0.04 0.77 -0.35 to 0.26 -0.003 0.039 -0.005 to -0.0001 
Ca
2+ -5.96e
-08 
1.00 -0.36 to 0.36 0.029 0.12 -0.007 to 0.067 -0.015 0.75 -0.11 to 0.08 -0.0005 0.25 -0.001 to 0.0003 
Mg
2+ 0.034 0.034 0.002 to 0.065 0.02 0.21 -0.01 to 0.05 -0.05 0.17 -0.13 to 0.02 -0.008 0.18 -0.001 to 0.0001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Na
+
, K
+
, Ca
2+
 and Mg
2+
 are measured in mmol/l. The coefficients (Coef.) are the mathematical weighting of the effects of the explanatory variables on the outcome variable. A 
positive coefficient signifies an increasing effect on the outcome variable by the explanatory variable. The very small coefficient seen for calcium (-5.96e-08 is equivalent to 0) 
implies no change between baseline and 5minute postictal (P=1.0). CI: confidence intervals. 
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Catecholamine changes during seizures  
 
Table 7.5 Catecholamine data in the 3 time periods for all Patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Age Epilepsy Sex Seizure Noradrenalin (pg/ml) Adrenalin (pg/ml)  
0 1 2 0 1 2 
1 47 LTLE M CPS 291 364 277 37 59 36 
2 31 LTLE M CPS 313 343 326 57 79 57 
3 32 RTLE F CPS 309 342 306 40 58 56 
4 29 LTLE F CPS 215 315 191 38 109 37 
5 37 LFLE M CPS 345 482 372 38 95 58 
6 40 RTLE M CPS 313 363 313 38 57 37 
7 43 LFLE M CPS 337 447 419 40 79 60 
8 49 RFLE M CPS 356 394 324 37 74 36 
9 46 RFLE M CPS 408 441 436 52 71 55 
10 38 RFLE M CPS 324 336 294 46 59 43 
11 26 LTLE M CPS 388 760 507 35 73 38 
12 49 LTLE F GTCS 406 1453 440 57 165 55 
13 39 LFLE F GTCS 473 642 574 57 174 59 
14 18 RFLE M GTCS 456 727 642 43 146 42 
15 44 RTLE M CPS 406 507 411 37 82 39 
16 43 RTLE M CPS 591 913 575 40 82 42 
Note that the noradrenalin change during generalized tonic clonic seizures are much higher than the 
normal reference ranges. The numbers 0, 1 and 2 are the time periods: 0= baseline, 1= 5minutes 
postictal and 2= 12hours postictal. RTLE and LTLE: left and right frontal lobe epilepsy. RFLE and LFLE: 
right and left frontal lobe epilepsy. GTCS secondary generalized tonic clonic seizures CPS complex 
partial seizures. Laboratory reference ranges provided are Adrenaline (<110 pg/ml) and Noradrenalin 
(70-500pg/ml) 
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Overall, the catecholamines increase significantly from the base line during seizures and 
returns to baseline by 12 hours postictal (Table 7.6). 
 
Table 7.6 Mean catecholamine concentrations in the three time periods  
Catecholamine Baseline (pg/ml) 5 minute 
postictal(pg/ml) 
12 hours 
postictal(pg/ml) 
 
Noradrenalin 
 
371(88) 
 
 
552(299) 
 
400(125) 
 
Adrenalin 
 
43(8) 
 
 
91(38) 
 
47(10) 
Catecholamines increases to levels greater than the base line at the 5 minute postictal (NA & A: P<0.001 
and P<0.001 respectively) 
 
The result of the analysis indicate that from the baseline, there is a significant increase 
of about 181pg/ml for noradrenalin (P<0.001, 95%CI 79pg/ml to 283pg/ml) and 48pg/ml 
for adrenalin (P<0.001, 95% CI 35pg/ml to 60pg/ml). There is no difference between the 
baseline and 12hours postictal serum levels of the catecholamines (P=0.58 and 0.57 for 
adrenalin and noradrenalin respectively). On average, catecholamine increase is higher 
in secondary generalised tonic clonic seizures compared to complex partial seizures by 
about 252 pg/ml and 35pg/ml for noradrenalin and adrenalin respectively (noradrenalin: 
P=0.001, 95%CI 93pg/ml to 385pg/ml and adrenalin: P<0.001, 95%CI 21pg/ml to 
49pg/ml). Unlike the electrolytes, prolonged seizure duration does not affect the serum 
level of the catecholamines (P= 0.22 and 0.54 for noradrenalin and adrenalin 
respectively). 
  
Table 7.7 Results of Catecholamine analysis 
 
Variable 
Noradrenalin adrenalin 
Coef. P value 95%CI(pg/ml) Coef. P value 95%CI(pg/ml) 
 
5minute postictal vs. 
Baseline   
 
181 
 
<0.001 
 
79 to 283 
 
48 
 
<0.001 
 
35 to 60 
12hours Postictal vs. 
Baseline  
30 0.57 -72 to 132 4 0.58 -9 to 16 
Partial vs. 
Generalised seizures  
252 0.001 105 to 399 35 <0.001 21 to 49 
 
The coefficients (Coef.) are the mathematical weighting of the effects of the explanatory variables on the 
outcome variable. A positive coefficient signifies an increasing effect on the outcome variable by the 
explanatory variable. CI: confidence intervals. 
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Interaction of catecholamines, electrolytes and the QTc interval during seizures 
 
Table 7.8 Electrolytes and QTc in the preictal and postictal state for all patients  
Patient Timing of sampling Na 
mmol/l 
 
K 
mmol/l 
 
Ca 
mmol/l 
Mg 
mmol/l 
A 
pg/ml 
N 
pg/ml 
 
 QTc 
(s) 
1 baseline 141 3.7 2.23 0.95 37 291 0.51 
 5minutes postictal 140 4.1 2.21 1.12 59 364 0.53 
2 baseline 135 4.2 2.41 0.99 57 313 0.53 
 5minutes postictal 138 4.1 2.39 1.14 79 343 0.53 
3 baseline 141 3.7 2.27 0.86 40 309 0.50 
 5minutes postictal 142 4.1 2.19 1.01 58 342 0.51 
4 baseline 144 4.0 2.38 0.86 38 215 0.49 
 5minutes postictal 141 3.7 2.29 0.91 109 315 0.52 
5 baseline 141 4.3 2.38 0.91 38 345 0.44 
 5minutes postictal 140 3.8 2.36 0.91 95 482 0.43 
6 baseline 138 4.9 2.34 0.93 38 313 0.45 
 5minutes postictal 141 3.9 2.26 0.91 57 363 0.51 
7 baseline 138 3.8 2.32 0.92 40 337 0.51 
 5minutes postictal 141 4.4 2.33 0.92 79 447 0.57 
8 baseline 140 4.4 2.23 0.91 37 356 0.48 
 5minutes postictal 141 4.5 2.2 0.89 74 394 0.51 
9 baseline 142 3.6 2.13 0.78 52 408 0.47 
 5minutes postictal 145 3.5 2.08 0.82 71 441 0.47 
10 baseline 138 4.2 2.26 0.82 46 324 0.45 
 5minutes postictal 142 3.9 2.21 0.90 59 336 0.51 
11 baseline 143 3.9 2.41 0.84 35 388 0.48 
 5minutes postictal 139 3.5 2.27 0.77 73 760 0.57 
12 baseline 143 3.6 2.15 0.85 57 406 0.59 
 5minutes postictal 141 4.6 2.32 0.84 165 1453 0.44 
13 baseline 139 3.9 2.23 0.85 57 473 0.46 
 5minutes postictal 142 4.4 2.35 0.87 174 642 0.41 
14 baseline 144 3.1 2.15 0.85 43 456 0.48 
 5minutes postictal 143 4.0 2.29 0.78 146 727 0.44 
15 baseline 141 4.4 2.27 0.82 37 406 0.47 
 5minutes postictal 145 4.2 2.32 0.8 82 507 0.41 
16 baseline 134 4.3 2.16 0.8 40 591 0.44 
 5minutes postictal 137 4.0 2.25 0.89 82 913 0.49 
 
 
 
 
 
 
Na, K, Ca, Mg, A, N and QTc represent Sodium mmol/l, potassium mmol/l, calcium mmol/l, 
magnesium mmol/l, adrenaline pg/ml, noradrenalin pg/ml and corrected QT interval (s).  
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Overall, mean QTc values at the baseline and 5 min postictally are the same (p=0.67), 
0.48 (0.03) seconds and 0.49 (0.05) seconds respectively. However after checking for 
interaction of the peri-ictal concentrations of the electrolytes and catecholamines, QTc 
was higher than baseline by about 0.17s (P=0.001, 95%CI 0.07s to 0.27s) for adrenalin. 
Further analysis suggested that, whereas there was no linear relationship between QTc 
and the electrolytes at baseline, the 5 minute postictal concentrations of “Na
+
” and “A” 
were seen to decrease the QTc interval by 0.014s (P=0.02, 95%CI -0.03s to -0.002s) and 
0.009s (P<0.001, 95%CI -0.001s to -0.0003s) per 0.1mmol/l and 1pg/ml increase in the 
electrolyte and catecholamine respectively. The serum levels of the other electrolytes 
did not show this interaction at the 5minute postictal, with the QTc interval. However, 
overall, every one unit increase in serum level of K, Ca and noradrenalin, shortens the 
QTc interval by 0.05s (P=0.016, 95%CI -0.09s to -0.009s), 0.21s (P=0.027, 95%CI -0.41s to 
-0.025s) and 0.00008s (P=0.02, 95CI%-0.0002s to -0.00001s) respectively.  When the 
serum concentration of magnesium increased by 0.1 mmol/l, the QTc interval increases 
by about 0.19s (P=0.041, 95%CI 0.008s to 0.37s). 
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7.5 Discussion 
 
In summary, adrenaline and noradrenalin increases significantly during seizures which is 
still obvious in the 5 minute after the cessation of clinical seizure. The change in serum 
concentration of the electrolytes K, Na, and Ca with a seizure is not significant. However 
serum magnesium is increased with a seizure. When the seizure duration is increased, 
serum potassium and magnesium decreases, and serum sodium increases. There is a 
complex interaction of the catecholamines and the electrolytes with the QTc interval. 
Whereas the overall peri-ictal changes in concentration of serum adrenalin increase the 
QTc interval, at 5 minutes after the seizure, the changes in serum levels of sodium and 
adrenalin act to shorten the QTc interval.  In addition rise in serum potassium, calcium 
and noradrenalin shortens the QTc interval and a rise in serum magnesium acts to 
prolong the QTc interval.  
 
This study describes the elevation of serum catecholamines with seizures in agreement 
with the reports from previous studies (Aminoff et al. 1984; Simon et al. 1984).  Five 
minutes after the cessation of clinical seizure activity, high levels of catecholamines are 
recorded. This shows that massive elevations of catecholamine occur during a seizure. 
Such sudden increases of catecholamines may have; 1) Direct adrenoceptor mediated 
myocardial damage and 2) indirect myocardial dysfunction through the changes in 
electrolyte homeostasis (Shimizu et al. 2008; Whitted et al. 2010).  Increased serum 
adrenaline and noradrenalin such as may occur during epileptic seizures can generate 
hypokalaemia, hypomagnesaemia and hypocalcaemia. In this study, increasing 
hypokalaemia and hypomagnesaemia were observed with increasingly prolonged 
durations of a seizure. This effect may be due to ongoing epinephrine and 
norepinephrine induced intracellular influx of these ions. This is potentially important as 
hypokalaemia and hypomagnesaemia affect ventricular repolarisation by prolonging the 
QT interval. In contrast to other studies, I did not find any changes in serum calcium with 
seizures. Previous studies suggest a dynamic calcium homeostasis with seizures, with 
just before a seizure, hypocalcaemia attributed to hyperventilation related alkalosis and 
as the seizure progresses, the catecholamine surge further compromises the 
hypocalcaemia due to a catecholamine mediated intracellular loading. This study did not 
confirm these findings, although it is possible that with different timings of electrolyte 
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sampling and with a larger number of patients, a change in serum calcium might have 
been observed. However, unaltered calcium has been previously reported in the 
interictal phase in patients with epilepsy (Hamed et al. 2004; Natelson et al. 1979a). The 
finding of unchanged serum levels of sodium but increased sodium levels when the 
seizure is prolonged supports the findings of previous reports (Hamed et al. 2004; 
Natelson et al. 1979a; White et al. 1992). The change in serum magnesium during a 
seizure described in this study supports the work of Natelson (Natelson et al. 1979b). 
However with increased duration of seizures, serum magnesium was observed to fall. 
This may be attributable to elevated catecholamines which cause increased lipolysis and 
increased free fatty acid binding of magnesium together with cyclic AMP mediated 
intracellular loading of magnesium (Whitted et al. 2010). The clinical importance of 
hypomagnesaemia will be the likelihood for prolongation of the QT interval. However in 
this study when I attempted to evaluate the exact effect of serum magnesium on the 
corrected QT, no significant interactions were found.   
 
Ventricular muscle repolarisation measured by the QT interval on the ECG has several 
properties. A change in autonomic tone modifies heart rate and cardiac muscle 
electrolyte handling through both neural and receptor mediated mechanisms. This 
affects the QT interval. In light of this the QT interval is adjusted for changes due to the 
heart rate [corrected QT (QTc)]. Some studies have suggested QTc to be prolonged in 
epilepsy (Neufeld et al. 2009; Surges et al. 2010). In this study also I have described 
increased QTc with epileptic seizures. Prolonged QTc is a risk for fatal cardiac 
arrhythmias and sudden death. The findings of the present study may provide a possible 
mechanism to explain some cases of SUDEP. In addition QTc shortening was also 
observed with increasing serum concentrations of the electrolytes and catecholamines. 
This is likely to be due to the increased heart rate (Neufeld et al. 2009).  Furthermore, 
Bazette’s squareroot formula can lead to signifcant over-correction and under-
correction with small changes in the heart rate. Arguably, it is possible that over-
correction at higher heart rates in the peri-ictal period, produced much less prolonged 
QTc interval. The cardiac Troponin did not change during both seizure types in contrast 
to earlier studies (Hajsadeghi et al. 2009; Woodruff et al. 2003). This may be due to the 
relative young age of the study subjects compared to that in the Woodruff study (2003) 
in which the subjects were elderly epilepsy patients with the additional risk for 
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atherosclerosis and myocardial ischemia. Additionally, multiple seizures and not single 
seizures have been reported to be associated with increased serum Troponin 
(Hajsadeghi et al. 2009) and it is not surprising that single seizures evaluated in this 
study were not associated with Troponin release.  
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Chapter 8 
 
Limitations and Conclusion  
 
8.1 Limitations 
  
The studies described in this thesis have a number of limitations:  
 
The lack of controls i.e. “newly diagnosed epilepsy patients” to match up with the 
chronic epilepsy cohort that this study group offers made it difficult to definitely assign 
the findings of abnormal interictal HRV as a consequence of epilepsy. I recommend any 
future study on the heart rate variability to be evaluated in both newly diagnosed and 
chronic epilepsy which would provide an unbiased relation between epilepsy and 
abnormal heart rate variability, although of course there will be significant practical 
difficulties in recording seizures in a newly diagnosed cohort. Equally the lack of a 
normal control population means that the extent of the abnormalities (for instance 
changes of HRV with prolonged medical history of epilepsy) cannot be easily assessed.  
 
For study chapter 4, the major limitation identified in this study is the biological 
significance of the SDNN derived from the 10 second ECG recording.   Further studies 
could help provide greater understanding into its clinical utility. Nevertheless it was 
useful in evaluating the HRV during epileptic seizures because of the highly variable 
length of seizures and the fact that 10 seconds segments would be generally devoid of 
movement of artefacts. Power spectral analysis on the ictal ECG segments in study 
chapter 5 would have help outline the spectral components of the ECG segment. 
However, this analysis requires the use of a minimum of 2 minutes ECG segments and 
this is practically impossible in seizures. Almost all simultaneous ECG recording during 
seizures have movement artefacts which may render large segments of ECG unusable 
for RR interval analysis. This allows us to revisit the issue of further studies to delineate 
the clinical significance of 10 second segments of ECG in RR interval analysis.  
 
In study chapter 6, I have used 12 hour blocks for the day and night. This may not be 
physiological considering the geographic location of the patients and I cannot rule out 
the effects it could have had on the results.  The patients were either incumbent or 
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supine for most part of the day during data acquisition and I probably measured only the 
resting heart rate and its variability which is controlled by vagal efferent activity. 
However previously published studies have established the HRV is not affected by 
posture (Ewing et al. 1991). But since this is only one report and have not been 
replicated in other studies, the effects of this on the results cannot be entirely overruled. 
I have also utilised multiple recordings per patient over 24 hours and even though a  
robust statistical method that takes into account the correlation between the multiple 
measures per person(Hanley et al. 2003) was used, large sample bias could still have 
been introduced.   
 
In the study chapter 7, electrolytes and catecholamines were determined in the 
immediate postictal period because of ethical and technical constraints. The earliest 
time after the seizure, which was chosen to be 5 minutes in this study could have missed 
transient and crucial changes in the electrolytes during and immediately after the 
seizure. In addition the small data set may have introduced small sample bias in the 
results. Nevertheless significant finding that corroborate earlier reports have been 
amply described and these can serve to direct future studies on this subject. 
 
An experiment to determine whether the changes in skin resistance during a seizure can 
be used as an index of sympathetic function during seizures was started. In all 10 
patients were recruited. Adhesive skin contacts electrodes were placed on the 
hypothenar and dorsal surfaces of the palms on either side after preparing the skin 
surface with commercially available skin prep gel. Two skin resistance channels were 
thus produced and these were connected to the Nicolet one EEG amplifier used for the 
acquisition of electrophysiological data. Different filter settings were applied to these 
channels (LFF=0.5Hz and HFF=5Hz). However, this was abandoned due to limitations in 
the experimental procedure such as;  
• The inability of the electrodes to keep because of sweatiness of palms or the 
movements of the hands during the acquisition of data.  
• Technical and logistic difficulties that demanded the constant electrode 
management. 
• Introduction of EEG artefact in skin channel and multiple deflections of skin 
voltage that were not related to the occurrence of seizures. 
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8.2 Conclusions 
 
The major conclusions that can be drawn from the studies in this thesis are; 
 
1. Subclinical seizures (electrographic seizures without clinical accompaniment) do not 
alter heart rate variability. Subclinical seizures are highly localised and it is possible that 
acute cardiovascular autonomic dysfunction will not occur when the ictal discharges do 
not spread to brain areas controlling autonomic function. This finding is in accord with 
the view that any change in heart rate variability in subclinical seizures most likely 
indicates ictal discharges in the insula and other parts of the central autonomic network 
such as the hypothalamus and the medullary cardiovascular centres.  
 
2. During overt seizures (clinical seizures), the heart rate variability decreases and it is 
seen to return to the pre seizure state within 20 seconds after the cessation of 
electrographic activity.  This sudden and precipitous decrease of the heart rate 
variability reduces the resilience of the heart to respond to rate and rhythm changes. 
This could unmask rhythm and mechanical abnormalities in persons with and without 
latent cardiac disease and sudden death. This is an important finding that could provide 
a possible mechanism for SUDEP.  
 
3. An epileptic seizure irrespective of the hemispheric side and location decreases the 
heart rate variability and increases the mean heart rate. Therefore heart rate variability 
estimated during the ictal period cannot be used to accurately localise and or lateralise 
the epileptic focus in the cerebral cortex during presurgical evaluation. 
 
4. Intractable epilepsy does not disrupt the circadian rhythm of the heart rate variability. 
However, the heart rate variability in epilepsy patients decreases for every year the 
patient has intractable epilepsy which is independent of age related changes in the heart 
rate variability. Depressed heart rate variability is an independent risk factor that can 
help to predict mortality due to cardiac arrhythmia. Therefore, this may mean the 
epilepsy patient is at an increased risk of fatal arrhythmias.  
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5. Epileptic seizures increases serum concentrations of adrenalin, noradrenalin, 
magnesium and the corrected QT interval but have no effects on the serum potassium, 
sodium and calcium. The increased catecholamine and the associated cardiac 
repolarisation abnormalities might be a mechanism for SUDEP.  
 
Other conclusions that can be drawn from this study are: 
 
6. Female patients with epilepsy have lower cardiac sympathetic tone compared to their 
male counterparts in the interictal state.  
 
7. High seizure frequency and antiepileptic polytherapy with carbamazepine based 
regimen may increase the cardiac sympathetic tone.   
 
8. The effects of aging on HRV alone may not be responsible for the decrease in HRV 
associated with prolonged medical history of epilepsy.  
 
9. There is asymmetry of central cardiac autonomic function in the interictal period. 
Right hemispheric lesions increase parasympathetic activity to the heart and left 
hemispheric lesion stimulate cardiac sympathetic activity.  
 
10. Temporal lobe epilepsy is particularly associated with higher cardiac sympathetic 
tone.  
 
11. The age, gender, duration of epileptic seizure, carbamazepine related antiepileptic 
drug polytherapy and the epilepsy duration do not affect the ictal change in HRV. 
 
12. The prolonged seizure duration will not affect the level of catecholamine increase in 
serum but significantly changes the serum electrolyte concentrations.  
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What is the significance of the findings in this study in relation to heart rate variability in 
epilepsy?  Firstly, heart rate variability is substantially affected in intractable epilepsy in 
both the ictal and interictal period. Reduced HRV means an increased cardiac 
sympathetic tone and this implies that in epilepsy there may be an enhanced risk of 
ventricular arrhythmias and sudden cardiac death. Given the prognostic and risk 
predictive power of the HRV on fatal arrhythmias and the fact that people with epilepsy 
have a higher mortality compared to the general population, these findings point to an 
important potential mechanism in the production of SUDEP.  The question now is could 
the HRV in epilepsy patients be modified by the use of cardioprotective measures such 
as beta blocker therapy, antiarrhythmic drugs and exercise training? This has been 
suggested in post myocardial infarction patients who have much reduced HRV. This 
offers a potential opportunity to provide protection against SUDEP.  Secondly, there is 
really no correlation between the HRV and mean heart rate. Very significant HRV 
abnormalities can occur despite relative normal mean heart rates. I suggest therefore 
that methods to evaluate heart rate variability should be incorporated in the clinical care 
of patients with intractable epilepsy. By so doing epilepsy patients at risk of cardiac 
autonomic dysfunction could be identified and treatments provided with the aim to 
improve cardiac autonomic activity.  
 
Finally, the findings emphasise the further benefits of strict control of seizures in 
epilepsy because of the detrimental effects of the significant physiologic changes that 
occur in seizures.  Overall this thesis confirms that epilepsy is associated with altered 
cardiac autonomic dysfunction. A common finding is the reduced heart rate variability 
which is identical to that which occurs in other patient groups at major risk for sudden 
cardiac death. The responsible factors for the reduced HRV include, prolonged medical 
history of epilepsy, the cortical pathology itself, seizures and their frequency and the 
antiepileptic drug treatment. There may be other factors yet to be identified. The 
practical importance of these findings is that they provide a plausible explanation for at 
least some cases of SUDEP, both in ictally-related and also in non ictally-related cases.  
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8.3 Future directions 
 
 Possibilities for future studies of the heart rate variability in epilepsy that arise from this 
work are: 
 
1. Longitudinal HRV studies in newly diagnosed epileptics for prolonged periods of follow 
ups to determine beyond any reasonable doubt the extent to which the reduction in 
HRV is progressive in epilepsy patients. This provides one explanation for the 
observation that the risk of SUDEP is greater the more prolonged is the history of 
epilepsy. Any such study should include the carbamazepine vs. non carbamazepine 
treated groups and the seizure frequency per year.  
 
2. Longitudinal controlled experiment in intractable epilepsy patients in which the effect 
of specific interventions designed to modify HRV will be studied. The experimental group 
will have HRV modification interventions and the effects should be compared to a 
control group in whom no interventions were carried out. Changes in HRV (and SUDEP 
rates if this is possible to ascertain) should be compared in both groups, at specified 
follow-up intervals.  
 
3. Further detailed electrolyte studies in both clinical and experimental epilepsy. This 
should detail the sampling of blood for analysis closer to the offset of seizures and if 
possibly during the seizure in the case of experimental epilepsy. Serum changes with 
multiple seizures should be compared and this could help unravel changes in the plasma 
electrolytes during seizures. 
 
4. Longitudinal studies on the measurement of QTc interval before and immediately 
after epileptic seizures will help confirm whether QTc prolongation become evident 
after epileptic seizures. 
 
5. Study/studies that will develop a more robust method for evaluating the skin 
resistance during seizures may help to evaluate sympathetic activity during seizures. 
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6. Direct studies of SUDEP- Large scale studies in patients who have subsequently died in 
SUDEP such as the MORTEMUS should incorporate evaluation of the HRV in the study 
design because the association of reduced HRV in epileptic patient’s could have very 
important implications for SUDEP. 
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Appendices 
 
Appendix 1.1  
 
Copy of Consent form 
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Appendix 1.2  
 
Copy of Patient information sheet 
 
 
  
 
Patient information sheet used for the recruitment; this provided a brief information on 
the project 
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Patient information sheet continued. 
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Appendix 1.3  
 
Individual HRV plots  during subclincal seizures (chapter 4) 
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Individual mean heart rate plots  over time during subclincal seizures 
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Appendix 1.4  
 
Individual HRV plots during clinical seizures (Chapter 5) 
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Individual mean heart rate plots during clinical seizures (Chapter 5) 
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Appendix 1.5  
 
Skewness of HRV data in chapter 6 
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All data are normally distributed except the LF/HF ratio which was logarithmically transformed before 
fitting into the statistical model. [Stata command qnorm (var)] 
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Appendix 1.6  
 
24 hour profile plots of RMSSD in each patient  
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24 hour profile plots of sdnn in each patient  
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24 hour profile plots of mean heart rates  in each patient  
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24 hour profile plots of Log LF/HF ratio in each patient  
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All the graphs beginning from left to right, starts from 8am to 7am  
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